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Abstract 
Identification and Characterization of Novel Mutants of Campylobacter jejuni 
Jeffrey Paul Holt 
Jennifer J. Quinlan, Ph.D. 
 
 
 
Campylobacter jejuni is one of the most prevalent diarrheal diseases worldwide, having a 
major effect on human health both in developed and developing countries.  While it can 
be difficult to grow and manipulate in the lab, it remains persistent in our food supply.  
Mechanisms of virulence in humans have begun to be elucidated with the help of 
completed genome sequences and development of molecular research tools.  Despite this, 
knowledge of C. jejuni genetics and virulence still trails behind many other intracellular 
pathogens.  In the work presented here a signature tagged mutagenesis system previously 
created for C. jejuni was implemented and a quantitative real-time PCR based system for 
detection of the mutagenesis system was developed.  The mutagenesis system was then 
used to identify two novel characteristics of C. jejuni.  First, a novel red growth 
phenotype was identified in C. jejuni which responded to adenine supplementation the 
same as red yeast mutants and was always associated with a decrease in virulence. 
Second, a major restriction barrier in C. jejuni strain NCTC11168 was identified.  We 
identified one gene, cj1051c, which when knocked out allowed a 1000-fold increase in 
transformation efficiency with plasmid purified from a C. jejuni host, as well as permitted 
transformation with plasmid purified from an E. coli host.  In this work we implemented 
an existing signature tagged mutagenesis system and constructed a novel detection 
system allowing the quantification of many random mutants in a single screen.  This 
system was then used to identify two novel characteristics of C. jejuni providing an 
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increased knowledge of C. jejuni physiology and virulence as well as potential tools for 
future research.  
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Chapter 1: Introduction 
 
Campylobacter jejuni 
Background.  Campylobacter jejuni is a Gram-negative motile bacterium with 
characteristic polar flagella and corkscrew cell morphology.  It is an enteric intracellular 
human pathogen, efficiently infecting the gut with a low infectious dose [1].  
Campylobacter has only been recently studied as it was not recognized as a human 
pathogen until its routine culture in the 1970’s [2, 3].  Campylobacters were probably 
visually noticed first back in 1886 by Theodor Escherich in the colonic mucus of sick 
infants, but ignored due to the inability to be cultured [3].  Campylobacter was not 
successfully cultured until 1909 [3] and C. jejuni until 1931 [3, 4].  The involvement of 
C. jejuni in human disease was not recognized until 1957 [3].  This contrasts with 
Salmonella and E. coli which have been grown and studied as causes of human diseases 
since the late 1800’s.  The microaerophillic nature of C. jejuni and its sensitivity to other 
conditions may be the reason for this approximate 100 year lag.  It requires oxygen for 
growth, but can only tolerate it at low levels [3].  Routine culture requires a 
microaerophillic environment, traditionally 5% oxygen, 10% carbon dioxide, and 85% 
nitrogen.  Culture cannot be achieved in an aerobic environment which is approximately 
21% oxygen, 0.03% carbon dioxide and 78% nitrogen.  C. jejuni is also notorious for 
sensitivity in culture to desiccation, extreme pHs, and high cell densities [2, 3, 5, 6].  The 
genus Campylobacter (Greek for curved rod) was created in 1963 to distinguish its 
members from their original classification under the genus Vibrio [3, 7].  The genus 
comprises 11 species, notably C. jejuni, C. coli, and C. lari with C. jejuni divided into 
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subspecies jejuni and doylei [3].  The use of “C. jejuni”  here will be as it is commonly 
used referring to the Campylobacter considered to be of most concern for human 
infection: Campylobacter jejuni subsp jejuni [3, 7].  However, C. coli is sometimes 
grouped with C. jejuni since it is believed these organisms are re-converging due to 
overlapping niches within current agriculture practices, accelerated by frequent genetic 
exchange [3, 8]. 
Infection.  C. jejuni infections are a major cause of diarrheal disease worldwide.  They 
are the leading cause of foodborne illness in the UK [9, 10] and trail only Salmonella in 
bacterial foodborne illness in the US [11].  Infections are likely due to cross 
contamination during food preparation as much as improper cooking since C. jejuni cross 
contaminates at significant levels when contaminated meat is not handled properly [12], 
and consumers admit to improper kitchen sanitization practices during food preparation 
[13-19].  Additionally C. jejuni cross contaminates even when proper techniques are 
followed [12] and several different bacteria [20-22] including C. jejuni [21] survive and 
persist through hot water/soap washing.  This persistence by C. jejuni is not universal.  
Older studies [23, 24] had found thorough washing to be sufficient to remove C. jejuni 
from surfaces, however there have been advances in C. jejuni enrichment procedures 
since these original studies which could account for this difference in findings.  Newer 
studies may have been able to recover C. jejuni with greater sensitivity and therefore find 
recoverable isolates after washing. 
Acute Disease.  Sickness from C. jejuni  infections (campylobacteriosis) can occur 2 to 5 
days after exposure resulting in watery or sticky diarrhea, occasionally progressing to 
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bloody diarrhea spanning up to a week usually associated with severe cramping and fever 
[2, 5, 7, 25-29].  The infection is usually self limiting without antibiotic treatment [2, 5, 
26, 29].  However, some people are asymptomatic during infection [5, 28] which may 
allow opportunity for several secondary conditions associated with C. jejuni to manifest.  
Progression of the infection to the blood stream is rare [7, 26, 28, 29], usually in persons 
with compromised immune systems [5, 29] or the very young and old [7, 29, 30].  Death 
is rare [26, 31], an estimated 100 people per year die from C. jejuni infections [5].  
Infection incidence, but not disease, appears to be dose dependant [28] which may be 
attributable to variation in individual host responses to C. jejuni.  Although 
Campylobacter induced abortions in sheep are common [3], it is not common in humans 
[27, 32, 33], but there have been reported cases [27, 34, 35].  In developing countries, 
clinical manifestations are different than those observed in developed countries.  Adults 
rarely show symptoms and act as carriers in developing countries, whereas symptomatic 
infections commonly occur in infants and is considered ubiquitous in children under 2 
years old resulting in a higher mortality rate [29].   
Sequelae.  C. jejuni infection is thought to be a causative agent of the neuropathy disease 
Guillain-Barré Syndrome (GBS) [7].  GBS is an autoimmune-mediated disease leading to 
neuropathy of the peripheral nervous system believed to be induced by molecular 
mimicry of neural outer peptides by C. jejuni [7, 36].  It commonly causes rapid 
weakness of the limbs and respiratory muscles but is normally self limiting with full 
recovery common over the course of weeks to months [7].  Whereas some paitents 
require breathing aids during recovery [29, 37], and can have severe permanent 
neurological effects [29], but mortality is low [37].  Immunoproliferative Small Intestinal 
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disease (IPSID) (aka Alpha Chain disease) is associated with Campylobacter infections 
[38, 39].  IPSID is a mucosa-associated lymphoma which results in plasma cells 
infiltrating the intestinal wall and secreting incomplete antibodies carrying only the heavy 
chain [40-42].  Since antibiotic treatment is effective against this disease, and a similar 
condition is due to H. pylori infections [41-43], it was presumed due to a bacterial 
infection before a causative agent was able to be isolated.  A subsequent study found C. 
jejuni to be the only pathogen associated with IPSID [38] which was followed up by a 
second case [39].  C. jejuni may initiate this disease through DNA damage caused by 
toxin secretion along with extended stimulation of the immune system from a chronic 
infection [38].   
Persistence in Food Products.  C. jejuni contamination is common on chicken in 
grocery stores [44, 45], even on the outside of packages [46], as it is a commensal in 
birds [3, 5] allowing it to quickly spread unnoticed through a flock [47] potentially 
accelerated by flies [48].  High throughput carcass processing exaggerates the problem by 
spreading contamination between birds.  Chicken ‘liquor’, the juices evacuated from 
thawed chicken carcasses, has been found to be an efficient protectant for C. jejuni [24].  
Chicken carcasses have as high as 5 logs of C. jejuni per bird with prevelances of 77% to 
94% of carcasses contaminated [44, 45, 49].  There are other less common sources of C. 
jejuni infection as well.  C. jejuni infection can occur from unpasteurized milk [50, 51] 
with an infectious dose as low as 500 organisms [1] and possibly from unchlorinated 
water [52-54].  Cows may also be an important stable reservoir [55].  Dogs and cats can 
become infected by C. jejuni and transmit the infection to humans [25, 26, 56, 57] but 
human to human transmission is rare [3, 58].  Survival in water may be due to invasion 
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and survival of C. jejuni within protozoa [59].  This persistence in the environment by 
intracellular invasion of protozoa may also allow for evasion from disinfection [60] 
allowing transmission to chickens by contaminated water [61]. 
Unique Characteristics.  Other enteric intracellular pathogens have a repertoire of 
specialized virulence factors.  With a genome almost a third the size of these (~1.7 Mbps 
vs ~5.0 Mbps), C. jejuni may have different, possibly multi-functional, proteins for 
invasion.  For instance, intracellular bacterial pathogens commonly have specialized 
Type III Secretion Systems for injecting epithelial cells with invasion factors [62].  C. 
jejuni does not appear to have a Type III Secretion System and appears to use its 
flagellum for injection of invasion factors [63, 64].  Additionally during cell invasion, the 
internalization of C. jejuni is mediated by host cell microtubule rearrangement instead of 
the commonly used microfilament rearrangement induced by other pathogens [62, 65].  
After internalization C. jejuni does not induce apoptosis, instead it kills host cells by 
oncosis [66].  Oncosis was originally termed for ‘accidental cell death’ by cell swelling 
due to defects in ion pumps, compared to apoptosis which is a highly regulated event and 
leads to cell shrinkage and death [67].  C. jejuni can perform both O-linked and N-linked 
glycosylation of its proteins.  While O-linked capability by itself is fairly common, N-
linked in prokaryotes is very rare and C. jejuni was the first found to have that capability 
[68-70].  Other notable features of the genome are a low GC percentage (31%), genes 
with related functions are generally not clustered together in operons, a lack of common 
DNA repair functions such as mismatch repair and SOS response, low numbers of sigma 
factors (three predicted), and an abundance of homopolymeric tracts which are expected 
to be susceptible to phase variation by slipped strand mispairing [64]. 
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Phase Variation 
Phase variation allows high frequency on-off switching of gene activity.  Classically 
associated with antigenic surface structures, it allows for rapid change to evade host 
immune responses that is hereditable but reversible [71].  One particular type of phase 
variation, slipped strand mispairing, can be due to several types of DNA sequence repeats 
including homopolymeric repeats (a tract of the same base repeated).  Abundance of this 
type of repeat was one of the notable characteristics of C. jejuni after the first genomic 
sequence was completed [64].  Phase variation from slipped strand mispairing results 
from an insertion or deletion in long stretches of a repeated nucleotide, or repeats of 
simple sequences, either within the ORF of a gene or within its promoter [71, 72].  For 
homopolymeric repeats, a single insertion or deletion within the repeat region causes a 
frameshift turning ‘off’ the gene through mutation or early termination.  Likewise this 
gene can be turned back ‘on’ through insertions or deletions anywhere within the tract to 
re-establish the reading frame.  This on-off switching rate is directly related to repeat 
length [73], and can be up to a million times more frequent than inactivation by point 
mutations [72] giving a bacterial population much more plasticity. 
 
Mechanisms of Bacterial Pathogenicity 
Strategies and Mechanisms of Cell Invasion.  Pathogens utilize different methods for 
the various steps of the invasion process, however many of them use similar overall 
strategies.  Some of the major steps of the invasion process include 1) modulation of 
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motility, 2) cell invasion by the Zipper or Trigger mechanism, 3) intracellular survival in 
a vacuole or throughout the cytosol, and 4) methods for inducing host cell death. 
Motility.  Different motility based strategies have arisen in pathogenic bacteria.  Some 
use temperature shifts when entering a host to turn off motility machinery such as 
observed in Yersinia and Listeria [74, 75].  Salmonella also shuts off its motility as a 
necessary step for virulence [76], however the structural form of the flagellum may still 
be used for attachment [77, 78].  Other pathogens, such as Helicobacter and Legionella, 
require a fully functioning motility system for invasion but not attachment [79-81].  C. 
jejuni also needs a fully functioning motility system for invasion as it uses it for 
attachment and invasion factor secretion [47, 63]. 
Zipper Mechanism Of Invasion.  Both Yersinia and Listeria use this method of entry into 
non-phagocytotic cells.  This system works by expression of an invasin protein(s) on the 
outside of the bacterium that binds and stimulates a receptor on the outside of the host 
cell.  This stimulation initiates a signal cascade resulting in the phagocytic cup formation 
around the bacterium followed by entry into the cell as a vacuole.  This last step relies on 
actin polymerization for membrane extension followed by depolymerization for 
retraction into the cell.  [82-84]  While C. jejuni does not utilize actin re-arrangement 
during invasion, it is not clear if it uses Zipper, Trigger, or some other strategy of 
invasion [62, 65]. 
Trigger Mechanism of Invasion.  Shigella and Salmonella utilize this invasion strategy 
for cell invasion.  In this system, a Type III Secretion System (T3SS) is used to inject 
factors into the target host cell.  These factors mediate actin rearrangement resulting in a 
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ruffled appearance of the cell membrane around the invading bacterium followed by 
engulfment and endocytosis [85-88].  C. jejuni invasion resembles a T3SS based 
invasion, however uses a modified flagellum in place of a T3SS [47, 63].  Not all reports 
support this type of invasion [89] and it may be mediated by activation of host G-protein 
coupled receptors [90].  Additionally, C. jejuni does not use actin rearrangement, instead 
the invasion relies on microtubule polymerization [62, 65].   
Vacuole Intracellular Strategy.  Salmonella is a well characterized example of 
intracellular survival and replication within vacuoles [87].  Following invasion, 
Salmonella-containing vacuoles break off from the normal phagocytic pathways, never 
entering the late lysosomal stage [91], by attracting several cellular signal molecules to 
the vacuole [92].  The vacuoles then become associated with and engulfed by the Golgi 
network [93].  Each of these steps is induced by different specialized factors secreted by 
Salmonella.  C. jejuni seems to invade within vacuoles [94] that also escape the late 
lysosomal stage and associate with the Golgi followed by escape from the vacuole and 
dispersement throughout the cytosol [95]. 
Cytosol Intracellular Strategy.   Other pathogens (i.e. Listeria) have the ability to escape 
from the vacuole following internalization into the cytosol of the host cell to survive, 
move, and replicate.  Lysis of the vacuole is performed by a specific pore forming lysin 
factor allowing Listeria to escape into the cytosol [96].  Once in the cytosol Listeria can 
then replicate and move about the cell by induction of actin polymerization [97-99].  This 
actin based movement allows association of the Listeria to the sides of the cells where 
protrusions are formed leading the transfer of the bacteria from its original host cell to a 
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neighbor cell where the same lysin as above allows escape from the now double 
membrane bound vacuole [98, 100].  Shigella also has a lysin similar in function to 
Listeria’s [101].  It also has factors to regulate actin based motility within the cytosol but 
appear to function differently than Listeria’s [102, 103].  C. jejuni has been observed in 
the cytosol eventually, whether it follows this strategy though is unclear [95].   
Host Cell Death.  Some pathogens, such as Shigella and Salmonella, kill their host cells 
by inducing apoptosis through excretion of factors activating pro-apoptosis signaling 
cascades [104, 105].  Yersinia induces host cell death by secreting a factor which binds to 
MAPK kinase preventing its normal functionality in activating the anti-apoptosis 
regulator NFkB, ultimately resulting in the induction of apoptosis.  Other methods exist 
for inducing apoptosis as well, such as Neisseria factors leading to an influx of Ca
2+
 
which activates caspases leading to induction of apoptosis [106].  C. jejuni does not 
appear to induce apoptosis, instead it kills host cells by oncosis [66].  Oncosis was 
originally termed for ‘accidental cell death’ by cell swelling due to defects in ion pumps, 
compared to apoptosis which is a highly regulated event and leads to cell shrinkage [67].   
There are various strategies employed by intracellular pathogens to gain access to cells 
and survive within them.  Most of these bacterial processes are highly regulated events 
with specialized factors for invasion.  Research in C. jejuni genomics and virulence have 
begun to identify some factors in this process [63, 107-109], however little is known 
comparatively and even a large scale mutant screen failed to identify specialized 
virulence factors [110].  While this suggests C. jejuni may be more opportunistic in its 
pathogenicity compared to some of the organisms described above, the current level of 
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knowledge in this area is not sufficient to conclude this.  Therefore continued work is 
needed in order to identify classical and non-classical factors C. jejuni utilizes in causing 
disease in humans. 
Identification of Virulence Factors.  Methods of random mutagenesis in many types of 
bacteria are commonly based on a transposon system.  In this type of system, a 
transposable element containing a resistance marker flanked by inverted terminal repeats 
is randomly integrated into target DNA by transposase activity.  Selection for the marker 
allows for selection of mutants with transposon integrations.  This is done such that a 
pool of bacteria is created, each with a different random mutation potentially covering all 
non-essential genes.  This pool of bacteria can then be screened for mutants of interest.  
The location of the insertion can be determined by sequencing out from the known 
sequence in the transposon.  A transposon based mutagenesis system for C. jejuni has 
been successfully developed [111] but has limited application for virulence screening 
since thousands of mutants would need to be screened individually.   
Signature tagged mutagenesis (STM) was developed to address this issue [112].  In this 
system unique sequences of DNA, or tags, are added to the transposable element, such 
that pools of random mutants are made, each with its own unique tag.  Now a single 
screen can be used on a pool of different random mutants with detection of the tags 
before and after to identify which mutants did not make it through the screen and are 
therefore of interest.  Grant et al [113] developed a C. jejuni STM system containing 78 
unique tags which was successfully used on two common laboratory strains 81-176 and 
NCTC11168.  This is the system which is employed throughout this work. 
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Red Phenotype of Yeast 
In mutagenesis studies of yeast, a red growth phenotype was identified over sixty years 
ago which was subsequently identified as a buildup of a metabolism intermediate AIR (1-
(5'-Phosphoribosyl)-5-aminoimidazole).  This is the result of mutations in ade1 and ade2 
genes downstream in its metabolism which degrades and accumulates as a red pigment 
(see Appendix 6) [114, 115].  AIR is part of the purine synthesis pathway generating 
ATP and GTP for DNA and RNA synthesis.  Adenine supplementation of yeast growth 
media downregulates this pathway, as the adenine can be converted to ATP and 
biosynthesis is not needed.  However, this can be toxic in some bacteria as the adenine in 
some cases cannot be converted to GTP, leaving the cell with depleted GTP stocks [116].  
In yeast, adenine supplementation is not toxic but does lead to the downregulation of the 
purine synthesis pathway preventing red pigment production in otherwise red yeast 
mutants at 1.0 mM of adenine, but not at 0.1 mM [117].  This prevention of pigment 
production is due to the downregulation of the pathway containing AIR synthesis, 
therefore AIR is not produced in sufficient quantities to produce a visible pigment.  For 
the same reason, when mutations are made before AIR synthesis in the pathway, AIR 
again does not build up and pigment production is prevented in otherwise red strains 
[118].  Consistent with a buildup of a metabolic intermediate, the red pigment production 
in ade1/2 mutants is accumulated over time and is effected by growth rate [117].  Growth 
rate is likely important as it is an indicator of cell health, and a cell which is poorly 
growing likely has a lower metabolic throughput occurring, and therefore would take 
longer to build up an intermediate.  The purified red pigment from ade1/2 mutants of 
yeast has absorbance spectrum peaks at 490 nm and 540 nm [114] and inhibits restriction 
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endonuclease activity [119].  This phenotype in yeast, along with the identified ade1/2 
mutations causing it, has been extensively used as a genetic tool [120-133].  The purine 
biosynthesis pathway is predicted to be present in C. jejuni with ade1 and ade2 
functionally equivalent to cj0512 and cj0702 respectively.  However there is little 
sequence homology between the yeast and C. jejuni genes. 
 
 
Restriction Modification Systems 
Restriction Modification (R-M) systems are widely found across many different phyla of 
bacteria with diversity in both their specificity and strategy.  A database for information 
of all known systems, REBASE, currently has almost 50,000 entries [134].  R-M systems 
were originally identified in the 1950’s from findings that bacteriophage DNA would 
become imprinted by the bacterial host it was propogated in and this would ‘restrict’ the 
strains of bacteria that the virus could infect [135].  Likewise, propogation in a different 
host permitted a different range of hosts the virus could infect [136].  This imprinting was 
found to be methylation of the DNA, by DNA methyltransferase activity, protecting it 
from endonuclease degradation.  At specific recognition sites genomic DNA is protected 
after replication by methylation of the unmethylated strand.  But foreign DNA, such as 
from a bacteriophage, without either strand methylated is subject to digestion [137].   
R-M System Types.  Four main types exist for classifying R-M systems, as well as 
several subtype designations [138].  A Type I R-M system generally consists of three 
genes designated hsdR, hsdM, and hsdS which have restriction, modification, and 
specificity functions respectively.  Specificity subunits bind to target DNA sequences and 
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are responsible for determining the target sequence.  Modification subunits bind to 
specificity subunits and methylate target DNA sites if only one strand is methylated (ie: 
following genome replication).  If neither strand is methylated, the restriction subunit 
binds to the modification-specificity complex resulting in cleavage of the bound DNA 
strand.  This protein complex generally forms as a 2:2:1 ratio of HsdR, HsdM, and HsdS 
subunits although the restriction subunits tend to bind less strongly allowing methylation 
to occur preferentially over restriction [139, 140].  The actual cleavage site that occurs is 
not consistent, and is at some variable distance from the recognition site [140, 141].  
Type II R-M systems generally consist of two genes, a methyltransferase (MTase) and a 
restriction endonuclease (REase) which usually act independently of each other [138, 
141].  Since the Type II REase enzymes cleave their target DNA at specific positions, 
they have been extensively used in molecular biology techniques.  Thousands of these 
have been characterized and broken down into further subtypes based on cleavage 
characteristics and physiological requirements [138].  Type III R-M systems also consist 
of two genes, res and mod, with restriction and methyltransferase (modification) 
activities respectively [138].  The Mod protein can methylate DNA independently, 
whereas the Res protein requires complexing with the Mod protein as a likely 2:2 
complex for restriction activity [139].  This system is unique in that the specificity sites 
are only methylated on one strand of a given target sequence, however a specificity site is 
required on both strands in opposite orientations, thereby still requiring one strand to be 
methylated to prevent Res acitivity [141].  Type IV R-M systems are a less well studied 
type covering those which only cleave fully modified targets [138].  These are varied, but 
the characterized McrBC system in E. coli contains two genes mcrB and mcrC which are 
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processed into three proteins.  McrC does not bind DNA but is a co-factor for restriction 
activity.  Gene mcrB produces two proteins McrBL and McrBS.  McrBL binds to the DNA 
and determines the specificity and, along with McrC, is able to cut the DNA with the 
McrBS influencing the complex and activity of the other two [139]. 
Restriction Barriers.  Bacteria can have multiple active R-M systems present and these 
can be active against not only bacteriophage DNA, but any DNA including plasmids.  
This activity against plasmids can result in decreased or complete inhibition of plasmid 
transformation into these strains called a restriction barrier.  These systems can therefore 
create a restriction barrier to plasmid transformation between species or even between 
strains of the same species by one or several of the systems present [142, 143].  This can 
complicate molecular biology work in these strains so researchers have found ways 
around this by deletion of R-M systems in target strains [144-147], in vivo methylation of 
plasmids [148-154], modification of plasmids to remove recognition sites [151], or 
finding plasmids naturally without recognition sites [155]. 
R-M Systems in C. jejuni.  Some characterization of R-M systems in C. jejuni has been 
done; cj0031 (Type IIG) is subject to phase variation [156], cj1461 has dam-like activity 
[157], and the Type I system of strain NCTC11168 (cj1549c, cj1551c, cj1553c) has been 
analyzed against other common strains and has a similar grouping to RM1849 and 81-
176 but not 81116, as well as being subject to phase variation [158].  Other cases of 
phase variation in R-M systems have been found which may be useful in maintaining a 
diverse population as well as finding balance between susceptibility to bacteriophage 
predation and uptake of DNA from the environment [159].  Phase variation has been 
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found in a Type I hsdS subunit in Neisseria gonorrhoeae [160] and in a Type II MTase 
component of Helicobacter pylori [161].  Several methyltransferases of Type III R-M 
systems have been identified to be susceptible to slipped strand phase variation across 
diverse species including: Haemophilus influenzae [73], N. gonorrhoeae [162], H. pylori 
[163], and Mycoplasma hypopneumoniae [164].  As these enzymes can effect gene 
expression, this may be a strategy to variably, but reversibly, modulate expression for 
multiple genes maintaing a diverse or quickly adaptable population [159, 165].  
  
16 
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Abstract 
Campylobacter jejuni is an important diarrheal pathogen worldwide, is the leading 
foodborne illness in the UK, and is one of the leading causes in the US.  While C. jejuni 
research is trailing other enteric pathogens, recently developed genetic tools and 
completed genomic sequences are facilitating genetics research in this important 
pathogen.  The signature tagged mutagenesis system previously developed for C. jejuni 
was independently implemented and validated.  A PCR-based detection system for 72 of 
the STM tags was developed along with tagged positive and negative control strains to 
allow quantification of mutants through a screen.  A cell invasion screen was used here 
demonstrating the use of the PCR detection system and control strains on C. jejuni 
mutants.  An interaction with pUC19 and an unknown locus in C. jejuni strain 
NCTC11168 was identified.  Continued research on the genetics of human pathogens will 
increasingly allow a better understanding how they cause disease and how to manage 
them.  C. jejuni is an important human pathogen but our knowledge of its virulence 
determinants and genetics trails behind many other pathogens.  This work improves on a 
method of detection for a powerful genetic screen.  Additionally we provide evidence of 
a novel interaction between pUC19 and an unknown locus in C. jejuni strain 
NCTC11168. 
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Introduction 
Campylobacter jejuni is an important human pathogen worldwide as a leading cause of 
diarrheal illness [9-11] as well as causing sequelae such as the autoimmune neuropathy 
Guillain-Barré Syndrome [7].  It was more recently identified as a human pathogen 
compared to other enteric pathogens, can be difficult to work with in the laboratory, and 
has several unique features with respect to cellular invasion and genomic characteristics 
[3].  This has resulted in knowledge regarding C. jejuni pathogenicity and genomics 
trailing behind other enteric pathogens.  Recently, published genomic sequences and 
development of molecular tools for C. jejuni have facilitated a greater understanding of 
this important human pathogen.   
Transposon mutagenesis is an important tool in the study of bacterial genetics allowing 
the creation of bacterial mutants by insertion of a transposon containing a selection 
marker randomly into the genome.  This is a powerful method that when working at high 
efficiency can disrupt all non-essential genes in a genome allowing for a full genome 
screen for a particular phenotype of interest.  These systems have been developed for 
many species of bacteria [166-170] including C. jejuni [111].  Transposon mutagenesis 
works especially well for positive screens, where the mutants of interest can be easily 
selected.  However, for screens of virulence determinants the interest is in those mutants 
that, for instance, do not invade host cells.  Thus, a negative screen is required to find 
those mutants not represented in the collected internalized bacteria.  Signature-tagged 
mutagenesis (STM) was developed as a way to quantify individual mutants in a mixed 
pool [112], thus allowing mutants that do not survive the screen to be identified.  This is 
accomplished by inserting uniquely identifiable sequences, or tags, into the transposon 
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sequence.  Pools of mutants can then be created and screened, with each individual 
mutant tracked by a unique tag.  Two STM systems for C. jejuni were developed and 
used to screen for factors involved in chicken colonization [113, 171] as well as for cell 
invasion [110].  
The work presented here uses a C. jejuni STM system [113] and independently validates 
it with an easier to purify transposase.  Additionally a PCR-based detection system, 
coupled with tagged control strains, was developed to allow quantitative tracking of 
individual mutant strains in a pool of random mutants through a particular screen.  In this 
case we used a cell invasion screen for virulence as an example.  The tags used in this 
system are derived from the original STM system [112] and are further sequenced for 
their reliable use in the PCR detection system developed here and any other system which 
may be developed in the future.  Overall, this work provides a platform for enhanced 
studies of this important human pathogen. 
 
Methods 
Culture Conditions.  Campylobacter jejuni strain NCTC11168 was obtained from the 
ATCC (Manassas, VA) and routinely grown on Mueller Hinton (MH) Agar with 5 µg/ml 
trimethoprim (TrM) and supplemented with 20 µg/ml chloramphenicol (Cm), 2 µg/ml 
tetracycline (Tet), 50 μg/ml kanamycin (Kan), and 5% horse blood where appropriate.  
All C. jejuni cultures were grown in a Binder (Bohemia, NY) CB150 incubator set to 
37°C, 5% O2, 10% CO2, and 85% N2.  E. coli strain DH5α was obtained from The E. 
coli Genetic Stock Center (New Haven, CT), grown on LB agar aerobically at 37°C with 
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appropriate antibiotics as above.  Bacterial strains used in this study are listed in Table 1 
and plasmids in Table 2. 
 
 
Table 1: Bacterial Strains Used in Chapter 2 
Strain Description Source 
E. coli 
  
    DH5α Plasmid host 
 
    BW25141 Plasmid rescue host [172] 
    BL21(DE3)/pLysS Transposase expression host Promega 
C. jejuni 
  
   NCTC11168 Wild type C. jejuni strain  [173, 174] 
   NCTC11168∆flgK 
Known non-motile and invasion 
deficient strain 
[47] 
   NCTC11168∆cj0046::Tn 
Positive Control Strain  - Tagged 
wild type strain 
This work 
   NCTC11168∆flgK               
∆cj0046::Tn 
Negative Control Strain – Tagged 
withDeficiency for Cell Invasion 
and Motility 
This work 
   NCTC11168 
Δcj0046::CAT+Tag1 
Alternative cj0046 mutagenesis This work 
   NCTC11168Δcj1365c cj1365c knock out mutant This work 
   NCTC11168 
Δcj0046::Tn_pUC19- 
Positive Control Stain, pUC19-
free 
This work 
   NCTC11168 ∆flgK    
∆cj0046::Tn_pUC19- 
Negative Control Strain, pUC19-
free 
This work 
   NCTC11168 
Δcj1365c_pUC19- 
cj1365c knock out mutant, 
pUC19-free 
This work 
   NCTC11168∆cj0390 cj0390 knock out mutant This work 
   NCTC11168 
∆cj0390_pUC19- 
cj0390 knock out mutant, pUC19-
free 
This work 
   NCTC11168∆cj0390-/+ cj0390 complementation strain This work 
   NCTC11168  
      ∆cj0390-/+_pUC19- 
cj0390 complementation strain, 
pUC19-free 
This work 
   TxMy 
Random mutant with Tag# x and 
serial# y 
This work 
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Table 2: Plasmids Used in Chapter 2 
Strain Description Source 
   pUC19 E. coli cloning plasmid [175] 
   pMALC9 Transposase expression plasmid [176] 
   pAJG40 - 134 Transposon source plasmids [113] 
   pRY112 CAT cassette source [177] 
   pJH19 pUC19 + cj0046 This work 
   pJH20 pJH19 + CAT + Tag#1 This work 
   pJH22 pJH19 + Transposon with Tag#1 This work 
   pJH23 pJH19 + Transposon with Tag#3 This work 
   pJH25 pUC19 + cj0390 knock out construct This work 
   pJH26 cj0390 expression plasmid This work 
   pJH27 
cj0390 expression construct within 
cj0046 
This work 
   pJH28 pUC19 + cj1365c knock out construct This work 
 
 
 
Generation of Random Mutants.  Mutagenesis was performed similar to previous work 
[113, 176] by in vitro transposition followed by transformation and insertion into the 
chromosome by homologous recombination.  Transposase C9 [178], a hyperactive 
mutant of Himar1, was purified as previously described as a maltose binding fusion 
protein expressed off of pMALC9 [176] but in BL21(DE3)/pLysS (Promgea, Madison, 
Wisconsin) with freeze thaw lysis.  Tagged transposons were previously developed and 
maintained on plasmids pAJG40 through pAJG134, each containing a unique tag 
sequence [113].    Briefly, 2 μg of NCTC11168 genomic DNA, 1 μg of one of pAJG40 – 
pAJG134 transposon source plasmids, and 150 ng transposase were combined in buffer 
[176] at 30°C for 6 hours.  Transposed DNA was then purified on a column (Qiagen, 
Valencia, CA) and repaired.  To repair the DNA 1.5 U of T4 DNA polymerase, NEB 
Buffer #2, and 25 μM of each dNTP were added and incubated for 20 minutes at 37°C 
followed by inactivation at 75°C for 10 minutes.  The reaction was then treated with 10 U 
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ligase overnight in 1x ligase buffer, and column purified (Qiagen, Valencia, CA).  
Repaired mutated DNA was used to naturally transform NCTC11168, see below.  Mutant 
colonies were picked after 3 days incubation on MH+TrM+Cm+5% blood plates. 
Natural Transformation of Campylobacter.  Natural transformation of C. jejuni was 
performed similar as before [113, 179].  Bacteria from a lawn of overnight growth on 
MH+TrM were harvested in 1 ml MH broth and pipetted on a MH+TrM plate and 
incubated upright at 37°C microaerophillically for 3 hours.  Purified DNA was then 
mixed into the bacteria and the plate incubated for an additional 4 hours.  Bacteria were 
harvested by scraping into 1 ml MH broth, diluted 1:10 or 1:100 when anticipated to be 
necessary, and plated to selective media. 
Electroporation of Campylobacter.  Production of electrocompetent C. jejuni strains 
and electroporation were performed as before [179].  Bacteria from a lawn of overnight 
growth on five MH+TrM were harvested into 10 ml MH broth, pelleted at 3000g for 20 
minutes at 4°C and resuspended in 5 ml ice cold wash buffer (272 mM sucrose, 15% 
glycerol).    This wash step was repeated three more times, and finally resuspended in 1 
ml ice cold wash buffer.  Cells were aliquoted in 100 µl and stored in -80°C until needed.  
To each 100 µl electrocompetent cell aliquot thawed on ice, approximately 5 µg DNA 
was added, gently mixed, and added to a 0.2 cm cuvette on ice.  Electroporation was 
performed with a BioRad MicroPulser (1 pulse of 2.5 kV, 600 ohm, 10 µF) and the 
electroporated cells transferred to 200 µl SOC, mixed, and spread on MH+TrM plates.  
Plates were incubated upright for 5 hours, bacteria harvested into 1 ml MH broth, spun 
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10000 g for 2 minutes, resuspended in 100 µl MH broth and plated to selective media.  
Negative controls (no DNA) were performed in parallel. 
Mutant Verification.  The location of the transposon insertion in mutant strains was 
determined by plasmid rescue.  Mutant genomic DNA (1 µg) was digested overnight with 
SspI.  Digestions were purified up by phenol:chloroform and ethanol precipitation, and 
ligated overnight with 400 U T4 DNA ligase.  Ligation reactions were ethanol 
precipitated and electroporated into E. coli BW25141 [172], containing the λ pir gene 
necessary for the oriR6kγ origin of replication, according to BioRad protocols.  Colonies 
were picked from LB+Cm plates after 48-72 hour incubation at 37°C.  The insertion site 
was determined by sequencing off the transposon in the subsequent plasmid with either 
primer ajg227 or CC001 [113] (Appendix 1).  The number of transposon insertions per 
mutant isolate was determined by southern blot.  Genomic DNA of each mutant (1 µg) 
was digesed overnight with SspI and run on an agarose gel.  The gel was visualized to 
verify that each mutant DNA was digested but not degraded and that all lanes had 
roughly equal amounts.  The separated DNA was transferred to a charged nylon 
membrane (GE Healthcare Piscataway, NJ) with a BioRad Vacuum Blotter according to 
manufacturer’s instructions and UV crosslinked.  Probing and detection of the membrane 
was done with DIG High Prime Kit (Roche Indianapolis, IN) according to manufacturer’s 
instructions.  The probe was PCR amplified from the transposon with primers jph41 and 
jph42 (Appendix 1) to produce a 428 bp fragment prepared and labeled with DIG High 
Prime Kit according to manufacturer’s instructions. 
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Design of PCR Detection System.  Software was developed to design the primers and 
probes such that each tag specific primer is compatible with a common primer and probe 
and does not mishybridize to another tag or another location in the transposon.  This 
primer design software was written in the Java language under the Eclipse platform 
feeding appropriate data to the Primer3 algorithm [180] running locally on Perl.  The 
software fed Primer3 each different transposon (each containing a different tag sequence) 
to design sets such that the left primer and probe annealed in the common region of the 
transposon, and the right primer annealed to the unique tag region. A mishybridization 
data file was created and also sent to Primer3 for each transposon containing all of the 
other tag sequences.  The software collected a maximum of 100 primer/probe sets for 
each transposon and was able to find left primers and probes present in each set, and 
selected the common left primer and probe which scored best with all of the designed tag 
specific right primers.  The top scoring primers and probes where then aligned to the 
NCTC11168 genome to make sure there would be no significant mishyrbidization 
outside of the transposon.  A graphical user interface (Appendix 2) allowed reporting of 
Primer3 output to visualize which parameters were the limiting factors in primer design 
for each tag, allowing manual adjustment of parameters in order to maximize the number 
of tags included, while minimizing differences, i.e.: Tm, between reactions.  Sensitivity 
of the assay was performed by PCR of Tag#1 on serial dilutions of linearized source 
plasmid and determined by the lowest concentration to reliably amplify sufficient for Ct 
determination. 
Control Strain Construction.  Tagged control strains were constructed to be used in 
parallel with random transposon mutants for direct comparison to a wild type strain and a 
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cell invasion deficient strain.  Pseudogene cj0046 was cloned by PCR amplification with 
primers jph38 and jph39 (Appendix 1) containing BamHI and EcoRI sites respectively.  
The PCR reaction was cleaned up with an Omega Cycle Pure Kit and digested with 
BamHI and EcoRI followed by ligation into pUC19, digested with the same enzymes, to 
create the plasmid pJH19 (Appendix 8.1) which was maintained in DH5α. 
Initial disruptional mutagenesis of cj0046 was performed by cloning the Cm
R
 cassette 
and a Tag sequence into the native unique SpeI site of cj0046 in pJH19.  The Tag#1 
sequence and SpeI site were included in primer jph35 to PCR amplify the Cm
R
 cassette 
off of pRY112 [177] with jph34 also containing an SpeI site.  The resulting amplicon was 
digested with SpeI and ligated into pJH19 digested with the same enzyme to create 
plasmid pJH20 which was maintained in DH5α.  Strain 
NCTC11168Δcj0046::CAT+Tag1 was created by electroporation of pJH20 into 
NCTC11168 as above and selecting for Cm
R
 isolates.  Verification of recombination at 
the cj0046 locus was done with PCR amplification of the mutant genomic DNA with 
primers jph43 and jph44 which anneal outside of the mutagenesis region.   
Another strategy for disruptional mutagenesis of cj0046 was performed for creation of 
the positive and negative control strains.  The contents of a transposon was cloned into 
the unique SpeI site in pJH19 by amplification of pAJG40 (Tag#1) or pAJG42 (Tag#3) 
with primers jph54 and jph55 which include SpeI sites to create plasmids pJH22 and 
pJH23 respectively.  Strain NCTC11168Δcj0046::Tn was created by electroporation of 
pJH22 into NCTC11168 as above and NCTC11168∆flgK∆cj0046::Tn was created by 
electroporation of pJH23 into NCTC11168∆flgK.  Strains 
25 
 
NCTC11168Δcj0046::Tn_pUC19- and NCTC11168∆flgKΔcj0046::Tn_pUC19- were 
created by electroporation of only the mutagenesis insert of pJH22 or pJH23 obtained by 
digestion with PvuII and the 3577 bp band gel extracted.  Mutagenesis of cj0046 was 
verified by PCR with primers jph43 and jph44 which anneal outside the mutated region.  
All PCR reactions were performed with Phusion Polymerase (New England BioLabs) 
and gel extractions with Omega Gel Extraction Kit (Omega Bio-Tek, Norcross, GA). 
Construction of cj1365c Mutants.  To demonstrate the influence of pUC19 presence on 
motility, different cj1365c mutants were created.  Knock out mutagenesis of cj1365c was 
performed by transformation of suicide plasmid pJH28 containing ~1.2 kbps region 
upstream of cj1365c, Cm
R
 cassette, and ~1.5 kbps downstream of cj1365c cloned into 
pUC19. The upstream region was cloned by PCR of NCTC11168 genomic DNA with 
primers jph156 and jph157 (Appendix 1) containing BstBI and BamHI sites respectively.  
The Cm
R
 cassette was cloned by PCR of pRY112 [177] with primer jph158 containing an 
SpeI site and jph147 containing a BstBI site.  The downstream region was cloned by PCR 
of NCTC11168 genomic DNA with primers jph159 and jph160 containing EcoRI and 
SpeI sites respectively.  Each PCR product was digested with appropriate enzymes and 
gel purified.  All three fragments were then ligated together with EcoRI/BamHI digested 
and gel purified pUC19 resulting in plasmid pJH28 which was maintained in DH5α.  
Strain NCTC11168Δcj1365c was created by electroporation of pJH28 into NCTC11168 
as above.  For strain NCTC11168Δcj1365c_pUC19- the insert of pJH28 was cut away 
from the pUC19 backbone by BsaI overnight digestion and gel extraction, followed by 
PvuII overnight digestion and the larger 3.7 kbps band gel extracted.  Approximately 5 
μg of the purified mutagenesis insert was then electroporated into NCTC11168 as 
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described above.  Chloramphenicol resistant isolates were screened for correct 
mutagenesis by PCR of mutant genomic DNA with primers jph161 and jph162 which 
anneal outside the mutated area.  PCR amplicons were sequenced for verification. 
Construction of cj0390 Mutants.  To demonstrate the influence of pUC19 presence on 
motility, different cj0390 mutants were created and complemented.  Knock out 
mutagenesis of cj0390 was performed by transformation of suicide plasmid pJH25 
(Appendix 8.2) containing ~1.4 kbps region upstream of cj0390, Cm
R
 cassette, and ~1.3 
kbps downstream of cj0390 cloned into pUC19.  The upstream region was cloned by 
PCR of NCTC11168 genomic DNA with primers jph144 and jph145 (Appendix 1) 
containing EcoRI and SacI sites respectively.  The Cm
R
 cassette was cloned by PCR of 
pRY112 [177] with primers jph146 and jph147 containing SacI and BstBI sites 
respectively.  Downstream region was cloned by PCR of NCTC11168 genomic DNA 
with primers jph178 and jph149 containing BstBI and BamHI sites respectively.  Each 
PCR product was digested with appropriate enzymes and gel purified.  All three 
fragments were then ligated together with EcoRI/BamHI digested and gel purified 
pUC19 resulting in pJH25 plasmid which was maintained in DH5α.  Strain 
NCTC11168∆cj0390 was created by electroporating pJH25 into NCTC11168.  Strain 
NCTC11168∆cj0390_pUC19- was created by electroporating NCTC11168 with the 
insert of pJH25 cut away from the pUC19 backbone by BsaI overnight digestion/gel 
extraction, followed by PvuII overnight digestion/gel extraction.  Chloramphenicol 
resistant isolates were screened for correct mutagenesis by PCR of mutant genomic DNA 
with primers jph150 and jph151 which anneal outside the mutated region.  PCR 
amplicons were sequenced for verification.   
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Construction of cj0390 Complementation Strain.  Complementation of cj0390 was 
achieved by insertion of a cj0390 expression construct within the presumed pseudogene 
cj0046 within the cj0390 knockout strain.  This was accomplished by cloning the cj0390 
ORF by PCR with primers jph152 and jph153 (Appendix 1), containing EcoRI and BstBI 
sites respectively, into pWM1007, cut with the same enzymes, in front of the strong 
synthetic promoter to create plasmid pJH26 (Appendix 8.3).  The region of pJH26 
including this expression construct and the adjoining Kan
R
 cassette was PCR amplified 
with primers jph154 and jph155 both containing an SpeI site and cloned into pJH19 
(Appendix 8.1) disrupting cj0046 at the native SpeI site to create plasmid pJH27 
(Appendix 8.4).  Plasmid pJH19 was created by PCR amplification of the cj0046 ORF 
with primers jph38 and jph39 containing BamHI and EcoRI sites respectively followed 
by ligation into pUC19 [175] digested with the same enzymes.  Plasmid pJH27 was 
electroporated as above into strain NCTC11168∆cj0390 to create strain 
NCTC11168∆cj0390-/+.  A pUC19 free strain was also created by digestion of pJH27 
with PvuII overnight followed by gel extraction and electroporation of the cj0046 
embedded expression construct into strain NCTC11168∆cj0390_pUC19- to create strain 
NCTC11168∆cj0390-/+_pUC19-. 
Cell Invasion Assay.  Caco-2 cells were seeded to 6 well plates at 3x10
6
 cells per well, 
and incubated in a 5% CO2 cell culture incubator overnight.  Cells were washed three 
times with PBS and infected at an MOI of 1000 (in cases of mixed culture invasion the 
combined MOI was 1000) in DMEM 1% FBS for 1 hour in 37°C microaerophillic 
incubator.  Infected cells were washed three times with PBS followed by addition of 
DMEM 1% FBS with 200 μg/ml gentamicin in 37°C microaerophilic incubator.  Cells 
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were washed three times with PBS and bacteria harvested by treatment of 1 ml/well PBS 
+ 0.1% Triton X-100, for either culture or PCR detection.  For culture detection the cell 
lysate was dilution plated to MH+TrM plates in triplicate, followed by colony counts 
after ~48 hours of 37°C microaerophillic incubation.  For PCR detection the cell lysate 
was DNA extracted with the Qiagen DNeasy Kit and eluted in 100 µl of low-EDTA TE.  
This was then quantified by the tag detection PCR designed above on an Applied 
Biosystems 7500 machine in triplicate, and converted to copy number by comparison to 
standard curves (copy number = 10^((Ct-b)/m).  Student’s t-test was used to compare 
samples for both detection methods. 
Motility Assay.  Motility was determined by soft agar stabs.  Bacteria cultures were 
resuspended in MH broth to an OD600 = ~0.5, a metal wire was dipped in each culture 
and stabbed into a plate of MH broth + 0.4% agar.  Each plate contained a positive 
control (NCTC11168) and a non-motile negative control (NCTC11168∆flgK) to account 
for plate to plate variation.  After 48 hour incubation diameters of growth for each sample 
were measured and compared with paired t-tests. 
 
Results 
Mutant Production.  Purification of transposase as a fusion protein was successful only 
when purified from host BL21(DE3)/pLysS using freeze/thaw lysis.  Purification from 
host TB1 with French press lysis repeatedly resulted in transposase degradation.  With 
the purified transposase a total of 1223 random mutants across 16 tags were produced and 
stored individually at -80°C.  The rate of mutant production per reaction (between 3000 
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and 10000 mutants/reaction) was found to be similar to the previous work (~5000 
mutants/reaction) [113].   
Mutant Verification.  A subset of 18 strains was randomly selected to determine 
whether the mutations produced were unique and distributed across the genome.  Table 3 
lists the transposon insertion site in the genome for each strain and the gene it disrupted 
as determined by plasmid rescue and sequencing.  No duplicate mutations were found, 
however one gene (cj0628) was found twice.  A subset of 34 strains (containing the 18 
used above) was selected to determine whether each mutant contained only a single 
transposon insertion.  Southern analysis of these strains produced a single band per strain 
(data not shown). 
 
Table 3: Insertion Sites Determined for Verification Mutants 
Mutant Insertion Site Gene Disrupted 
T4M5 588130 cj0628 
T4M6 1605192 cj1682c 
T4M7 1130264 cj1201 
T4M8 1236006 cj1306c 
T5M6 1348284 cj1413c 
T5M8 986245 cj1051c 
T5M10 296866 cj0325 
T6M200 776626 cj0829c 
T6M201 25960 cj0020c 
T6M203 240835 cj0262c* 
T6M205 588134 cj0628 
T6M207 520276 cj0558c 
T6M209 1480528 cj1549c 
T6M210 642018 cj0688 
T6M217 1636712 cj1727c 
T6M218 1351324 cj1417c 
T7M2 1316706 cj1378 
T7M3 848641 cj0912c 
* Insertion was intergenic upstream of the listed gene. 
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PCR Detection System Design.  Due to the small size of the tag sequences (~40 bp) a 
PCR reaction could not be designed entirely within the tag region of the transposon.  
Instead, we designed a reaction such that there was one tag specific primer for each tag 
sequence which would then share a general primer and probe upstream in the non-
variable portion of the transposon.  The source plasmids were sent out for sequencing to 
cover the area of the transposon where the probe and primers would anneal.  The results 
are listed in Appendix 3 which matches well to previous sequencing work with this set.  
Generally two different flanking sequences around the tags were found which dictated 
different probe designs; these are designated as flanking region A or B in Appendix 3.  
Due to this, it was necessary to design two different sets of general probe and primer 
sequences such that each tag specific primer was coupled with one of these two 
primer/probe sets depending on which flanking region it had.  The two sets of primers 
and probes designed here are listed Appendix 4 and Appendix 5 for set A and set B 
respectively.  Combined, these two sets total 72 tags from the original 95 [112] after 17 
were eliminated from the previous study for dot blot analysis [113] and 6 more tags were 
eliminated here; 1 (Tag#36) for difficulties in sequencing, 1 (Tag#27) for having a unique 
flanking region, and 4 (Tag#’s 18,47,59,70) which were poorly suited for primer design.  
Sensitivity of the assay for Tag#1 was determined to be approximately 28 template 
copies.  The cell invasion assay was increased to the 6 well format in order to provide 
sufficient DNA template from internalized bacteria when running at maximum strain 
complexity (72 tags).  Assuming 5x10
5
 internalized bacteria (and therefore tag copies) 
were recovered per well, followed by DNA extraction and elution in 100 µl, would result 
in recovery of 5x10
3 
tags/µl.  At a maximum complexity of 72 tags per sample, 
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approximately 69 copies/µl of a given tag would be present.  If one microliter would be 
used as temple per PCR reaction for a given tag, this would result in approximately 69 
copies of that tag expected to be present for detection, which is above the 28 copy limit.  
However the negative control strain (approximately 100-fold less internalization) would 
fall below this limit.  If needed, lower complexity invasions would not only allow more 
copies per tag in the reaction, but would also allow more of the extracted DNA to be used 
per PCR reaction since <72 PCR reactions will be run with that extraction sample.  
Additionally the cell invasion procedure could be scaled up again as needed. 
Construction and Validation of Control Strains.  Positive control (NCTC11168 
∆cj0046::Tn) and negative control (NCTC11168∆flgK∆cj0046::Tn) strains were 
successfully constructed by inserting a transposon with Tag#1 into NCTC11168 and 
Tag#3 into NCTC11168∆flgK respectively.  This provides one tagged strain with wild 
type levels of cell invasion, and one tagged strain with a documented deficiency in cell 
invasion.  The insertion site for both strains was the native SpeI site of the pseudogene 
cj0046.  Cell invasion of each control strain was compared to their parental strains and 
verified the pseudogene disruption did not affect the invasion phenotype as there was no 
significant difference, see Figure 1.  As these strains are intended to be used as a mixed 
culture, and differentiated by the tags, we assessed whether the observed invasion 
deficiency of strain NCTC11168∆flgK was maintained when it was mixed with wild type 
culture in the invasion reaction.  The fold difference in invasion between the two strains 
was roughly the same when invaded as two pure cultures (165-fold) compared to when 
invaded as a mixed culture (93-fold) where they were differentiated by the Kan
R
 marker 
in NCTC11168∆flgK, see Figure 2. 
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Figure 1: Cell Invasion of Parental and Tagged Control Strains 
Comparison of internalized bacteria recovered after cell invasion of the tagged control 
strains constructed in this work and their wild type parental strains.  No significant 
difference was found between each tagged control strain and its parental strain indicating 
the tagging process did not modify cell invasion levels. 
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Figure 2: Cell Invasion of Isogenic and Mixed Cultures 
Internalized C. jejuni recovered from cell invasions of NCTC11168 and 
NCTC11168∆flgK as pure cultures or when mixed together.  The fold differences 
between the wild type and deficient strains were similar when used as pure cultures (165-
fold) or as mixed cultures (93-fold) supporting the feasibility of a multi-strain cell 
invasion assay. 
 
 
 
PCR Detection of a Mixed Culture Cell Invasion.  Standard curves were developed for 
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Tag#1 detected and the negative control strain had 2.1x10
7
 copies of Tag#3 detected for a 
5.0-fold difference which were found not to be significantly different.  To see if this 
would be replicated, and to test a higher complexity invasion, a pool of 5 cultures was 
made (2 controls and 3 unknowns) and used to invade six wells of cells.  Generally across 
the six wells the relative relationships of the strains were consistent.  A limitation was the 
starting concentrations (‘Input’ on Figure 5) which were quite different.  Differences in 
starting concentrations usually result in different internalization levels regardless of 
invasion capability.  Relative to the positive control, there was a 5.1 fold decrease for the 
negative control, 2.7 fold decrease for T4M7, 2.5 fold decrease for T6M218, and a 233 
fold decrease for T7M3. 
 
Figure 3: Standard Curves for PCR Quantification of Selected Tags 
PCR quantification of serial dilutions of template for each tag was performed to create a 
standard curve for each.  The slope and y-intercepts where then calculated from each 
curve and displayed.  This was used to calculate the copy number of the target template 
present in the sample taking into account differences in reaction efficiencies. 
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Figure 4: Cell Invasion Detected by Culture and PCR Methods 
Cell invasion of a mixed culture of positive control and negative control bacteria detected 
both by culture and PCR methods.  While the culture method shows the expected 
difference between the two, the PCR method did not find a significant difference.  The 
PCR method also reported approximately 100-fold more bacteria present than the plating 
method.  Together these results suggest the purified DNA from the internalized bacteria 
was contaminated with DNA from the gentamicin-killed extracellular bacteria. 
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Figure 5: PCR Detection of a Mixture of Five Cell Internalized C. jejuni Strains  
PCR results of a cell invasion with a pool of five bacterial cultures along with the pre-
invasion starting pool (‘Input’).  One positive control, one negative control, and three 
unknowns were pooled and used for invasion assays in 6 replicate wells. Generation of 
equalized starting cultures is the biggest challenge here, but we can see the ability of the 
PCR system to detect individual mutants in a mixed pool. 
 
 
 
Effect of pUC19 on Motility.  Mutagenesis of both cj1365c and cj0046 (with two 
different mutagenesis strategies) in the presence of pUC19 sequences unexpectedly 
resulted in motility deficient strains (Figure 6).  The motility deficiency was verified 
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resulting mutants (NCTC11168Δcj0046::Tn_pUC19-) (Figure 7).  Similarly when 
cj1365c was mutated with the same construct as before, except with the pUC19 
sequences removed, it resulted in isolates with full wild type levels of motility (Figure 8).  
Mutagenesis of cj0390 resulted in non-motile isolates as expected [181, 182] however 
complementation did not recover motility (Figure 9).  The defect was verified across 
multiple isolates, Figure 9 presents representatives.  The cj0390 knockout strain 
(NCTC11168∆cj0390) had an average diameter of 1.2 mm and the complemented strain 
(NCTC11168∆cj0390-/+) had an average diameter of 1.3 mm.  Both were significantly 
different (p<0.05) from the wild type (NCTC11168) with an average diameter of 4.5 mm.  
When both the cj0390 mutant strain and the strain with the complemented cj0390 
mutation were created with pUC19 sequences removed it again produced a cj0390 mutant 
that was non-motile, however the complementation did partially restore motility, see 
Figure 10.  Again, Figure 10 presents representative isolates.  The pUC19 free cj0390 
knockout strain (NCTC11168∆cj0390_pUC19-) had an average diameter of 2.2 mm and 
the complementation strain (NCTC11168∆cj0390-/+_pUC19-) had an average diameter 
of 3.2 mm.  While both strains were still significantly less motile (p<0.05) than the wild 
type strain (NCTC11168) the complemented strain had significantly higher motility 
(p<0.05) than the knock out strain. 
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Figure 6: Motility of C. jejuni Mutants Constructed with pUC19 Present 
Motility of mutants created in the presence of pUC19 sequences, compared to the wt 
(NCTC11168) and a non-motile control (NCTC11168ΔflgK) strains.  All strains had a 
motility defect. 
 
 
 
 
Figure 7: Motility of cj0046 Mutants with and without pUC19 Present 
Motility of cj0046 mutants constructed with and without pUC19 present compared to 
wild type (NCTC11168) and a non-motile control (NCTC11168ΔflgK) strains.  When 
mutagenesis constructs are used which do not contain pUC19 sequences, those isolates 
have full motility. 
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Figure 8: Motility of cj1365c Mutants with and without pUC19 Present 
Motility of a cj1365c mutant created without pUC19 sequences present compared to wt 
(NCTC11168) and non-motile control (NCTC11168ΔflgK) strains.  When cj1365c 
mutagenesis is repeated without pUC19 the resulting strains have full motility. 
 
 
 
 
Figure 9: Motility of cj0390 Mutant Strains with pUC19 Present 
Motility of the cj0390 knock out strain and the strain with complementation of the cj0390 
mutation both created with pUC19 present compared to wild type NCTC11168 and non-
motile control (NCTC11168ΔflgK) strains.  With pUC19 present in the knock out and 
complemented genomic insertions, motility cannot be complemented. 
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Figure 10: Motility of cj0390 Mutant Strains without pUC19 Present 
Motility of a cj0390 mutant and the complemented strain both created without pUC19 
compared to wild type NCTC11168 and a non-motile control (NCTC11168ΔflgK) 
strains.  When knock out and complemented strains are made without pUC19, 
complementation of motility in the knock out strain is partially successful. 
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mutagenesis system works as intended and is portable between labs.  We utilized here a 
fusion protein version of the tranposase which allows for easier purification and is 
therefore more accessible to non-specialized labs.   
Development of the Detection System.  Classically the detection of tags contained in 
each mutant strain was performed by dot blot procedures resulting in a semi-quantitative 
measurement of each tag (and therefore each mutant) [113].  Here we developed a real 
time PCR based method to quantify each tag in a mixed sample allowing for more precise 
and accurate measurement of each mutant through any particular screen.  We 
successfully developed the system for 72 of the tags in the system (Appendix 4 and 
Appendix 5), allowing for the quantitative measurement of 72 strains in a single screen.  
Placing an internal positive control with wild type levels of invasion in a screen with 
unknown strains and measuring each unknown against that control maximizes the 
accuracy of measurement.  Considering the PCR system cannot detect non-tagged strains, 
we constructed tagged control strains to achieve this.  Two strains were tagged, and 
therefore two tags were sacrificed, for positive and negative controls for cell invasion.  
The wild type NCTC11168 was tagged with Tag#1 as the positive control and can be 
measured by the tag in parallel with the unknown strains.  Strain NCTC11168∆flgK was 
tagged with Tag#3 to be used as a negative control since it is non-motile and is deficient 
for cell invasion [47].  These two strains provide a reference to interpret results of 
unknown mutants.  For unknown quantification, a mixed sample of control strains and 
unknown mutants is passed through a given screen.  The DNA from bacteria recovered 
from the screen is used as template for PCR reactions for each of the tags present.  Each 
Ct would then be corrected to copy number from master standard curves constructed for 
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each tag created previously.  The copy number for each unknown would then be 
represented as a ratio to the positive control copy number measured in that sample.  The 
negative control would then serve as a reference for the amount of deficiency of a given 
mutant.  By comparing each mutant to the internal control strains screened in parallel 
allows for implicitly accounting for sample-to-sample variation in a given screen.  Master 
standard curves are made once for each tag and not made in each run as would be 
performed for an absolute PCR quantification.  This is valid here as we are looking at a 
ratio of unknown and known from a single sample, corrected with standard curves for the 
unknown and known tags which were also both made in the same PCR run.  Therefore 
run to run variations in both PCR runs (tag detection and standard curves) are cancelled 
out.  Multiple sets of standard curves can be produced to cover all tags needed, but each 
should have a positive control (Tag#1) included in every run.  Any calculation of an 
unknown from a curve should be compared to the positive control curve run in parallel 
with that one.  In addition the quantification is not absolute, but relative for screening 
purposes so there is no need for standard curves to be run alongside tag detection in each 
run which would not be feasible for 72 tags.  To verify the feasibility of this use of the 
control strains, we showed that the tagged versions of the strains behaved the same as 
their parental strains in a cell invasion assay.  Likewise when they were used in that assay 
as a mixed culture they still maintained their individual phenotypes. 
Screen for Virulence Factors.  To demonstrate the application of the STM system with 
the PCR detection and control strains we used a cell invasion screen for virulence.  A 
mixture of the positive and negative control strains was used to invade three wells of 
cells.  Upon cell lysis each well was quantified for each strain by the standard culture 
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method as well as the PCR detection system.  In this case the internal invasion controls 
allowed for elimination of well-to-well variation of cell numbers, cell state, and 
incubation conditions.  By the culture method the negative control strain invaded 100-
fold less than (p<0.05) the positive control strain as expected (Figure 4).  However the 
PCR results did not replicate this.  They showed a non-significant 5-fold less negative 
control strain invasion than the positive control.  While the values for the PCR results in 
Figure 4 cannot be directly compared to the culture results since they were not a true 
absolute quantification (can only truly be used for ratio between the PCR samples) they 
are over 2 logs higher than expected.  We speculate, based on these two PCR anomalies 
in this data, that we may be getting carryover DNA from the external bacteria which were 
killed by the gentamicin treatment but not fully washed away.  Further as the entire lysate 
was used for the DNA extraction, bacteria which were attached to the outside of the cells 
and killed by the gentamicin may not have been washed away and would have 
contaminated their non-internalized DNA with the DNA from the internalized bacteria.  
This contamination would be expected to have the effects of giving higher than 
anticipated overall recovery, and to dilute any invasion defect making it appear more like 
the wild type.  If this is the case we may need to spin out the cellular debris before DNA 
extraction, or may need to include an extra DNase step before lysis of the cells to fully 
remove non-internalized bacterial DNA from the assay.  However we cannot ignore that 
this unexpected 100-fold higher recovery with the PCR matches a previous report of 500-
fold higher recovery of internalized C. jejuni with a 48 hour anaerobic incubation step 
following cell lysis before microaerophilic incubation as the bacteria may be more 
sensitive to oxidative stress when internalized [95].  This extra incubation was not 
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included in our assay and could account for the 100-fold higher PCR result as the PCR 
would detect both groups of internalized bacteria: the group we successfully cultured 
needing only microaerophilic conditions, and the group requiring anaerobic preincubation 
which we did not culture. 
Despite these potential issues a higher complexity culture was used for an invasion to test 
whether the negative control would still give the unexpected result, and to see if there 
were any potential issues with a higher complexity invasion.  Five strains were pooled, 
invaded into cells, DNA extracted from cell lysate, PCR performed for each tag in each 
well, standard curve corrected and displayed in Figure 5.  Overall the major limitation of 
this assay was the starting cultures.  They were not the same starting concentrations 
leading to different internalization levels, specifically for the random mutant T7M3.  
These strains were normalized by reading the OD600 of a resuspension, calculating their 
concentration from a standard curve, and adding the calculated volume to achieve a pool 
with the same concentration of each.  In the future they would probably need to be all the 
same OD600 reading and the same volumes used for each to achieve closer starting 
concentrations.  However the data from the assay shows the same relationship between 
the control strains, 5-fold decrease relative to the wild type.  Interestingly for two of the 
unknowns, T4M7 and T6M218, while their starting concentrations were much lower than 
the negative control, their internalized amounts were consistently higher than it, but not 
quite so high as the positive control.  Therefore with the correct starting concentrations, 
these two certainly may have wild type levels of invasion. 
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Interaction of pUC19 with an Unknown Locus in C. jejuni.  Mutagenesis of two 
genes, cj0046 and cj1365c, using a pUC19-based suicide plasmid for the mutagenesis 
yielded strains with significantly decreased motility (Figure 6) and they had a non-
uniform diameter (data not shown).  This was consistent across multiple isolates of each 
mutagenesis reaction; no isolates were found to have wild type motility.  Mutagenesis of 
cj0046 and cj1365c with the same mutagenesis constructs but with the pUC19 sequences 
removed resulted in both strains having wild type motility (Figure 7 and Figure 8).  We 
found a similar effect with mutagenesis and complementation of cj0390.    While the 
complimented motility was not at the wild type level, it was significantly higher than the 
knock out strain.  This is likely due to the cj0390 expression construct in the 
complemented strain being constructed as a genomic insertion giving lower expression 
than if plasmid based.   
It appears that during mutagenesis with pUC19-based suicide plasmids the remaining 
pUC19 sequences may be recombining elsewhere in the genome where they affect 
motility.  Attempts at a plasmid rescue similar to the transposon insertion site procedure 
but modified for pUC19 failed (data not shown).  This would have required the majority 
pUC19 sequence to be inserted however (oriV and AmpR).  Likely only a fragment of 
pUC19 recombined at some unknown locus in the genome, however since multiple 
isolates from every reaction showed the effect, then this event must be fairly efficient.  
Since each of these isolates was selected for the mutagenesis marker, each of them 
therefore had the pUC19 sequences in them at some point during the targeted 
mutagenesis.  This linkage between the targeted mutagenesis event and the pUC19 
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recombination event, with selection for the targeted mutagenesis event, explains why the 
pUC19 event was found so often. 
 
Conclusions 
Signature tagged mutagenesis is a powerful system for negatively screening large scale 
numbers of mutants with the minimal number of screens.  A STM system was developed 
for C. jejuni allowing these types of screens for an understudied organism [113].  Here 
we have independently implemented and validated the STM system.  Additionally we 
have developed an enhanced PCR-based detection system for the STM allowing true 
quantification of each mutant strain in a pool through any desired screen.  We also 
developed control strains which allow positive and negative control strains for cell 
invasion to be run in parallel with up to 70 unknown strains within the same screen and 
detected in parallel with the PCR detection system.  To demonstrate the system, a cell 
invasion screen for virulence was performed with positive control, negative control, and 
random mutants.  While this demonstrated limitations of the screen, the PCR detection 
system was able to effectively measure each mutant and control strains independently in 
a pool before and after the screen.  The limitations of the cell invasion screen found were 
getting equal starting concentrations of strains in a mixed pool, and potential non-targeted 
DNA coming through the assay minimizing the ability to differentiate internalized strains 
from non-internalized strains.  Strategies for circumventing these screen limitations are 
discussed above.  An effect of pUC19 with an unknown locus in NCTC11168 was 
discovered here resulting in a characteristic motility deficiency in soft agar.  While the 
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locus of this interaction could not be identified, the effect was consistent and alarming.  
The E. coli plasmid pUC19 is a very common cloning plasmid, and C. jejuni researchers 
using this as a base for a suicide plasmids may unknowingly introduce a secondary 
phenotype to what they are attempting to characterize.  Use of these newly produced 
pUC19-free control strains should be properly validated for the given screen they are to 
be used in, including the cell invasion screen as was done with the pUC19
+
 strains above.  
The tools and data presented here should be a valuable asset to C. jejuni researchers 
facilitating enhanced genomic studies of this important, but understudied, human 
pathogen. 
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Chapter 3: Characterization of a Virulence Associated Red Growth Phenotype in 
Campylobacter jejuni 
 
Prepared for Submission to BMC Microbiology 
 
Abstract 
Campylobacter jejuni is an important human enteric pathogen worldwide.  Identification 
of factors involved in virulence would allow for the development of tools and strategies 
to manage infections from this pathogen.  A transposon based random mutagenesis was 
performed on C. jejuni strain NCTC11168 and a novel red growth phenotype was 
identified.  This phenotype was associated with cell invasion and motility deficiencies, 
but not with growth rate deficiency.  Attempts to identify the genetic locus responsible 
for it by transposon mutagenesis were unsuccessful.  A similar red phenotype has been 
characterized in yeast from mutations in ade1 or ade2, and the equivalent genes in C. 
jejuni were investigated to determine if a similar mechanism was involved.  Results were 
inconclusive as to whether the ade1/2 orthologs in C. jejuni are responsible for the red 
phenotype.  The pigment develops over time on plated culture, and appears not to be 
protein based consistent with the yeast phenotype.  However, no major absorbance 
spectrum peaks were associated with the red color, with minimal similarity to the spectra 
from the yeast phenotype.  From the absorbance spectrum data, the observed red color of 
the bacteria may also be the result of a spectrum-wide bias towards red color relative to 
the wild type strain rather than individual peaks.  The genetic locus responsible for this 
phenotype appears to have mutated in the background of our transposon mutagenesis 
studies, and likely occurs elsewhere.  Identification of this phenotype will provide 
increased knowledge to the research community of a distinct phenotype which will likely 
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occur again with this bacterium in other labs.  Additionally since it is associated with 
virulence, identification of the red pigment and its associated genetic locus/loci may 
allow for a better understanding of the virulence mechanisms of this unique pathogen as 
well as potentially provide a tool to manage it. 
 
Introduction 
Campylobacter jejuni is an important enteric human pathogen worldwide.  In developed 
countries it is a widespread cause of foodborne illness as the leading cause in the UK [9, 
10] and the second leading bacterial cause in the US [11].  In developing countries, the 
clinical manifestations are different than those observed in developed countries.  
Specifically, adults rarely show symptoms and act as carriers.  Whereas symptomatic 
infections commonly occur in children under 2 years old resulting in a higher mortality 
rate indicating acquired immunity [29].   
Symptoms of C. jejuni infection can occur 2 to 5 days after exposure resulting in watery 
or sticky diarrhea sometimes progressing to bloody diarrhea typically associated with 
severe cramping and fever [2, 5, 7, 25-29].  The infection is usually self limiting and is 
commonly recovered without antibiotic treatments with death being rare [2, 5, 26, 29].  
However, some people are asymptomatic during infection [5, 28] which may allow 
opportunity for several secondary conditions associated with C. jejuni to unknowingly 
manifest.  C. jejuni infection is thought to be a causative agent of the neuropathy disease 
Guillain-Barré Syndrome (GBS) [7].  GBS is an autoimmune-mediated disease leading to 
neuropathy of the peripheral nervous system believed to be induced by molecular 
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mimicry of neural outer peptides by C. jejuni [7, 36].  Immunoproliferative Small 
Intestinal disease (IPSID) has also been shown to be associated with C. jejuni infections 
[38, 39].  IPSID is a mucosa-associated lymphoid-tissue lymphoma which results in 
secretion of incomplete antibodies carrying only the heavy chain [40-42].     
Knowledge of virulence mechanisms in C. jejuni trails that of other enteric pathogens 
likely due to several reasons: it was only more recently discovered as human pathogen 
compared to other enteric pathogens, can be difficult to work with in the laboratory, and 
seems to have several unique features [3].  Here we attempted to identify novel virulence 
genes of C. jejuni by screening random transposon mutants with a cell invasion screen.  
We identified and began to characterize three mutants with both a red growth phenotype 
and decreased virulence. 
Yeast with mutations in ade1 or ade2 show a red growth phenotype due to buildup of a 
metabolism intermediate AIR, which degrades into a red pigment (Appendix 6) [114, 
115].  The purified pigment has absorbance spectrum peaks at 490 nm and 540 nm [114] 
and inhibits restriction endonuclease activity [119].  The pigment production in these 
yeast mutants accumulates over time and is affected by growth rate [117].  Adenine 
supplementation at 1.0 mM downregulates the pathway involved and prevents red 
pigment production [117].  Mutations upstream in the pathway prevent AIR production 
and similarly prevent red production in the red yeast mutants [118].  This phenotype in 
yeast, along with the identified ade1/2 mutations causing it, has been extensively used as 
a genetic tool [120-133].  Identification of the genetic basis of the red phenotype in C. 
jejuni may allow a greater understanding of its virulence mechanisms, may provide a tool 
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for its control as a pathogen, and may provide a molecular tool to facilitate further 
studies. 
 
Methods 
Culture Conditions.  Campylobacter jejuni strain NCTC11168 was obtained from the 
ATCC (Manassas, VA) and routinely grown on Mueller Hinton (MH) Agar with 5 µg/ml 
trimethoprim (TrM) and supplemented with 20 µg/ml chloramphenicol (Cm), 50 μg/ml 
kanamycin (Kan), and 5% horse blood where appropriate.  All C. jejuni cultures were 
grown in a Binder (Bohemia, NY) CB150 incubator set to 37°C, 5% O2, 10% CO2, and 
85% N2.  E. coli strains DH5α and BW25141 were obtained from The E. coli Genetic 
Stock Center (New Haven, CT) and grown on LB agar aerobically at 37°C with 
appropriate antibiotics as above.   Caco-2 human epithelial cell line was obtained from 
the ATCC and grown in DMEM 10% FBS + NEAA + fungizone + 50 µg/ml gentamicin 
in a 5% CO2 incubator and used at passages less than 20.  Bacterial strains used in this 
study are listed in Table 4, and plasmids in Table 5. 
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Table 4: Bacterial Strains Used in Chapter 3 
Strain Red Description Source 
E. coli: 
      DH5α 
 
plasmid host 
    BW25141 
 
plasmid rescue host [183] 
   
C. jejuni:    
   NCTC11168 (-) Wild type C. jejuni [173, 174] 
   NCTC11168ΔflgK (-) Aflagellated mutant.  [47] 
   T4M9 + Transposon Mutant of cj0469 This work 
   T5M52 + Transposon Mutant of cj1365c This work 
   T5M52rev1 (-) Reversion of red color, Tn remains This work 
   T7M30 + Transposon Mutant of cj0390 This work 
   T7M30rev1 + Reversion of Transposon to wt This work 
   T34M24 +++ Intergenic Transposon Mutant This work 
   T34M26 + Transposon Mutant of cj0238 This work 
   T34M27 + Transposon Mutant of cj0238 This work 
   T35M1 + Transposon Mutant of cj0238 This work 
   T35M2 + Transposon Mutant of cj0490 This work 
   T35M6 + Transposon Mutant of cj0497 This work 
   T35M7 + Transposon Mutant of cj0497 This work 
   NCTC11168Δcj0390(w) (-) cj0390 Knock Out Mutant  This work 
   NCTC11168Δcj0390(R) + cj0390 Knock Out Mutant  This work 
   81116∆cj0390 (-) cj0390 Knock Out Mutant This work 
   81116∆cj0390/pJH26 (-) cj0390 Complementation Strain This work 
   NCTC11168Δcj1365c (-) cj1365c Knock Out Mutant This work 
   NCTC11168Δcj0238 (-) cj0238 Knock Out Mutant This work 
   NCTC11168∆cj0512 (-) cj0512 Knock Out Mutant This work 
   NCTC11168∆cj0702 (-) cj0702 Knock Out Mutant This work 
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Table 5: Plasmids Used in Chapter 3 
Strain Description Source 
     pMALC9 Transposase Expression Plasmid [176] 
   pAJG40 - 134 Transposon Source Plasmids [113] 
   pRY112 CAT Cassette Source [177] 
   pWM1007 Backbone for Expression Constructs [184] 
   pJH25 cj0390 Mutagenesis Plasmid This work 
   pJH26 cj0390 Expression Plasmid This work 
   pJH28 cj1365c Mutagenesis Plasmid This work 
   pJH29 cj1365c Expression Plasmid This work 
   pJH31 cj0238 Mutagenesis Plasmid This work 
 
 
Generation of Random Mutants.  Mutagenesis was performed similar to previous work 
[113, 176] by in vitro transposition followed by transformation and insertion into the 
chromosome by homologous recombination.  Transposase C9 [178], a hyperactive 
mutant of Himar1, was purified as previously described as a maltose binding fusion 
protein expressed off of pMALC9 [176] but purified from BL21(DE3)/pLysS (Promgea, 
Madison, Wisconsin) with extraction by freeze thaw lysis.  Tagged transposons were 
previously developed and maintained on plasmids pAJG40 through pAJG134, each 
containing a unique tag sequence [113].    Briefly, 2 μg of NCTC11168 genomic DNA, 1 
μg of one of pAJG40 – pAJG134 transposon source plasmids, and 150 ng transposase 
were combined in buffer [176] at 30°C for 6 hours.  Transposed DNA was then purified 
on a column (Qiagen, Valencia, CA) and repaired.  To repair the DNA 1.5 U of T4 DNA 
polymerase, NEB Buffer #2, and 25 μM of each dNTP were added and incubated for 20 
minutes at 37°C followed by inactivation at 75°C for 10 minutes.  The reaction was then 
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treated with 10 U ligase overnight in 1x ligase buffer, and column purified (Qiagen, 
Valencia, CA).  Repaired mutated DNA was used to naturally transform NCTC11168, 
see below.  Mutant colonies were picked after 3 days incubation on MH+TrM+Cm+5% 
blood plates for regular mutant production.  For the red phenotype screen, mutant 
colonies were recovered on MH+TrM+Cm plates, to be able to see the phenotype, and 
allowed to incubate for an extended time to allow for color production.  The location of 
the transposon insertion in mutant strains was determined by plasmid rescue.  Mutant 
genomic DNA (1 µg) was digested overnight with SspI.  Digestions were cleaned up by 
phenol:chloroform and ethanol precipitation, and ligated overnight with 400 U T4 DNA 
ligase.  Ligation reactions were ethanol precipitated and electroporated into E. coli 
BW25141 [172], containing the λ pir gene necessary for the oriR6kγ origin of 
replication, according to BioRad protocols.  Colonies were picked from LB+Cm plates 
after 48-72 hour incubation at 37°C.  The insertion site was determined by sequencing off 
the transposon in the subsequent plasmid with either primer ajg227 or CC001 [113]. 
Natural Transformation of Campylobacter.  Natural transformation of C. jejuni strains 
was performed similar as before [113, 179].  Bacteria from a lawn of overnight growth on 
MH+TrM were harvested in 1 ml MH broth and pipetted on a MH+TrM plate and 
incubated upright at 37°C microaerophillically for 3 hours.  Purified DNA was then 
mixed into the bacteria and the plate incubated for an additional 4 hours.  Bacteria were 
harvested by scraping into 1 ml MH broth, diluted 1:10 and 1:100, and plated to selective 
media. 
55 
 
Electroporation of Campylobacter.  Production of electrocompetent C. jejuni strains 
and electroporation were performed as before [179].  Bacteria from a lawn of overnight 
growth on five MH+TrM plates were harvested into 10 ml MH broth, pelleted at 3000 g 
for 20 minutes at 4°C and resuspended in 5 ml ice cold wash buffer (272 mM sucrose, 
15% glycerol).    This wash step was repeated three more times, and finally resuspended 
in 1ml ice cold wash buffer.  Cells were aliquoted in 100 µl and stored in -80°C until 
needed.  To each 100 µl electrocompetent cell aliquot thawed on ice, DNA was added, 
gently mixed, and added to a 0.2 cm cuvette on ice.  Electroporation was performed with 
a BioRad MicroPulser (1 pulse of 2.5kV, 600 ohm, 10 µF) and the electroporated cells 
transferred to 200 µl SOC, mixed, and spread on MH+TrM plates.  Plates were incubated 
upright for 5 hours, bacteria harvested into 1 ml MH broth, spun 10000 g for 2 minutes, 
resuspended in 100 µl MH broth and plated to selective media.  Negative controls (no 
DNA) were performed in parallel. 
Cell Invasion Assay.  Caco-2 cells were seeded to 6 well plates at 3x10
6
 cells per well, 
and incubated in a 5% CO2 cell culture incubator overnight.  Cells were washed three 
times with PBS and infected at a multiplicity of infection (MOI) of 1000 cfu/cell in 
DMEM 1% FBS for 1 hour in 37°C microaerophillic incubator.  Infected cells were 
washed three times with PBS followed by addition of DMEM 1% FBS with 200 μg/ml 
gentamicin and incubated at 37°C microaerophilically for 1 hour.  Cells were washed 
three times with PBS and bacteria harvested by treatment of 1 ml/well PBS + 0.1% 
Triton X-100, followed by dilution plated to MH+TrM in triplicate.  Colony counts were 
performed after ~48 hours of 37°C microaerophillic incubation. 
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Creation of Knock-Out Strains.  NCTC11168∆cj0390.  Knock out mutagenesis of 
cj0390 was performed by transformation of NCTC11168 or 81116 with a mutagenesis 
construct from plasmid pJH25 (Appendix 8.2) containing ~1.4 kbps region upstream of 
cj0390, Cm
R
 cassette, and ~1.3 kbps downstream of cj0390 cloned into pUC19.  The 
upstream region was cloned by PCR of NCTC11168 genomic DNA with primers jph144 
and jph145 containing EcoRI and SacI sites respectively (Appendix 1).  The Cm
R
 cassette 
was cloned by PCR of pRY112 [177] with primers jph146 and jph147 containing SacI 
and BstBI sites respectively.  Downstream region was cloned by PCR of NCTC11168 
genomic DNA with primers jph178 and jph149 containing BstBI and BamHI sites 
respectively.  Each PCR product was digested with appropriate enzymes and gel purified.  
All three fragments were then ligated together with EcoRI/BamHI digested and gel 
purified pUC19 resulting in plasmid pJH25 which was maintained in E. coli DH5α.  For 
electroporation into C. jejuni, the mutagenesis insert of pJH25 was cut away from the 
pUC19 backbone by BsaI overnight digestion and UV-free gel extraction, followed by 
PvuII overnight digestion and UV-free gel extraction.  Approximately 5 µg of 
mutagenesis insert was electroporated into wild type NCTC11168 as described above to 
create strain NCTC11168∆cj0390(w) for a white isolate and NCTC11168∆cj0390(R) for 
a red isolate. The same was done for 81116 to create strain 81116∆cj0390.  
Chloramphenicol resistant isolates were screened for correct mutagenesis by PCR of 
mutant genomic DNA with primers jph150 and jph151 which anneal outside of the 
mutagenesis region.  PCR amplicons were sequenced for verification. 
NCTC11168Δcj1365c. Knock out mutagenesis of cj1365c was performed by 
transformation of NCTC11168 with a mutagenesis construct from plasmid pJH28 
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(Appendix 8.5) containing ~1.2 kbps region upstream of cj1365c, Cm
R
 cassette, and ~1.5 
kbps downstream of cj1365c cloned into pUC19.  The upstream region was cloned by 
PCR of NCTC11168 genomic DNA with primers jph156 and jph157 containing BstBI 
and BamHI sites respectively.  The Cm
R
 cassette was cloned by PCR of pRY112 with 
primer jph158 containing an SpeI site and jph147 above.  The downstream region was 
cloned by PCR of NCTC11168 genomic DNA with primers jph159 and jph160 
containing EcoRI and SpeI sites respectively.  Each PCR product was digested with 
appropriate enzymes and gel purified.  All three fragments were then ligated together 
with EcoRI/BamHI digested and gel purified pUC19 resulting in plasmid pJH28 which 
was maintained in E. coli DH5α.  For electroporation into C. jejuni the mutagenesis insert 
of pJH28 was cut away from the pUC19 backbone by BsaI overnight digestion and UV-
free gel extraction, followed by PvuII overnight digestion and the larger 3.7 kbs band 
UV-free gel extracted.  Approximately 5 μg of the purified mutagenesis insert was then 
electroporated into wild type NCTC11168 as described above to create the strain 
NCTC11168∆cj1365c.  Chloramphenicol resistant isolates were screened for correct 
mutagenesis by PCR of mutant genomic DNA with primers jph161 and jph162 which 
anneal outside the mutagenesis region.  PCR amplicons were sequenced for verification. 
NCTC11168∆cj0238.  Knock out mutagenesis of cj0238 was performed by 
transformation of NCTC11168 with a mutagenesis construct from plasmid pJH31 
(Appendix 8.7) containing ~1.9 kbps region upstream of cj0238, Cm
R
 cassette, and ~1.8 
kbps downstream of cj0238 cloned into pUC19.  The upstream region was cloned by 
PCR of NCTC11168 genomic DNA with primers jph189 and jph190 containing EcoRI 
and SacI sites respectively.  The Cm
R
 cassette was cloned by PCR of pRY112 with 
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primers jph146 and jph147 as above.  The downstream region was cloned by PCR of 
NCTC11168 genomic DNA with primers jph191 and jph203 containing BstBI and PstI 
sites respectively.  Each PCR product was digested with appropriate enzymes and gel 
purified.  All three fragments were then ligated together with EcoRI/PstI digested and gel 
purified pUC19 to create plasmid pJH31 which was maintained in DH5α.  For 
electroporation into C. jejuni the mutagenesis insert of pJH31 was cut away from the 
pUC19 backbone by BsaI overnight digestion and UV-free gel extraction, followed by 
EcoRI/PstI overnight digestion and the larger 4.5 kbps band UV-free gel extracted.  
Approximately 5 μg of the purified mutagenesis insert was then electroporated into wild 
type NCTC11168 as described above to create strain NCTC11168∆cj0238.  
Chloramphenicol resistant isolates were screened for correct mutagenesis by PCR of 
mutant genomic DNA with primers jph193 and jph194 which anneal outside the 
mutagenesis region.  PCR amplicons were sequenced for verification. 
NCTC11168∆cj0512.  Knock out mutagenesis of cj0512 was performed by overlapping 
extension PCR [185] leaving the downstream region in-frame to minimize polar effects.  
The upstream region of cj0512 was PCR amplified with primers jph219 and jph220 from 
NCTC11168 genomic DNA.  The downstream region of cj0512 was PCR amplified with 
primers jph221 and jph222 from NCTC11168 genomic DNA.  The Cm
R
 cassette was 
amplified with primers C1 and C2 [185] from pRY112.  After phenol:chloroform and 
ethanol precipitation of each individual amplicon, 500 ng of each of the three components 
were combined and thermal cycled without primers to anneal overlapping fragments and 
to fill in gaps.  The mutagenesis construct was created by PCR amplification of 2 µl of 
the annealing reaction above with outside primers jph219 and jph222.  The resulting 
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amplicon was purified by phenol:chloroform extraction and ethanol precipitation.  
Mutagenesis was performed by electroporating 1 µg of the purified mutagenesis construct 
into NCTC11168 as described above and selecting Cm
R
 colonies to create strain 
NCTC11168∆cj0512.  Mutants were verified for correct mutagenesis by PCR with 
primers jph223 and jph224 which anneal outside the mutated region.  The resulting 
amplicons were sequenced to verify the expected mutagenesis occurred. 
NCTC11168∆cj0702. Knock out mutagenesis of cj0702 was performed by overlapping 
extension PCR leaving the downstream region in-frame to minimize polar effects.  The 
upstream region of cj0702 was PCR amplified with primers jph225 and jph226 from 
NCTC11168 genomic DNA.  The downstream region of cj0702 was PCR amplified with 
primers jph227 and jph228 from NCTC11168 genomic DNA.  The Cm
R
 cassette was 
amplified with primers C1 and C2 from pRY112.  After phenol:chloroform and ethanol 
precipitation of each individual amplicon, 500 ng of each of the three components were 
combined and thermal cycled without primers to anneal overlapping fragments and to fill 
in gaps.  The mutagenesis construct was created by PCR amplification of 2 µl of the 
annealing reaction above with outside primers jph225 and jph228.  The resulting 
amplicon was purified by phenol:chloroform extraction and ethanol precipitation.  
Mutagenesis was performed by electroporating 1 µg of the purified mutagenesis construct 
into NCTC11168 as described above and selecting Cm
R
 colonies to create strain 
NCTC11168∆cj0702.  Mutants were verified for correct mutagenesis by PCR with 
primers jph229 and jph230 which anneal outside the region of mutagenesis.  The 
resulting amplicons were sequenced to verify the expected mutagenesis occurred. 
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All genomic DNA was extracted with a DNeasy Blood and Tissue Kit (Qiagen Valencia, 
CA).  All PCR reactions were performed with Phusion Polymerase (New England 
BioLabs) and gel purifications with a Gel Extraction Kit (Omega Bio-Tek, Norcross, 
GA).  Plasmid maps created in GENtle (http://gentle.magnusmanske.de/).  Removal of 
pUC19 backbone from mutagenesis constructs was previously found to be necessary as it 
cross-reacts in the genome effecting motility (see Chapter 2). 
Genetic Complementation.  Complementation of the cj0390 knock out in strain 81116 
was done by transformation with cj0390 expression plasmid pJH26 (Appendix 8.3).  The 
cj0390 ORF and native RBS was PCR amplified with primers jph152 and jph153 
(Appendix 1) containing EcoRI and BstBI sites respectively.  The amplicon was purified 
phenol:chloroform and ethanol precipitation.  Plasmid pWM1007 was digested with 
EcoRI and BstBI to remove the GFP ORF and RBS but leaving the strong synthetic 
promoter, and gel extracted.  The cj0390 purified ORF above was then ligated into the 
pWM1007 backbone to create plasmid pJH26 which was maintained in E. coli DH5α.  
Plasmid pJH26 was then electroporated into 81116∆cj0390 to create the complementation 
strain 81116∆cj0390/pJH26. 
Reversion of Transposon Mutants.  We attempted to revert the transposon mutations of 
T5M52 and T7M30 to wild type at these loci by electroporating plasmids containing the 
wild type version of the mutated genes and plating to non-selective media.  Transposon 
mutants were made electrocompetent and electroporated as described above.  Strain 
T5M52 was electroporated with plasmid pJH29 (Appendix 8.6) containing the wild type 
cj1365c ORF and strain T7M30 was electroporated with plasmid pJH26 (Appendix 8.3) 
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containing the wild type cj0390 ORF.  Approximately 200 colonies from the T5M52 
electroporation were screened for Cm sensitivity by plating colonies to both MH+TrM 
and MH+TrM+Cm.  The previously known link of cj0390 [181] with motility was used 
to select for revertants of T7M30.  After electroporation as above of T7M30 with the wild 
type version of cj0390, the electroporated bacteria were immediately stabbed into soft 
MH Agar (0.4% agar).  Any motile growth was subcultured and tested for motility and 
Cm sensitivity.  Construction of plasmid pJH26 is described above.  Plasmid pJH29 was 
constructed with the cj1365c ORF and native RBS PCR amplified with primers jph165 
and jph166 (Appendix 1) containing BstBI and BglII sites respectively.  The amplicon 
was purified phenol:chloroform and ethanol precipitation.  Plasmid pWM1007 was 
digested with EcoRI and BstBI to remove the GFP ORF and RBS but leaving the strong 
synthetic promoter, and gel extracted.  The cj1365c purified ORF above was then ligated 
into the pWM1007 backbone along with an adapter created by annealing jph163 and 
jph164 together (EcoRI and BglII overhangs) to create plasmid pJH29 which was 
maintained in DH5α.   
Sensitivity to Triton X-100.  Sensitivity of NCTC11168∆cj0238 to Triton X-100 was 
tested relative to NCTC11168.  Both strains were suspended in MH broth to 
approximately 1x10
8 
cfu, pelleted at 11000 g for 2 minutes, and resuspended in 1 ml PBS 
+ 0.1% Triton X-100.  Following a 2 hour incubation the Triton X-100 samples were 
diluted and plated.   
Motility Assay.  Motility was determined by measuring growth diameter in soft agar 
stabs.  Bacteria cultures were resuspended in MH broth to an OD600 = ~0.5, a metal wire 
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was dipped in each culture and stabbed into a plate of MH broth + 0.4% agar.  Each plate 
contained a fully motile positive control (NCTC11168) and a non-motile negative control 
(NCTC11168∆flgK) to account for plate to plate variation.  After 48 hour incubation 
diameters of growth for each sample were measured and compared with paired t-tests. 
Absorbance Spectrum.  Absorbance was measured on various samples across the visible 
spectrum from 380 nm to 740 nm.  Measurements were taken on bacteria cells and 
extracts from the wild type strain (NCTC11168), a moderately red strain (T5M52), and 
the intense red strain (T34M24) harvested from overnight growth on MH+TrM agar into 
MH broth and equalized to approximately OD600=0.5.  Each of these strains were spun 
down 3220 g for 20 minutes, resuspended in PBS and measured, followed by 
centrifugation at 10000 g for 2 minutes to remove bacteria cells and the supernatant 
measured.  Cell lysate was created for both measurement and a starting solution for the 
following extraction procedures.  Bacteria cells from above were resuspended in 1% SDS 
solution instead of PBS and incubated at room temperature for 5mins.  This lysate was 
measured after spinning down debris at 10000 g for 2 minutes, and additional lysate 
samples were variously treated.  Additional treatments were freeze/thaw cycling, 
phenol:chloroform, ethanol, and acetone.  For freeze/thaw cycling the SDS cell lysate 
was cycled between -80°C freezer and a 35°C water bath three times, and debris pelleted 
by spinning 10000 g for 2 minutes, and the supernatant measured.  Phenol:chloroform 
was added to SDS cell lysate, vortexed well and spun 12000 g for 3 minutes and the 
upper aqueous phase separated from the lower organic phase and both samples 
independently measured.  Two volumes of 99% ethanol were added to SDS cell lysate, 
incubated on ice 10 minutes, and spun 20000 g for 15 minutes at 4°C.  The resulting 
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supernatant was measured, and the pellet was dried and attempted to be resuspended in 
TE.    Acetone treatment of SDS cell lysate was the same as the ethanol. 
Growth Curves.  Growth curves were performed in T75 filter top flasks at 37°C under 
microaerophillic conditions with the wild type strain run in parallel in 20 ml of media 
pre-incubated overnight in the same conditions.  As indicated some were grown 
stationary in biphasic MH broth/agar, and some in shaking MH broth, as well as some 
samples supplemented with various amounts of adenine. Approximately 0.5 ml samples 
were taken at various time points and measured at 0D600 or by dilution and plating. 
Sequencing Potential Red Determinants.  Sequencing was performed on various genes 
which were identified as possible determinants of the red phenotype.  This was performed 
to see if mutations had occurred in these genes in red strains which could be the cause of 
the red phenotype.  Genes cj0238, cj0490, and cj0497 were sequenced in strains T4M9, 
T5M52, T7M30, and NCTC11168.  This was performed by PCR with the following 
primers: jph204 and jph205 for cj0238, jph197 and jph198 for cj0490, and jph199 and 
jph200 for cj0497 (Appendix 1).  Genes cj0453, cj0512, and cj0702 were sequenced in 
strains T5M52, T7M30, T34M24, and NCTC11168.  This was performed by PCR with 
the following primers: jph245 and jph246 for cj0453, jph215 and jph216 for cj0512, and 
jph217 and jph218 for cj0702.  Each PCR reaction was performed with Phusion 
Polymerase (New England BioLabs) and optimized to produce a clean single band.  
Reactions were purified by phenol:chloroform extraction and ethanol precipitation and 
submitted to Macrogen (Rockville, MD) for sequencing with the same primers used for 
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the amplification.  Results were compared with ClustalW2 [186] on EBI [187] for all 
sequences including the appropriate sequence from the published genome [64]. 
Expression Assay of ade1/2 Orthologs.  The orthologs of yeast genes ade1 and ade2 in 
C. jejuni, cj0512 and cj0702 respectively, were analyzed for expression levels by real 
time RT-PCR along with gene cj0453.  All expression levels were relative to a 16s 
endogenous control and measured in RNA extractions (NucleoSpin RNA II Kit, 
Macherey-Nagel, Bethlehem, PA) of a moderate red strain (T5M52) and the intense red 
strain (T34M24) relative to the wild type strain (NCTC11168).  RT-PCR reactions were 
performed on an Applied Biosystems 7500 machine in triplicate with Applied 
Biosystems Power SYBR Green RNA-to-Ct 1-Step Kit according to manufacturer’s 
recommendations.  Primers used in the assay were: jph231 and jph232 for 16s, jph237 
and jph238 for cj0453, jph233 and jph234 for cj0512, and jph235 and jph236 for cj0702 
(Appendix 1).  Data analysis was performed both by ∆∆Ct and relative standard curve 
methods of quantification according to manufacturer’s instructions.  Standard curves 
were performed for each target on with five different dilutions of template (NCTC11168 
genomic DNA) spanning three logs in triplicate. 
 
Results 
Initial Red Mutant Isolation.  A total of 1170 random mutants were created for 
virulence screening purposes.  Three mutants (T4M9, T5M52, and T7M30) grew with a 
distinct red phenotype on MH agar, and all 3 showed a decrease in cell invasion (Table 
6).  All three had wild type growth rates (see Figure 11).  They were all grown in shaking 
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broth cultures except for T4M9 which was grown in biphasic media along with wild type 
in parallel (data not shown) which was more similar to T4M9 than the shaking broth wild 
type in Figure 11.  Motility of T4M9 and T5M52 was not significantly different from the 
wild type, but T7M30 was non-motile in soft agar. 
 
Table 6: Red mutants initially isolated 
Mutant Gene Disrupted Annotation Invasion
1
 Motility
2
 
T4M9 cj0469 
amino-acid ABC transporter 
ATP-binding protein  37.6 * 96% 
T5M52 cj1365c putative secreted serine protease  44.8 * 92% 
T7M30 cj0390 putative transmembrane protein 194.6 * 24%  ** 
1
Fold Decrease in cell invasion relative to wt.
  2
Motility as percent of wt * p<0.05    ** p<0.001 
 
 
 
Figure 11: Growth Curves of Original Red Mutants 
Growth curves of wild type NCTC11168 (wt), an aflagellated mutant (∆flgK), and the 
three red strains (T4M9, T5M52, and T7M30).  All appear to have roughly the same rate 
of growth indicating the cells are healthy. 
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Characterization of Knock Out Strains.  Knock out mutants for both cj0390 and 
cj1365c in strain NCTC11168 were successfully created.  The cj0390 knock-out 
procedure produced approximately 50 non-red colonies and two red colonies.  Both white 
and red strains were non-motile as was the original transposon mutant (T7M30), and 
were verified by PCR and sequencing to have had cj0390 correctly knocked out.  
However, only the red isolate (NCTC11168∆cj0390(R)) showed a significant decrease in 
cell invasion whereas a white isolate (NCTC11168∆cj0390(w)) did not (see Figure 12).  
The invasion deficiency is much lower for NCTC11168∆cj0390(R) than the red cj0390 
transposon mutant (T7M30) (Figure 12).  Knock out mutagenesis of cj0390 from strain 
81116 was also performed, producing all white colonies.  The mutation in this strain also 
did not affect invasion ability, however the plasmid based complementation of the cj0390 
mutation (81116∆cj0390/pJH26 which was hyper-motile) showed a significant (p<0.05) 
increase in cell invasion (46 fold).  The cj1365c knock-out procedure produced only non-
red colonies.  The cj1365c knock out strain (NCTC11168∆cj1365c) did not show a 
decrease in invasion (see Figure 12), and was verified to be correctly mutated by PCR 
and sequencing.   
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Figure 12: Cell Invasion of Red and White Strains.   
Cell invasion of the original red transposon mutants T5M52 and T7M30, the spontaneous 
white isolate T5M52rev#1, the red transposon reversion strain T7M30rev#1, the white 
knock out strain NCTC11168∆cj1365c, a red isolate of knock out strain 
NCTC11168∆cj0390(R), and a white isolate of knockout strain NCTC11168∆cj0390(w).  
All of the strains with the red phenotype have a significant cell invasion deficiency 
whereas all non-red strains do not.  (* = p<0.05, R = red phenotype, w = wild type color) 
 
 
 
Red Mutant Transposon Reversions.  Reversion of the transposon mutations 
(replacement of the transposon mutated locus with the wild type version) was attempted 
in order to further determine whether the transposon mutations were responsible for the 
red growth or invasion deficient phenotypes.  For T5M52 no successful reversion of the 
transposon mutation was obtained, however 9 spontaneous non-red isolates were 
recovered.  All non-red colonies were resistant to Cm suggesting a transposon is still 
present in the genome.  PCR of the cj1365c region in these isolates produced amplicons 
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with sizes expected for a transposon insertion in cj1365c identical to T5M52.  Therefore 
all of the spontaneous non-red isolates appear to still have the transposon inserted into 
cj1365c, and one isolate (T5M52rev1) was tested and found not to have a significant 
decrease in cell invasion (Figure 12).  For T7M30, using motility to find a revertant was 
successful in producing one stab point that showed motility.  Subculture of the apparent 
motile region recovered an isolate (T7M30rev1) which was fully motile and Cm sensitive 
indicating loss of the transposon, however it maintained its red growth and invasion 
deficient phenotypes (Figure 12). PCR of the cj0390 region in this isolate showed wild 
type size of cj0390 indicating reversion of the transposon mutation back to wild type for 
that locus.   
Mutant Screen for Red Phenotype.  In order to determine the genetic basis for the red 
growth phenotype approximately 8500 random mutants of NCTC11168 were created and 
screened for the red growth phenotype.  A total of 7 mutant strains were found to present 
this phenotype, resulting in 6 unique insertion sites (Table 7).  T34M24 had an insertion 
site not within a gene but upstream of two operons, neither containing genes associated 
with virulence in the literature.  T34M26 and T34M27 have the identical insertion sites 
and are from the same mutagenesis reaction (same Tag number), therefore were probably 
the same mutant strain which replicated before it was plated on selective media.  Two 
genes, cj0238 and cj0497, were independently identified twice in the screen with 
different mutation sites.  Even though we believe we hit saturation (supported by these 
multiple finds) we did not find any of the original three genes identified (cj0390, cj0469, 
and cj1365c) as would have been  
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expected by a saturation level screen if they were involved in the red phenotype.  All 
isolates had a similar red appearance except one strain, T34M24, had an intense red color 
that did not appear to increase with time, but was a constant high intensity red (Table 8).  
Additionally, all red isolates were found to have a significant decrease in cell invasion 
(Table 8).  This invasion deficiency across the strains appears to cluster in two groups: a 
high level of invasion deficiency (~100+ fold) and a low level (~30 fold) with the 
exception of T34M24 which had only a 5.8-fold deficiency.  Strain T34M24 also has a 
more pronounced motility defect that the other red mutants excluding T7M30 where the 
transposon disrupted a known motility factor.  Several other mutants have a highly 
significant decrease in motility (T34M26, T34M27, T35M6, T35M7) but only T34M24 is 
practically non-motile.  The three disrupted genes (cj0238, cj0490, and cj0497) were 
sequenced in the three original red mutants T4M9, T5M52, and T7M30 to see if 
mutations were present to explain the phenotype in these strains.  Sequences were wild 
type for all genes in all strains. 
 
Table 7: Mutants Isolated from the Red Phenotype Screen 
Strains isolated from a new transposon mutant screen for the red phenotype.  Two genes 
have previously been reported to be involved in cell invasion.  Two genes were 
independently found twice, highly suggestive of their involvement in the phenotype. 
Mutant Gene Disrupted Tn Insertion 
Virulence 
Ref 
T34M26  cj0238 221714 n/a 
T34M27 cj0238 221714 n/a 
T35M1 cj0238 221728 n/a 
T35M2 cj0490 455855 [110] 
T35M6 cj0497 461698 [110] 
T35M7 cj0497 462125 [110] 
T34M24 Intergenic 1322402 n/a 
 
70 
 
Table 8: Characteristics of Red Mutants 
Characterization of all of the red mutants isolated compared to wild type and a cell 
invasion deficienct control.  All red isolates visually have the same red color except for 
T34M24 which is a much more intense color.  Interestingly this strain also have 
decreased growth rate but it’s level of cell invasion deficiency is lower than the others.   
Strain 
Gene 
Disrupted 
Red 
Phenotype 
Growth 
Rate 
Invasion 
Deficiency
1 
Invasion 
Category Motility
2 
NCTC11168 n/a (-) wt 1.0 0 100% 
ΔflgK  flgK (-) wt 164.8* H 17%3** 
T4M9 cj0469 + wt 37.6
* 
L 96% 
T5M52 cj1365c + wt 44.8
* 
L 92% 
T7M30 cj0390 + wt 194.6
* 
H 24%
** 
T34M24 Intergenic ++ weak 5.8
* 
vL 25%
** 
T34M26 cj0238 + ND 36.4
* 
L 76%
** 
T34M27 cj0238 + ND 34.8
* 
L 78%
** 
T35M1 cj0238 + ND 24.5
* 
L 81% 
T35M2 cj0490 + ND 176.9
* 
H 89% 
T35M6 cj0497 + ND 113.3
* 
H 63%
** 
T35M7 cj0497 + ND 83.8
** 
H 65%
** 
0 = No Significant Cell Invasion Deficiency  L = Low Level Cell Invasion Deficiency  H = High Level Cell Invasion Deficiency  
vL = Very Low Level Cell Invasion Deficiency 1Fold decrease cell invasion relative to wild type,  2 Motility as percent of wild type, 
 3 ΔflgK is non-motile, ND = Not Determined, measured diameter represents stab diameter, * p<0.05, ** p<0.001 
 
 
 
cj0238 Mutagenesis.  Knock out mutagenesis of cj0238 in NCTC11168 produced many 
colonies, all of which were found to be non-red.  Cell invasion was performed with this 
strain (NCTC11168∆cj0238) to see if the invasion deficient phenotype remained 
associated with cj0238 (~35 fold decrease for red transposon mutants of cj0238).  The 
knock out mutant had a small but significant decrease in invasion (10.2 fold).  Since 
cj0238 encodes for a putative ion channel involved in osmotic stress response there was a 
possibility these results could be produced due to higher sensitivity to Triton X-100 
independent of cell invasion.  The knock out mutant had a 5.7 fold decreased survival 
rate relative to wild type in a Triton X-100 survival assay (p<0.05). 
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Absorbance Spectra of Red Mutants.  Absorbance measurements across the visible 
spectrum were performed on moderately red mutant strains and the intense red strain 
(T34M24) compared to the wild type strain.  A variety of methods were tested to 
determine if a simple extraction method would permit the visualization of peaks in the 
absorbance spectrum of the red strains to aid in the identification of the factor(s) causing 
the phenotype.  Bacteria were harvested after 24 hours growth which is sufficient for the 
intense red mutant (T34M24) to present the full intensity of the phenotype, however for 
the moderately red strains the phenotype is very weak at that point.  This was required as 
older cultures do not resuspend fully and therefore are problematic for spectrophotometer 
readings.  Intact bacterial cells of red mutants resuspended in solution produced spectra 
that were very similar to the wild type, without any indication of peaks (Appendix 7.1).  
However when the resuspended bacteria were spun out of the media, the resulting 
solution did produce an overall increased absorbance on the blue side of the spectrum 
(shorter wavelengths) for the intense red strain relative to the wild type (Appendix 7.2).  
Additionally, there are peaks present around the wavelengths found for the AIR-derived 
pigment in yeast (490 and 540 nm) along with addition peaks at approximately 600 nm 
and 640 nm.  The absorbance spectrum of the moderately red strain in this sample looks 
approximately the same as the wild type.  Visually only the media from the intense red 
isolate had a detectable red color.  Cells lysed with SDS and several different treatments 
were performed to determine if by removing other cellular components absorbance peaks 
may become more prominent.  Cell lysate without treatment, with any insoluble debris 
spun away, produced spectra which again had increased absorbance in the blue side of 
the spectra and in this case decreased absorbance on the red side of the spectra (Appendix 
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7.3).  This was true for both a moderately red strain (T5M52) and the intense red strain 
(T34M24) but was much more pronounced for T34M24.  Peaks present in T34M24 are 
an exaggerated 400 nm peak, and again unique peaks at approximately 490 nm, 540 nm, 
600 nm, and 640 nm.  The red for this sample was visible in both the lysate supernatant 
and the pellet.  Similar results were obtained with SDS treatment followed by three freeze 
thaw cycles (data not shown).  Cell lysate was also treated with phenol:chloroform and 
both the aqueous and organic phases absorbances analyzed.  During this procedure red 
was only visible in the aqueous phase of T34M24 and not detectible visually in the 
organic phase.  Again T34M24 shows a higher absorbance in the blue spectrum (shorter 
wavelength) and slightly lower in the red spectrum (longer wavelength) in the aqueous 
phase (Appendix 7.4).  An exaggerated 400 nm peak is also still present along with a 
weak approximately 540 nm peak.  However, the organic phase spectra showed a slightly 
different pattern (Appendix 7.5).  Here, where no red was visible by eyesight, T34M24 
still has an exaggerated 400 nm peak but then has wild type levels of absorbance through 
the rest of the spectra.  Ethanol treatment of the SDS cell lysate resulted in all of the 
visible red color pelleting.  The visibly clear supernatant had a very similar spectra to the 
visibly clear organic phase spectra, with T34M24 having an exaggerated 400 nm peak but 
roughly wild type across the rest of the spectrum (Appendix 7.6).  There are very weak 
possible peaks at approximately 500 nm and 540 nm, but the absorbance spectrum was 
generally wild type other than at 400 nm.  The visually red pellet from the above ethanol 
treatment could not be resuspended.  The components which did resuspended had spectra 
which were essentially no different from the wild type (Appendix 7.7).  Acetone 
treatment of SDS cell lysate resulted in similar results to the ethanol treatment.  The 
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visible red color was precipitated, the supernatant had a spectra almost identical to the 
ethanol supernatant (data not shown), and the pellet could not be resuspended. 
Effect of Adenine Supplement on Red Phenotype.  Absorbance spectrum failed to find 
red peaks in the whole cells so the observed red intensity could not be quantified 
(Appendix 7).  However with visual inspection it was qualitatively noted that there was 
roughly equal red production in the non-supplemented media as with the media 
supplemented with 0.1 mM adenine, but with 1.0 mM adenine all cultures grew white.  
No growth was obtained on media supplemented with 10 mM or 100 mM adenine.   
Analysis of ade1/2 Orthologs and cj0453 in Red Mutants.  Sequence and expression 
analysis was performed on the C. jejuni orthologs of the yeast ade1 and ade2 genes 
(cj0512 and cj0702 respectively), plus cj0453 (Appendix 6).  Analysis was performed on 
one moderately red strain T5M52 and the intense red strain T34M24 in parallel with the 
wild type strain.  Sequencing of the entire open reading frame of all three genes showed 
complete wild type sequence (data not shown) in all three strains.  An initial ∆∆Ct based 
expression assay showed a small, but significant, difference in the regulation of cj0702 
and cj0453 but not cj0512 in both red strains (see Figure 13).  Relative to the wild type 
strain cj0702 appears to be down regulated in both T5M52 (0.72 fold) and T34M24 (0.82 
fold).  Whereas cj0453 also appears to be downregulated in T5M52 (0.67 fold) but 
upregulated in T34M24 (1.26 fold).  The differences seen in cj0512 between the red 
mutants and the wild type strain are roughly the same as cj0702, however the wild type 
strain had more variance which may have prevented them from being significant.  
Analysis by the ∆∆Ct method assumes the target reaction has the same efficiency as the 
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endogenous control efficiency.  An efficiency assay for the cj0512, cj0702, and cj0453 
PCR reactions was performed relative to the 16s endogenous control (see Figure 14).  
The absolute slope of the ∆Ct curve of target to endogenous control over template 
dilutions should be less than 0.1.  In Figure 14 the absolute slopes are: 0.4 for cj0512, 0.4 
for cj0702, and 0.3 for cj0453 none of which are acceptable for ∆∆Ct analysis.  Therefore 
the expression assay was repeated with standard curves run in parallel for a relative 
standard curve method of quantification with new RNA extractions (see Figure 15).  
None of the three genes in this assay were found to be downregulated, however some 
were slightly upregulated in red mutants relative to the wild type strain.  In the 
moderately red strain (T5M52) only cj0702 was significantly upregulated (1.8 fold), 
whereas in the intense red strain (T34M24) all three genes were significantly upregulated: 
cj0512 1.7 fold, cj0702 1.8 fold, and cj0453 1.4 fold. 
 
 
Figure 13: ∆∆Ct Expression Assay of ade Orthologs 
Expression assay with ∆∆Ct analysis of ade1/2 orthologs in C. jejuni cj0512 and cj0702, 
along with cj0453 which initiates another AIR metabolic branch.  These genes are 
analyzed in the moderate red strain T5M52 and the intense red strain T34M24 relative to 
the wild type strain (wt). 
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Figure 14: ade Ortholog PCR Efficiency Assay 
Efficiency assay for the two ade orthologs cj0512 and cj0702 along with the AIR 
metabolic side branch cj0453 relative to 16s.  Acceptable efficiencies for ∆∆Ct analysis 
produce absolute slopes less than 0.1. 
 
 
 
 
Figure 15: Relative Standard Curve Expression Assay of ade Orthologs 
Expression assay with relative standard curve analysis of ade1/2 orthologs in C. jejuni 
cj0512 and cj0702, along with cj0453 which initiates another metabolic AIR branch.  
These genes are analyzed in the moderate red strain T5M52 and the intense red strain 
T34M24 relative to the wild type strain. 
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Mutagenesis of ade1/2 Orthologs.  Knock out mutagenesis of cj0512 and cj0702 
produced mutant isolates with high efficiency, but all isolates grew slowly and were non-
red.  Several of each were subcultured and verified to be slow growers (colony 
appearance 3-4 days compared to 2 days with wild type) and non-red.  A representative 
isolate of the cj0702 knock out was tested by PCR and verified to have the correct size 
for a knock out.  cj0512 knock out could not be verified this way since there was not a 
substantial difference between wild type and mutant sizes.  Both NCTC11168Δcj0702 
and NCTC11168Δcj0512 strains were sequenced and verified that the mutagenesis 
occurred as expected.   
Effect of Adenine on Growth Rate.  Growth curves of the original three mutants T4M9, 
T5M52, and T7M30 all appeared to have wild type growth rates (see Figure 11).  
Mutants may have had a faster death rate overnight as seen by an apparent sharper 
decline in recovered bacteria and OD600 after overnight incubation (data not shown).  
We attempted to grow wild type, T5M52, and T34M24 strains in minimal media 
(MCLMAN [188]) but despite several attempts at the media preparation we failed to get a 
sufficient growth rate (see Figure 16).  In Figure 16 while T5M52 has a normal growth 
rate in MH as expected, T34M24 (the intense red isolate) did have a growth deficiency.  
Figure 17 shows a decrease in growth rate of the wild type strain when supplemented 
with 1.0mM adenine.  Further, in Figure 18 wild type growth was only partially inhibited 
by 0.1 mM adenine which is the concentration that allows red production, but had a much 
larger growth inhibition at 1.0 mM adenine, which is the red inhibiting concentration.  
While T34M24 had a growth deficiency the effect of the varying concentrations of 
adenine on that strain still imposed a dose dependent growth deficiency. The cj0512 
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knock out strain had a large growth deficiency as seen in Figure 17 and with such slow 
growth we were unable to see if there was an effect of adenine supplementation on the 
growth.  But it did not rescue the deficient growth rate. 
 
Figure 16: Growth Curves of Moderate Red and Intense Red Isolates  
Growth curves of wild type (wt), a moderate red strain (T5M52), and the intense red 
strain (T34M24) in MH broth or minimal media (McL). 
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Figure 17: Effect of Adenine on Wild Type and cj0512 Knock Out Growth Rates 
Growth curves of wild type (wt) and cj0512 knock out (NCTC11168 ∆cj0512) strains 
without and with 1.0 mM adenine. 
 
 
 
Figure 18: Effect of Adenine on Wild Type and T34M24 Growth 
Growth curves of wild type (wt) and the intense red strain T34M24 without adenine 
supplement (+ 0 Ade), with 0.1 mM adenine supplement (+ 0.1 Ade), and with 1.0 mM 
adenine supplement (+ 1.0 Ade). 
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Discussion 
Original Isolation of the Red Phenotype.  Three random transposon mutants (T4M9, 
T5M52, and T7M30) were isolated and found to all have an identically appearing red 
growth phenotype both in mass growth and at the colony level on MH plates which did 
not appear to diffuse into the agar.  All of these mutants had significant decreases in cell 
invasion with T7M30 having the largest.  Following identification of the transposon 
insertion site for each, two genes were selected for knock-out mutagenesis: cj1365c and 
cj0390.  Knock out mutagenesis resulted in NCTC11168 ∆cj1365c colonies all non-red, 
and NCTC11168∆cj0390 colonies to be all non-red except for two.  Of mutant isolates 
selected from these, only the red colonies of NCTC11168 ∆cj0390 produced a significant 
invasion deficiency.  This suggests neither cj0390 nor cj1365c are involved in either the 
red phenotype or invasion deficiency.  Mutagenesis of cj0390 was also tried in another 
strain (81116) which produced non-red isolates with wild type cell invasion.  However, 
complementation of this mutation produced a strain hyper-motile strain which was still 
not red, but had an increase in cell invasion.  Therefore cj0390 may not to be involved in 
the red phenotype, but could play a role in virulence.  All mutants wild type in color had 
wild type levels of cell invasion. 
Red Phenotype is Not Associated with Transposon Mutation.  As the red was not the 
apparent dominant phenotype from the knockout mutagenesis assay of cj0390 and 
cj1365c we suspected that whatever mutation had caused the red phenotype was not due 
to the transposon mutation of cj0390 or cj1365c.  To verify this, we attempted to revert 
the tranposon mutation to the wild type version in the red mutants T5M52 and T7M30 to 
see the effect on the phenotypes.  Reversion of cj1365c mutation failed, however 
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spontaneous non-red colonies were isolated which still contained the transposon mutation 
of cj1365c.  Reversion of cj0390 transposon mutation to wild type was successful, yet the 
red phenotype remained.  Therefore since the red phenotype and transposon mutation did 
not remain associated in these isolates, along with the knock-out results, we felt confident 
that neither cj1365c nor cj0390 were involved with the red phenotype.  Therefore the 
mutation leading to the red phenotype must be elsewhere and had occurred spontaneously 
independently of the transposon mutation.  Additionally, across the transposon mutants, 
knockout mutants, and transposon revertants, the virulence deficient phenotype was 
always associated with red isolates, and never with wild type color regardless of 
mutation.  Further, when the red phenotype was spontaneously lost, so was the invasion 
deficiency. 
Mutant Screen for Additional Red Isolates.  A random mutant screen for the red 
growth phenotype was performed to see if the genetic basis of the phenotype could be 
identified.  We screened approximately 8500 random mutants exceeding the estimated 
number to achieve a saturation mutagenesis (5088 at 95% confidence).  The screen 
successfully isolated seven strains with the red phenotype.  We did not re-isolate any of 
the original three genes (cj0390, cj0469, and cj1365c).  All three would have been 
expected with a saturation screen if they were involved in the red phenotype.  However it 
was consistent with the data showing (at least for cj0390 and cj1365c) that those genes 
were not responsible for the red phenotype.  All of the new isolates appeared to have the 
same red phenotype as the original three (color, color intensity, and color production rate) 
except T34M24.  This mutant strain had a higher intensity red which was present at all 
levels of visible growth, unlike the other mutants which take time to fully develop.  When 
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all red mutants were analyzed for cell invasion, ignoring T34M24, there appeared to fall 
into two groups.  One group with a high level of invasion deficiency (>100 fold decrease) 
and another group with a low level of invasion deficiency (~30-fold decrease).  There 
was significant cell invasion deficiency for T34M24 but it was very low (~6-fold).  All 
mutants appeared to have at least some motility deficiency, however T34M24 had a 
substantial deficiency and is almost non-motile in soft agar. 
The three genes identified by this screen were sequenced in the original three red mutants 
(T4M9, T5M52, and T7M30) to see if there were mutations present which may have 
caused the red phenotype.  The sequences of each gene in all three strains were the same 
as the wild type with no observed mutations throughout the open reading frames.  It is 
possible that the genes identified in the red phenotype screen could again not be involved 
in the red phenotype if a spontaneous background mutation occurred independent of the 
transposon, as we believe happened with the original three red mutants.  However, we did 
isolate two genes twice with different mutation sites (cj0238 and cj0497), which suggests 
their involvement in this phenotype. 
Mutagenesis of cj0238.  Knock out mutagenesis was performed on cj0238 to see if it 
would replicate the red growth and invasion deficient phenotypes.  While the knock out 
mutant of cj0238 did show a small but significant 10-fold decrease in cell invasion there 
were doubts about the authenticity of the data.  Since cj0238 is a probable ion channel 
utilized for osmotic stress response a mutant could therefore be more sensitive to Triton 
X-100 which is used in the final step of the cell invasion to harvest internalized bacteria.  
A sensitivity assay verified that NCTC11168∆cj0238 was more sensitive to Triton X-100 
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and therefore most, if not all, of the observed 10-fold decrease in cell invasion was most 
likely an artifact of this increased sensitivity. Other cell lysing agents are available to 
harvest internalized bacteria other than Triton X-100 which may be a topic for future 
work.   
The most relevant result from the cj0238 mutagenesis was that cj0238 also appears not to 
be involved with the red phenotype production.  This was surprising as two independent 
transposon mutants of cj0238 were found in the red mutant screen, therefore there was 
strong indication of its involvement.  At this point we lacked confidence that any other 
gene identified from the red mutant screen (Table 7) was involved in the phenotype.  It 
was apparent that whatever background mutation event was producing this phenotype it 
is occurring often, at least during the transposon mutagenesis process, and may not be 
identifiable by transposon mutagenesis.  We therefore examined a similar phenotype in 
yeast to see if a similar effect could be occurring here in C. jejuni which may not have 
been identified through a mutant screen. 
Adenine Reverts the Red Phenotype.  In yeast red pigmentation is due to ade1 or ade2 
mutations causing a buildup of AIR degrading to a red pigment.  These red mutant strains 
grow white when supplemented with 1.0 mM adenine, but not with 0.1 mM adenine.  
This is due to a downregulation of the overall pathway since adenine can be converted to 
ATP, and therefore AIR is not produced in quantities sufficient for a buildup to occur 
(Appendix 6).  Media supplemented with adenine was shown to eliminate red production 
in our red C. jejuni mutant strains at approximately the same concentration as in yeast.  It 
is unknown how much adenine is present in Mueller Hinton media, but if it is only in 
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trace amounts then concentrations to prevent red buildup are the same as in yeast with 
ade1 or ade2 mutations (red at 0.1 mM, white at 1.0 mM).  This suggests that the 
mechanism of red color production could be similar to the one observed in yeast.  
However, we expected additions of adenine to be a benefit to the mutants, but in growth 
curve experiments all strains (wild type or mutant) appeared to be slightly inhibited by 
0.1 mM adenine (red allowing concentration) and severely inhibited by 1.0 mM adenine 
(red preventing concentration).  The severely red mutant (T34M24) already had a growth 
deficiency, but that deficiency was increased with the addition of adenine.  There is 
documented adenine toxicity in other species of bacteria which is rescued by 
supplementations such as guanine.  This is due to the presence of the adenine 
downregulating the entire pathway which is also needed for GTP synthesis whose 
intermediates cannot be processed in some species (possibly in C. jejuni as well) from 
adenine.  Therefore excess adenine results in depleted stocks of GTP and therefore 
inhibits DNA replication (Appendix 6).  
This adenine toxicity may explain the red phenotype reversion by adenine 
supplementation independent of the AIR pathway.  It could be that the red pigment in our 
isolates is indeed a buildup of some product due to a mutation in a non-AIR pathway.  
The inhibition of red pigment production by adenine could be due to the overall stress on 
the cell, resulting in the slow growth from the presence of excess adenine, preventing the 
buildup of some non-AIR derived red product.  In yeast decreased growth rate does 
inhibit red pigment production.  This possibility could be addressed if a supplement could 
be identified that would allow a normal rate of growth in the presence of 1.0 mM adenine 
and see if the red phenotype still reverted.  If full growth rate allows red production in the 
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presence of 1.0 mM adenine then the red production is likely not in the AIR pathway 
after all.  If the red phenotype is still inhibited with a full growth rate and adenine 
supplement, then it would indicate the AIR pathway is involved in the red production. 
Orthologs of ade1/2.  Since adenine supplement of the media may revert the red 
phenotype in the same way as in yeast, we investigated whether the same mechanism in 
yeast producing the red pigment (mutations leading to excess AIR buildup) could also be 
occurring in our red C. jejuni mutants.  Buildup of AIR, and therefore red pigment, in 
yeast is due to mutations in ade1 or ade2 genes which in C. jejuni are equivalent to 
cj0512 and cj0702 respectively (Appendix 6).  Additionally in C. jejuni, but not in yeast, 
AIR is also utilized by cj0453 to supply the thiamine biosynthesis pathway (Appendix 6).  
These genes could produce this red pigment either by being mutated or downregulated.  
Therefore sequence and expression analysis was performed on each gene.  Sequence 
analysis was performed across the full open reading of each of these three genes in red 
mutants T5M52, T7M30, and T34M24, and no mutations were found.  In an initial 
expression assay cj0512 was not found to be expressed differently in red and wild type 
strains.  Gene cj0702 did appear to be significantly down regulated in both red mutants 
and cj0453 appeared to be downregulated in the moderate red mutant T5M52, but 
upregulated in the intense red mutant T34M24.  These expression differences were very 
small though and the results are suspect since the analysis method (∆∆Ct) was found not 
to be valid as the efficiencies of the different PCR reactions were too different.  A 
subsequent expression assay with new RNA extractions and valid analysis method 
(relative standard curve method) again found only small upregulation between red and 
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wild type strains.  In T5M52 only cj0702 was significantly upregulated, and in T34M24 
all three genes were significantly upregulated.   
There is currently no clear explanation as to why an upregulation of these genes would 
occur.  Possibly if the intense red mutant has higher AIR levels it may be high enough in 
that strain to induce upregulation of genes to utilize that component.  However more 
likely, it could be the result of a slight shift in the overall expression landscape of these 
mutants due to the red phenotype.  There is no evidence here of downregulation or 
mutations in these three gene (cj0512, cj0702, and cj0453) to explain the red phenotype. 
Red appears to develop over time (at mass growth and colony levels) in all but one isolate 
(the intense red isolate is fully red at all times of growth) which fits with the hypothesis 
of a buildup of a metabolic intermediate.    Likewise, growth of Cm
R
 mutants on plates 
with Cm (translational inhibitor) appears to produce slightly less intense red growth than 
plates without Cm.  Attempts to measure the red presence/intensity by absorbance spectra 
have failed as no distinct peaks/valleys were observed in the bacterial spectra of the 
mutants relative to the wild type.  Therefore these observations are purely qualitative. 
Since this apparent buildup takes time and presumably requires metabolic throughput to 
supply the buildup, it could be that the knockout strains of cj0512 and cj0702 grow so 
slowly and/or have such a disturbed metabolism that AIR buildup cannot occur.  If 
supplements could be identified allowing a full growth rate, these mutants could be red 
after all.  This fits in with the mutant screen which did not find cj0702 or cj0512 since 
that mutation would most likely produce a phenotype closer to the knock strains (slow 
growth, no red production). 
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However, as no mutations in cj0512, cj0702, or cj0453 were identified and no difference 
in expression levels were observed, these three genes are likely not involved with 
production of the red phenotype.  The knock out work of cj0512 and cj0702 was 
inconclusive without further investigation into the growth rate.  This does not rule out the 
possibility of the red phenotype in our mutants being produced from an AIR degradation 
product similar to yeast though.  The buildup could be in some other step of the pathway, 
just at a different position than identified in yeast. 
Absorbance Spectra of Red Mutants.  Absorbance spectra on red cell suspensions were 
attempted to identify a wavelength to measure the red intensity.  Additionally cell lysates 
followed by several treatments were attempted to identify peaks in extracts for 
comparison to the published yeast red pigment or otherwise aid in the identification of the 
responsible cellular component.  For these spectra, while the moderately red strain 
T5M52 had to be used before its red color fully developed, the intense red strain T34M24 
was fully red.  Absorbance spectra of whole cell suspensions showed no obvious peaks 
explaining the visibly distinct red color.  These results are different from the following 
cell lysis and extraction results likely due to the whole cells scattering more light making 
it very difficult to detect differences in absorbance.  This is supported by the measured 
absorbances of the whole cells being much larger than any of the lysed and extracted 
absorbances.  For cell lysate, and across almost all treatment methods, an exaggerated 
absorbance at 400 nm was noted.  This was regardless of the portion of the sample after 
treatment which was visually red, suggesting that this peak may not be involved in 
producing the red color.  For instance after the phenol:chloroform treatment the visible 
red was entirely in the upper aqueous phase.  However both the aqueous and organic 
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phases contained the exaggerated 400 nm peak.  But the aqueous phase did have a slight 
peak at approximately 540 nm which was not present in the organic phase.  This peak 
does coincide with one the two reported peaks of purified AIR-derived red pigment in 
yeast [114].  As this red color was present only in the aqueous phase suggests it is not 
protein based, consistent with AIR-derived pigment, and considering it precipitated with 
the DNA in the ethanol treated sample suggests it could be associated with the DNA.  
The AIR-derived red pigment in yeast was shown to inhibit restriction endonuclease 
activity [189].  If DNA bound, then the red pigment may alter gene expression leading to 
deficiencies in motility and invasion.  The other absorbance peak reported for the purified 
AIR-derived red pigment in yeast was at 490 nm.  The resuspension media spectra did 
have a peak around this wavelength, likely this solution was red from dead cells carried 
over from the scraping of the plate, along with lysis of other weakened cells from the 
abrupt change in osmolarity.  Red color was never observed to have diffused into the MH 
agar plates, even after extended incubations.  The above is consistent with an AIR-
derived pigment similar to that seen in yeast.  However, all of the spectra derived from a 
visibly red solution show a bias across the spectra which could equally explain the red 
coloration.  There is increased absorption at the blue side of the scale (shorter 
wavelength) relative to the wild type, and decreased absorption at the red side of the scale 
(longer wavelengths).  The crossing point is around 625 nm – 650 nm which is right 
around the wavelengths corresponding to a transition from orange to red.  Thus a 
substance absorbing more light in every wavelength except red, and absorbing less light 
in the red wavelengths will look red.  As this is a full-spectrum bias it provides no clues 
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as to whether it is a single chemical species (and what that could be) built up or depleted, 
or if it’s a shift in the overall makeup of the cell. 
Relation of Intense and Moderately Red Mutants.  Of all of the red strains isolated, the 
intense red strain T34M24 is the only strain which has a different visual appearance.  
Visually, T34M24 looks as if it could be caused by the same mechanism as the others, 
but as an exaggerated form producing pigment faster and ultimately producing more of 
the pigment such that it appears darker.  The growth and motility deficiencies of T34M24 
fit in with the hypothesis of the mechanism of the red phenotype being the same for both 
moderately red strains and T34M24, just arising from a more intense effect in the latter.  
However if this is the case, the much lower cell invasion deficiency in this strain cannot 
be rectified.  Throughout the work presented here, all strains with the red phenotype have 
had a decrease in cell invasion, however the effect on T34M24 was much lower even 
though the color was much more intense.  This suggests that the intense red phenotype 
may arise from a different mechanism than the other moderately red strains and therefore 
be an entirely distinct phenotype.  Mutant T34M24 was also unique in that it was the only 
transposon mutant which did not disrupt a gene, rather it was inserted upstream of two 
operons.  Therefore we cannot rule out some of its unique features (including difference 
in color) to be due to the misregulation of one or both of these opersons, or an interaction 
between that and the red phenotype.  The absorbance data provided no insight to this 
since although T5M52 never had peaks that T34M24 did not, they could have been too 
weak to be detected with the state T5M52 was used. 
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Conclusions 
A novel red phenotype was initially isolated in three transposon mutant strains all which 
had a decrease in cell invasion.  Two of the three genes were selected for further 
investigation and through knock out mutagenesis, transposon reversion, and spontaneous 
phenotype reversion we determined the transposon mutations were not involved with the 
red phenotype.  However the red phenotype and cell invasion were always linked.  An 
additional seven red transposon mutants were isolated but again did not have mutations 
that appeared to be the cause of the red phenotype.  These new red isolates also were all 
deficient for cell invasion.  A red phenotype in yeast is due to mutations in a metabolic 
pathway which is present in C. jejuni.  Adenine supplementation in these red yeast 
mutants prevents the production of the red phenotype.  The red C. jejuni mutants isolated 
here all grew wild type in color at the same concentration of adenine as reported for the 
yeast mutants.  Orthologs in C. jejuni of the genes in yeast responsible for the red 
phenotype were found not to be mutated or downregulated in our red mutants.  Knock out 
mutatgenesis was performed on two of them which resulted inconclusively as to whether 
they were truly red.  This uncertainty is due to both mutants (which appear wild type in 
color) having a severe growth defect which could prevent the buildup of the red pigment 
as was reported in yeast.  However, the adenine supplement was found to cause a growth 
defect in both red and wild type strains at the concentration required to inhibit the red 
phenotype.  Therefore more work is required to determine whether the adenine 
supplement reverts the red phenotype independent of growth rate.  Absorbance spectra of 
red mutant cells and extracts found weak peaks at the wavelengths reported for the red 
yeast pigment.  But overall they show a spectrum wide bias of increased absorbance in 
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the non-red spectrum, and decreased absorbance in the red spectrum relative to the wild 
type.  We have identified a novel phenotype in C. jejuni which was linked to a decrease 
in cell invasion, however to date we have not been able to identify the genetic locus 
responsible.  Work is ongoing with an LC/MS/MS collaboration to try and identify an 
AIR buildup in red strains, or some other component.  Additionally as the cost for 
sequencing of whole bacterial genomes continues to drop, it may be feasible to sequence 
several of these red isolates to look for possible mutations responsible.  Since the 
presence of the red phenotype results in decreased cell invasion, identification of the 
responsible factors could result in a useful tool for decreasing the intensity of C. jejuni 
infections.  Additionally it may provide a better understanding of C. jejuni metabolism 
and virulence.   
This work also produced several knock out mutants which may be the focus of future 
work.  A knock out of cj0238 still may have a cell invasion deficiency with a different 
lysing agent.  As this gene is predicted to be involved in osmotic stress response future 
research with this may provide important insights into C. jejuni stress management in 
different environments.  Knock out mutants of cj0512 and cj0702 have severe growth 
defects and therefore can be used to characterize C. jejuni metabolism by finding those 
supplements which affect this growth rate.  Knock out and complemented strains of 
cj1365c may provide insight into other aspects of virulence than cell invasion potentially 
in complement resistance or in processing of extracellular nutrients.  Gene cj0390 was 
knocked out and complemented in two strains of C. jejuni here with strong effects on 
motility and a possible link with virulence (overexpression resulted in an increase in cell 
invasion).  Future research on this may provide significant insights into C. jejuni’s 
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activities in the environment and within the intestines before entry into epithelial cells by 
a greater understanding of the mechanisms involved in motility.  This work has not only 
identified a virulence associated phenotype but produced several mutants whose 
characterization may provide significant insights to C. jejuni’s genetics, physiology, and 
virulence. 
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Chapter 4: Cj1051c is a Major Determinant for the Restriction Barrier of 
Campylobacter jejuni Strain NCTC11168 
 
Prepared for Submission to Applied and Environmental Microbiology 
 
Abstract 
Campylobacter jejuni is a leading cause of diarrheal illness in the world and research on 
it has benefitted greatly by the completion of several genome sequences and development 
of molecular biology tools.  However many hurdles remain to fully understand this 
unique bacterial pathogen.  One of the most common strains for genetics work in C. 
jejuni is NCTC11168.  While this strain is readily transformable with DNA for genomic 
recombination, it is difficult to transform with plasmids.  In this study we identified a 
gene, cj1051c, predicted to encode a restriction modification Type IIG enzyme that is at 
least partially responsible for the plasmid transformation barrier.  Deletion of cj1051c 
resulted in a strain with 1000-fold enhanced transformation efficiency with plasmid 
purified from a C. jejuni host.  Additionally this mutagenesis confers the ability to be 
transformed by plasmids isolated from an E. coli host.  Sequence analysis shows high 
variability in the specificity domain of cj1051c, as well as evidence for phase variation.  
We provide evidence that cj1051c is active in NCTC11168 and behaves as expected for a 
Type IIG enzyme.  Identification of this provides a greater understanding of the 
molecular biology of C. jejuni as well as a tool for plasmid work in strain NCTC11168.  
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Introduction 
Campylobacter jejuni is a Gram-negative microaerophilic pathogen and a major cause of 
diarrheal disease worldwide.  C. jejuni is the second leading cause of bacterial foodborne 
illness in the US behind Salmonella [11], and is the leading cause of foodborne illness in 
the UK [9, 10].  While an understanding of the genetics of C. jejuni trails many other 
enteric pathogens, completed genomic sequences and molecular tools have been 
developed which are allowing a greater understanding of this unique pathogen.  Genome 
sequencing revealed a number of homopolymeric tracts [64] which can lead to phase 
variation due to slipped strand mispairing affecting many cellular processes including 
capsule [108], motility [190, 191], bacteriophage infection [181, 192], and restriction 
modification [156, 158]. 
Restriction modification (R-M) systems’ primary function is likely the prevention of 
extracellular DNA from establishing in the cell.  Specifically the need for this protection 
is most apparent for bacteriophage and transposons, but may also play a role in 
preventing horizontal transfer facilitating speciation [193].  R-M systems are diverse in 
specificity and strategy, but their general function is to degrade non-self DNA which is 
determined by methylation patterns on the DNA.  At specific recognition sites fully 
methylated DNA is ignored, hemi-methylated DNA is methylated, and non-methylated 
DNA is digested (restricted) [194].  These systems complicate molecular biology work 
by inhibiting transfer of plasmids between species and even between strains of the same 
species of bacteria [142] as multiple systems within a single strain can all participate in 
the restriction barrier [143].  Identification and deletion of these systems are useful for 
developing strains which allow plasmid transformation [144-147].  Other approaches to 
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work around a restriction barrier have been to appropriately methylate the plasmid before 
transformation into the target species [148-154], elimination of the targeted sites in the 
plasmid to evade digestion [151], or use of plasmids with few or no naturally occurring 
target sites [155].  
R-M systems are categorized into 4 types based on a variety of features.  Type II R-M 
systems are the most common type commercially available as they recognize specific 
sequences and cleave within, or close to, those sequences and are therefore of greatest use 
for molecular biology techniques.  They usually have independent MTase and REase 
enzymes recognizing the same specificity sequence serving to methylate and restrict 
respectively.  Type II systems are further divided into subtypes of which subtype G 
designates those which have both MTase and REase functions in the same enzyme [138].   
C. jejuni strain NCTC11168 is one of the most common laboratory strains in 
Campylobacter research.  It was originally isolated from a patient with diarrhea [173, 
174], and was the first Campylobacter strain to be sequenced [64].  While C. jejuni is 
naturally transformable and amenable to electroporation for chromosomal insertion of 
DNA via genomic recombination, plasmid transformation of NCTC11168 is problematic.  
It has also been found that transformation occurs much more readily with DNA derived 
from a C. jejuni host than an E. coli host [195] suggesting a restriction barrier.  
Complementation assays in NCTC11168 therefore are commonly performed by 
expression constructs inserted into the genome (into a pseudogene [196-199], or near 
ribosomal genes [200]).  Not only does this add complications in strain construction, but 
there are always risks of side effects when disrupting the genome.  Additionally a single 
genomic copy of an expression construct gives lower expression levels than from 
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expression off the (potential) multiple copies of plasmid present per cell.  Often this copy 
number enhancement of expression levels is useful to obtain sufficient expression from 
synthetic constructs to compare to the native form. 
Here we attempted to identify factors in NCTC11168 which may contribute to its 
restriction barrier by screening random transposon mutants for plasmid transformation.  
We successfully identified a gene, cj1051c, which when knocked out allows 1000-fold 
increase in plasmid transformational efficiency with plasmid derived from a C. jejuni 
host.  Further, this mutation allows transformation with plasmid derived from an E. coli 
host.  This work provides increased knowledge into the molecular biology of C. jejuni 
and allows for the increased use of plasmid based techniques with this important 
pathogen. 
 
Methods 
Sequence Analysis.  R-M systems of NCTC11168 were identified and classified with 
REBASE [134] and the annotated genome sequence [64, 201].  The homology and 
genetic context of cj1051c in NCTC11168 was compared against other common 
laboratory strains 81116 [202] and 81-176 [203, 204] using ClustalW2 [186] on EBI 
[187] as well as mVISTA [205, 206] and Pfam [207].  Search for homologs of cj1051c 
was performed with protein BLAST [208] and compared with ClustalW2 and Pfam. 
Culture Conditions.  Campylobacter jejuni strain NCTC11168 was obtained from the 
ATCC (Manassas, VA) and routinely grown on Mueller Hinton (MH) Agar with 5 µg/ml 
trimethoprim (TrM) and supplemented with 20 µg/ml chloramphenicol (Cm), 2 µg/ml 
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tetracycline (Tet), 50 μg/ml kanamycin (Kan), and 5% horse blood where appropriate.  
All C. jejuni cultures were grown in a Binder (Bohemia, NY) CB150 incubator set to 
37°C, 5% O2, 10% CO2, and 85% N2.  E. coli strains DH5α and BW25141 were obtained 
from The E. coli Genetic Stock Center (New Haven, CT) and grown on LB agar 
aerobically at 37°C with appropriate antibiotics as above.  Plasmid pWM1007 [184] was 
maintained either in a C. jejuni host (RM1849) or an E. coli host (DH5α) and extracted 
with Omega Plasmid Mini Kit II (Omega Bio-Tek, Norcross, GA).  Bacterial strains and 
plasmids used in this study are listed in Table 9. 
Generation of Random Mutants.  Mutagenesis was performed similar to previous work 
[113, 176] by in vitro transposition followed by transformation and insertion into the 
chromosome by homologous recombination.  Transposase C9 [178], a hyperactive 
mutant of Himar1, was purified as previously described as a maltose binding fusion 
protein expressed off of pMALC9 [176] but in BL21(DE3)/pLysS (Promgea, Madison, 
Wisconsin) with freeze thaw lysis.  Tagged transposons were previously developed and 
maintained on plasmids pAJG40 through pAJG134, each containing a unique tag 
sequence [113].    Briefly, 2 μg of NCTC11168 genomic DNA, 1 μg of one of pAJG40 – 
pAJG134 transposon source plasmids, and 150 ng transposase were combined in buffer 
[176] at 30°C for 6 hours.  Transposed DNA was then purified on a column (Qiagen, 
Valencia, CA) and repaired.  To repair the DNA 1.5 U of T4 DNA polymerase, NEB 
Buffer #2, and 25 μM of each dNTP were added and incubated for 20 minutes at 37°C 
followed by inactivation at 75°C for 10 minutes.  The reaction was then treated with 10 U 
ligase overnight in 1x ligase buffer, and column purified (Qiagen, Valencia, CA).  
Repaired mutated DNA was used to naturally transform NCTC11168, see below.  Mutant 
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colonies were picked after 3 days incubation on MH+TrM+Cm+5% blood plates.  The 
location of the transposon insertion in mutant strains was determined by plasmid rescue.  
Mutant genomic DNA (1 µg) was digested overnight with SspI.  Digestions were cleaned 
up by phenol:chloroform and ethanol precipitation, and ligated overnight with 400 U T4 
DNA ligase.  Ligation reactions were ethanol precipitated and electroporated into E. coli 
BW25141 [172], containing the λ pir gene necessary for the oriR6kγ origin of 
replication, according to BioRad protocols.  Colonies were picked from LB+Cm plates 
after 48-72 hour incubation at 37°C.  The insertion site was determined by sequencing off 
the transposon in the subsequent plasmid with either primer ajg227 or CC001 [113]. 
Natural Transformation of Campylobacter.  Natural transformation of C. jejuni strains 
was performed similar as before [113, 179].  Bacteria from a lawn of overnight growth on 
MH+TrM were harvested in 1 ml MH broth and pipetted on a MH+TrM plate and 
incubated upright at 37°C microaerophillically for 3 hours.  Purified DNA was then 
mixed into the bacteria and the plate incubated for a further 4 hours.  Bacteria were 
harvested by scraping into 1 ml MH broth, diluted 1:10 or 1:100 when anticipated to be 
necessary, and plated to selective media. 
Electroporation of Campylobacter.  Production of electrocompetent C. jejuni strains 
and electroporation were performed as before [179].  Bacteria from a lawn of overnight 
growth on MH+TrM were harvested into 10 ml MH broth, adjusted OD600 ~5, pelleted at 
3000 g for 20 minutes at 4°C and resuspended in 5 ml ice cold wash buffer (272 mM 
sucrose, 15% glycerol).    This wash step was repeated three more times, and finally 
resuspended in 1 ml ice cold wash buffer.  Cells were aliquoted in 100 µl and stored in    
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-80°C until needed.  To each 100 µl electrocompetent cell aliquot thawed on ice, DNA 
was added, gently mixed, and added to a 0.2 cm cuvette on ice.  Electroporation was 
performed with a BioRad MicroPulser (1 pulse of 2.5 kV, 600 ohm, 10 µF) and the 
electroporated cells transferred to 200 µl SOC, mixed, and spread on MH+TrM plates.  
Plates were incubated upright for 5 hours, bacteria harvested into 1 ml MH broth, spun 
10000 g for 2 minutes, resuspended in 100 µl MH broth and plated to selective media.  
Negative controls (no DNA) were performed in parallel. 
Mutagenesis of cj1051c.  Knock out mutagenesis of cj1051c was performed by 
overlapping-extension PCR [185] maintaining the original frame to avoid polar effects.  
The region upstream of cj1051c was PCR amplified with primers jph239 and jph240 
(Appendix 1).  Downstream of cj1051c was PCR amplified primers jph241 and jph242.  
The tetracycline resistance gene, tetO, was PCR amplified from pTet (extracted from 81-
176)  using primers jph247 and jph249 containing the same overlapping regions as C1 
and C2 for cross compatibility of the markers [185].  After phenol:chloroform and 
ethanol precipitation of the individual amplicons, 500 ng of upstream and downstream 
amplicons were combined with 1.6 µg of the tetO amplicon and thermal cycled without 
primers to anneal overlapping fragments and to fill in gaps.  The mutagenesis construct 
was created by PCR amplification of 2 µl of the annealing reaction above with the 
outside primers jph239 and jph242.  The resulting amplicon was purified by 
phenol:chloroform extraction and ethanol precipitation.  Mutagenesis was performed by 
electroporating the purified mutagenesis construct into NCTC11168 as described above 
and selecting Tet
R
 colonies to produce strain JH1.  Mutants were verified for correct 
mutagenesis by PCR with primers jph243 and jph244 which flank the mutated region.  
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All PCR reactions were performed with Phusion Polymerase (New England BioLabs) 
and gel extractions with  Omega Gel Extraction Kit (Omega Bio-Tek, Norcross, GA).  
Complementation of cj1051c.  Complementation was performed by expression of 
cj1051c driven by the Kan
R
 promoter as it was known to have activity in this strain and 
the native promoter of cj1051c was not obvious.  This expression construct along with 
the Cm
R
 marker was cloned within a presumed pseudogene (cj0046) of JH1.  The cj0046 
ORF was cloned by PCR amplification with primers jph38 and jph39 (Appendix 1) 
containing BamHI and EcoRI sites respectively followed by ligation into pUC19 [175] to 
create plasmid pJH19 (Appendix 8.1).  The expression construct for cj1051c 
complementation was created by overlapping-extension PCR similar to Hansen et al 
[185] with SpeI sites included at either side for subsequent cloning.  The Cm
R
 cassette 
was PCR amplified from pRY112 [177] with primers jph250 (C1 [185] with SpeI site 
added) and C2 [185].  The Kan
R
 promoter was PCR amplified from pWM1007 with 
primers jph251 and jph252, and the cj1051c ORF was PCR amplified from NCTC11168 
genomic DNA with primers jph253 and jph254 containing an SpeI site.  After 
phenol:chloroform and ethanol precipitation of the three amplicons above individually, 
100 ng of Cm
R
 cassette, 100 ng of Kan promoter, and 500ng of cj1051c ORF were 
thermal cycled without primers to anneal overlapping fragments and to fill in gaps.  The 
expression construct was created by a PCR with 2 µl of the above annealing reaction as 
template using outside primers jph250 and jph254.  The complementation construct for 
cj1051c was created by cloning the above expression construct into the native unique 
SpeI site of cj0046 previously cloned in pJH19 to create pJH35.  Sequences from pUC19 
in pJH35 were removed by linearization with BamHI followed by gel extraction and NspI 
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digestion and gel extraction to yield the linear cj1051c complementation construct.  This 
construct was then ethanol precipitated and electroporated into JH1 resulting in double 
crossover at the cj0046 locus to create the complemented strain JH2.  Insertion at the 
target site was verified by PCR with primers jph43 and jph44 which flank the mutated 
region.  All PCR reactions were performed with Phusion Polymerase (New England 
BioLabs) and gel extractions with  Omega Gel Extraction Kit (Omega Bio-Tek, Norcross, 
GA).   
 
 
Table 9: Bacteria Strains and Plasmids used in Chapter 4 
Name Description Source 
E. coli: 
      DH5α plasmid host 
     BW25141 plasmid rescue host [172] 
   C. jejuni: 
      81-176 pTet Source [204] 
    RM1849 D781 [184] 
    NCTC11168 Wild type C. jejuni [173, 174] 
    JH1 Knock Out Mutant of cj1051c This work 
    JH2 Complementation Strain for cj1051c         This work 
   Plasmids: 
      pUC19 E. coli cloning plasmid [175] 
    pMALC9 Transposase expression plasmid [176] 
    pAJG40 - 134 Transposon source plasmids [113] 
    pRY112 CmR source [177] 
    pWM1007 GFP expression plasmid, KanPr source [184] 
    pJH19 pUC19 + cj0046 This work 
    pJH35 pJH19 + cj1051c Expression Construct This work 
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Results 
Mutant Screen for Transformation.  A random screen was performed to try and 
identify factors of NCTC11168 which inhibited plasmid transformation.  Approximately 
40,000 random transposon mutant isolates of NCTC11168 were produced, harvested as a 
pool, grown overnight, and made electrocompetent.  One µg of pWM1007 purified from 
either E. coli (DH5α) or C. jejuni (RM1849) was electroporated into the electrocompetent 
mutant pool followed by selection for the plasmid antibiotic marker.  No transformants 
were obtained with plasmid purified from E. coli, however 164 transformants were 
obtained with plasmid purified C. jejuni.  The transposon insertion sites for 2 of the 
transformants were found to be the same location in gene cj1051c, a probable restriction 
modification enzyme. 
Sequence Analysis of cj1051c.  Analysis of the predicted R-M and methylation systems 
of NCTC11168 [64] revealed seven potential systems (Figure 19).  One Type I system, 
one Type IV system, three Type IIG systems with restriction and modification 
components fused (including cj1051c), one Type II system containing only a methlyation 
component, and a dam-like methylation enzyme.  Comparison of the genetic region of 
cj1051c in NCTC11168 with other common laboratory strains 81116 and 81-176 
revealed differences between each strain (Figure 20A).  The genome sequence of 81116 
at the equivalent locus contains a poly(A)7 tract generating a stop codon and two ORFs, 
C8J_0993 and C8J_0992.  Restoration of a full-length ORF by a deletion to a poly(A)6 
tract results in a gene with high nucleotide identity across the majority of the cj1051c 
ORF except for regions in the predicted specificity domains, see Figure 20B.  In strain 
81-176 the cj1051c locus is entirely absent, and a BLAST search did not find it elsewhere 
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in the 81-176 genome.  A BLASTp search for Cj1051c found 60 C. jejuni and C. coli 
strains with high similarity across the protein sequence but variation in the predicted 
specificity regions.  Only two strains, C. jejuni 110-21 and C. jejuni DFVF1099 [209], 
had complete sequence identity at the cj1051c locus (data not shown).  Additionally, 33 
strains contain a poly(G)9 tract between the two predicted specificity regions (data not 
shown).  We found evidence in 3 strains of possible phase variation due to insertions or 
deletions in this tract leading to premature termination (Figure 21). 
 
 
Figure 19: Predicted R-M Systems of NCTC11168 
Predicted methylation and R-M systems of C. jejuni strain NCTC11168 based on 
REBASE and genomic sequence.  White arrows indicate methylation or R-M system 
genes, grey arrows indicate the genomic context of the adjacent genes. 
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Figure 20: Comparison of cj1051c and its Genomic Context across Strains 
Comparison of cj1051c and its genomic context across common C. jejuni laboratory 
strains.  Grey regions indicate nucleotide identity.  A) Comparison of common laboratory 
strains NCTC11168, 81116, and 81-176 in the region of cj1051c. Insertional mutation 
indicated by “*” in 81116 results in a frameshift and premature ORF termination.  B) 
Nucleotide alignment of NCTC11168 cj1051c and 81116 C8J_0993 + C8J_0992 
showing percent identity across the cj1051c ORF below the Pfam predicted regions of 
cj1051c: N = HSDR_N_2 (PF13588) Type I restriction enzyme R protein N terminus, M 
= N6_Mtase (PF02384) N-6 DNA Methylase, S = Methylase_S (PF01420) Type I 
restriction modification DNA specificity domain. 
 
 
 
 
Figure 21: Phase Variation at the G9 Tract of the cj1051c Locus 
A portion of a ClustalW2 comparison of the cj1051c locus in strains C. coli 1417, C. coli 
7--1 and C. jejuni 1336 with apparent phase variation in the G9 tract (red box) 
prematurely terminating the reading frame compared to a representative full length gene 
from strain C. coli H6.  Both C. coli 1417 and C. jejuni 1336 appear to have single 
nucleotide deletions, whereas C. coli 7--1 appears to have a 2 bp insert.  This region is 
between the two specificity domains predicted in the protein, therefore these mutations 
may not inactivate the enzyme.  ‘Cj’ represents Campylobacter jejuni, ‘Cc’ represents 
Campylobacter coli, followed by the strain designation. 
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Effect of cj1051c on Transformation Efficiency.  To test the transformation efficiency 
of the cj1051c transposon mutant several attempts were made to cure it of pWM1007 
with marker-free subculturing, heat and oxidative stress, and rifampicin treatment [210].  
As this failed, a Tet
R
 knock out strain of cj1051c was produced (JH1) as well as a 
complemented strain (JH2).  Transformation efficiency was tested with 1 µg of 
pWM1007 purified from a C. jejuni host (RM1849) on strains NCTC11168, JH1, and 
JH2.  Wild type NCTC11168 did take up pWM1007 at a low efficiency of 12.4 (±3.3) 
colony forming units per microgram of plasmid (cfu/µg), while the knock out strain JH1 
had about a 1000-fold increase (1.8x10
4
 ±9.9x10
2
 cfu/µg) in transformation efficiency 
(p<0.001).  The complemented strain JH2 had approximately 2-fold less (1.1x10
4
 
±1.1x10
3
 cfu/µg) transformational efficiency than JH1 (p<0.05).  The above data is 
representative of replicates across different electrocompetent stocks and plasmid 
purifications, and compared with Student’s t-test. 
Effect of Plasmid Host on Transformation.  Plasmid pWM1007 purified from several 
C. jejuni strains (NCTC11168, JH1, RM1849) and E. coli (DH5α) were used to transform 
NCTC11168 and JH1 strains naturally and by electroporation (see Table 10).  
Transformation by electroporation of NCTC11168 was most efficient with plasmid 
prepared from NCTC11168, reduced for plasmid from JH1, and least efficient with 
plasmid from RM1849.  Electroporation of NCTC11168 with plasmid purified from E. 
coli failed.  Electroporation of JH1 with plasmid purified from any C. jejuni strain was 
highly efficient and was successful with plasmid purified from E. coli, albeit at low 
efficiency. 
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Table 10: Effect of Host on Plasmid Transformation Efficiency 
Effect of plasmid host on transformational efficiency into the wild type (NCTC11168) 
and cj1051c knock out (JH1) strains. 
  
 
 
Transformation Efficiency into Target 
Strain (cfu/µg) 
Method Plasmid Host NCTC11168 JH1 
Electroporation NCTC11168 1.1x10
3
 ±1.9x10
2 
1.2x10
4
 ±1.5x10
3 
 
JH1 1.1x10
2
 ±8.1 2.9x10
4
 ±5.1x10
3 
 
RM1849 1.2x10
1
 ±3.2 1.9x10
4
 ±9.9x10
2 
 
DH5α 0 2.6x101 ±2.3 
    Natural Transformation RM1849 0 2.0x10
3
 ±1.4x10
2 
 
DH5α 0 0 
 
 
 
 
 
Effect of cj1051c on Natural Transformation.  Natural transformation of wild type and 
JH1 by pWM1007 purified from both C. jejuni (RM1849) and E. coli (DH5α) was 
attempted, see Table 10.  Natural transformation with plasmid purified from C. jejuni 
failed for the wild type strain, but was successful for JH1.  Transformation by plasmid 
purified from E. coli failed for both wild type and JH1 C. jejuni strains. 
 
Discussion 
Campylobacter jejuni strain NCTC11168 is one of the most common laboratory strains 
for Campylobacter research, however the restriction barrier inhibiting transformation 
with plasmids from E. coli hosts and other C. jejuni hosts is a major limiting factor in its 
use.  While it can readily take up DNA for homologous recombination by natural 
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transformation or electroporation, plasmid transformation is problematic.  This often 
necessitates the generation of chromosomal integrants for complementation studies with 
this strain.  Analysis of the methylation and R-M systems of C. jejuni strain NCTC11168 
revealed several systems.  Some or all of these systems potentially play a role in the 
restriction barrier of NCTC11168 and we therefore screened random mutants to identify 
which factors may be involved.  cj0031 is subject to phase variation [156], cj1461 has 
dam-like activity [157], and the Type I system has a similar grouping to RM1849 and 81-
176 but not 81116, as well as being subject to phase variation [158].  To our knowledge 
this is the first study examining C. jejuni’s R-M systems involvement in plasmid 
transformation. 
Mutagenesis and Complementation of cj1051c.  Gene cj1051c is predicted to encode a 
Type II (subtype GSγ) R-M system enzyme with both restriction and methyltransferase 
activities [134].  REBASE [134] predicts its recognition sequence to be GAG(N)5GT 
which occurs 11 times on the plasmid used, pWM1007.  We initially identified this gene 
from two transposon mutants which apparently facilitated electroporation of pWM1007.  
Both of these mutants had the same transposon insertion site suggesting they were sibling 
strains from the same pre-transformation parental mutant strain.  This would be expected 
since the mutant pool was grown overnight before electroporation.  The other 162 
transformed mutant isolates did not have their mutation sites mapped in this study, but 
may contain unique mutations relevant to plasmid transformation.  This may be the topic 
of future work.  Subsequent knock out mutagenesis of cj1051c resulted in a strain (JH1) 
which permitted natural transformation of plasmid from a C. jejuni host, permitted 
electroporation of plasmid from an E. coli host, and has about a 1000-fold increase in 
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electroporation efficiency with plasmid from a heterologous C. jejuni host.  This implies 
that this single factor, cj1051c, could be a major contributor to the restriction barrier in 
this strain.  Complementation of JH1 by genomic expression of cj1051c resulted in a 
strain (JH2) with approximately 2-fold less (p<0.05) transformational efficiency than 
JH1.  Small effects were expected from the complementation strain based on previous 
work in the lab with genomic complementation.  Non-native promoter and ribosome 
binding site, as well as the cj1051c ORF being so large (4.0kbps, 4
th
 largest in genome 
[64]) coupled with only a single copy (genome, not plasmid, based) results in a low 
expected activity level.  Indeed the knock out mutant was not fully complemented to wild 
type levels, but it was significantly lower than the knock out mutant.  We believe this 
verifies cj1051c to be a major factor in the restriction barrier of NCTC11168. 
Phase Variation of cj1051c.  Comparison of cj1051c across other common C. jejuni 
laboratory strains 81116 and 81-176 showed that it has not been maintained.  An 
insertional mutation in a poly-A tract of the cj1051c locus in 81116 has caused a 
frameshift leading to premature termination of the open reading frame, likely eliminating 
any activity.  In 81-176 the cj1051c locus is absent, which was previously noted along 
with another clinical strain [211].  Further support of phase variation at this locus is 
provided by the finding of a poly(G)9 tract in most of the BLASTp hits for Cj1051c 
which would be expected to be highly susceptible to phase variation.  We found evidence 
that this has occurred in 3 strains with truncated ORFs due to mutations in this tract.  But 
as this tract occurs between the two predicted specificity regions, and not towards the 
beginning of the ORF, it is unclear whether the truncation would result in an inactive 
enzyme or one with modified activity.  This being the third R-M system to be identified 
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in C. jejuni which may be susceptible to phase variation could explain why all of the 
Type II REases present are fused to their MTases (Figure 19).  Otherwise if non-fused 
enzymes were common any inactivation of an MTase, but not the paired REase, by phase 
variation would be fatal. 
Specificity Domain Variation.  In R-M systems, the specificity domain determines the 
recognition site of the targeted DNA that the enzyme binds to.  The cj1051c locus in 
NCTC11168 and 81116 does differ in the predicted specificity region (Figure 20) of the 
gene, which based on the sequences deposited at NCBI appears to be common.  BLASTp 
search for Cj1051c found only two strains with complete identity, whereas 60 strains of 
C. jejuni and C. coli appear to have maintained the cj1051c locus with high sequence 
similarity throughout the protein except with variation in the predicted specificity region.  
This agrees with previous sequence analysis for this locus describing it as the first case of 
a Type IIG enzyme with divergence in the specificity domain between closely related 
strains [212].  Likely Type II enzymes having both restriction and methylation 
components fused would be most available to this variation as they share the same 
specificity domain and therefore their targets would change together.  However any 
change in the target sequence would likely target a non-methylated region and therefore 
require methylation of the new site to occur before restriction to prevent a lethal effect.  
High variation in the specificity domain may serve to protect against quickly evolving 
bacteriophage or to limit horizontal transfer between strains.  C. jejuni is noted for its 
high degree of phase variation which can affect bacteriophage infection [181, 192] 
possibly driving up bacteriphage variation, which may be then countered by a more 
flexible restriction system.  Flexibility in the specificity domain would also minimize 
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horizontal transfer of genetic material between strains, as evidenced by the plasmid work 
here, which would tend to maintain more diverse populations [193]. 
Cj1051c Acts as a TypeIIG Enzyme.  Table 10 shows a range of transformation rates 
into either the wild type strain or JH1 based on the host from which the plasmid was 
extracted.  When the plasmid is purified from another C. jejuni host (RM1849) it is able 
to transform JH1 with a much higher rate than into the wild type strain.  This suggests 
that there is Cj1051c REase activity in the wild type strain cleaving the plasmid due to 
lack of methylation at the recognition site and is sufficient to create a major restriction 
barrier to transformation.  Additionally, the wild type strain transforms better with 
plasmid purified from the wild type than from JH1.  This suggests that the lack of 
Cj1051c MTase activity in JH1 results in restriction of the plasmid upon entry into the 
wild type strain.  This provides evidence that Cj1051c is active in NCTC11168 and 
behaves as expected for a Type IIG enzyme having both restriction and methylation 
activities.  The fact that the wild type is transformed better with plasmid purified from the 
knock out strain than RM1849 also suggests there may be another active R-M system 
present in the wild type and knock out strains which is not present in RM1849.  But 
considering the transformation rate into JH1 is high regardless of the plasmid’s C. jejuni 
host strain suggests cj1051c is a major determinant of the restriction barrier. 
Application.  This presents possibilities for future work developing methods and tools 
for plasmid work in NCTC11168 as we anticipate the effects observed here should be 
replicated with any plasmid provided it contains the recognition sequence.  Due to its 
ability to be transformed by plasmids from an E. coli host, researchers could use JH1 as 
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the parental strain for their own targeted mutagenesis studies followed by plasmid-based 
complementation.  Its ability to naturally transform plasmid may also be useful in labs 
without electroporation equipment.  Additionally since NCTC11168 transforms plasmid 
extracted from it, JH1 could be used as an intermediate host to bridge the restriction 
barrier.  Plasmid constructs developed in E. coli could be transformed into JH1, followed 
by transformation into the wild type NCTC11168 strain.  This would facilitate 
mutagenesis and plasmid based complementation studies in the wild type NCTC11168 
strain using plasmid constructs developed in E. coli.  Not only would this eliminate 
complications and potential side effects from genomic disruptions for complementation, 
but should additionally permit higher expression rates as multiple copies of the 
expression construct will be present.  Finally since this factor plays a role in the 
restriction barrier of plasmid from an E. coli source it may be possible to follow a 
strategy used in other species for artificial modification [150].   Expression of cj1051c in 
an E. coli host may allow any plasmid construct developed in that host to be directly 
transformed into NCTC11168 as it would be appropriately methylated. 
 
Conclusions 
Our findings that C. jejuni strain NCTC11168 was not successfully transformed by a 
plasmid from E. coli and only very weakly transformed with a plasmid from another C. 
jejuni strain likely explains the lack of plasmid work in this strain and the lack of success 
mentioned in the literature [200].  We have shown a major determinant of this is a 
restriction barrier mediated by cj1051c which when knocked out, allows approximately 
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1000-fold enhanced transformation efficiency of plasmid purified from another C. jejuni 
host.  This mutation also allows natural transformation of plasmid from another C. jejuni 
host and transformation of plasmid from an E. coli host.  Additionally the commonly 
used strain for C. jejuni plasmid work, 81116, has a homolog of cj1051c inactivated by 
an insertional event in a homopolymeric tract potentially explain the higher 
transformation rate for this strain.  This along with the other examples of homopolymeric 
tract inactivations in other strains at this locus suggests it is subject to phase variation.  
This increases the understanding of the active underlying molecular biology functions at 
work in C. jejuni, as well as providing a tool which increases the accessibility of strain 
NCTC11168 to common plasmid-based molecular biology techniques. 
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Chapter 5: Conclusions 
Campylobacter jejuni is an important human pathogen and possibly the leading cause of 
diarrheal illness worldwide.  Even in developed countries it is either the leading cause, or 
one of the top causes, of foodborne illness.  Besides the acute diarreheal illness caused by 
C. jejuni infections, secondary conditions such as GBS, and possibly IPSD, can occur.   
The major source of C. jejuni infections, at least in developed countries, is from 
contamination of chicken products.  Contamination of C. jejuni in chicken products at the 
market level is widespread and has been persistent due to its carriage in chickens at high 
levels without causing symptoms or disease.   
Likely this prevalence of infection in the human population will remain as trends over the 
previous years have remained steady.  Increased knowledge of how this pathogen, which 
presents challenges in the lab due to its sensitivity to many conditions, remains prevalent 
in our food supply is needed to develop new methods and tools for its control.  
Knowledge of C. jejuni genetics and mechanisms involved in human pathogenicity trails 
behind many other enteric pathogens.  This knowledge gap is likely due to many factors 
including: difficulty in culture and manipulation, having been more recently cultured 
successfully and identified as a pathogen, and that it appears to have unique features from 
other intracellular pathogens complicating research.  Despite this, completed genomic 
sequences and molecular tools have been developed facilitating a greater understanding 
of the molecular mechanisms involved in this unique and important human pathogen. 
In Chapter 2 we independently implemented and validated one of these powerful 
molecular tools developed for C. jejuni, the signature tagged mutagenesis system.  
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Implementation of the system was performed with an easier to purify transposase here in 
the US, having been developed in the UK, allowing more accessibility of the system to 
researchers in the US.  A library of mutant strains produced from this system was 
initiated which may also provide an important resource to C. jejuni researchers in this 
country.  We also developed a PCR-based detection system to improve upon the methods 
previously used with the STM system.  This new detection system allows the 
quantification of 72 different tagged strains in a pool, allowing large scale screening with 
minimal samples while still providing a quantification of each strain.  Tagged control 
strains were also developed such that they could be included in every pool of unknown 
mutants to be screened in parallel to allow accurate comparisons.  This overall system of 
mutagenesis and quantification is most powerful for negative screening purposes, where 
instead of a screen enriching those mutants of interest they are removed from the pool.  
Therefore quantification allows the identification of those strains underrepresented in the 
pool after the screen.  The example used to show the feasibility of the detection system 
with the STM system was a cell invasion screen for virulence.  In this screen, genes of 
interest as possible virulence factors are those that when mutated result in a decrease in 
cell invasion, and are therefore underrepresented in the pool of collected intracellular 
bacteria.  Therefore coupling the previously developed STM system with the detection 
system we developed provides a powerful tool for the much needed future research on the 
molecular mechanisms of C. jejuni. 
Also in Chapter 2 we identified a previously undescribed interaction with pUC19 and an 
unknown motility locus in C. jejuni.  Since it is not capable of replicating in C. jejuni, 
pUC19 was used as a backbone for suicide plasmid construction for mutagenesis studies.  
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We found a motility deficiency in three mutants made with pUC19-based suicide 
plasmids which were not expected to have an effect on motility.  Creation of these 
mutants with the same mutagenesis construct, but the pUC19 sequences removed, 
resulted in mutants with full motility.  Additionally, when we mutated the motility factor 
cj0390 with pUC19 present we could not complement the motility.  Only with both 
knockout and complementation constructs free of pUC19 sequence were we able to 
produce motile strains from expression of cj0390 in a cj0390 knock out strain.  
Preliminary work to identify the locus in C. jejuni responsible failed, yet knowledge of 
this may help other researchers from unknowingly creating phenotypes unrelated to their 
targeted work. 
Using the STM system we implemented in Chapter 2, we identified a novel phenotype in 
C. jejuni which is associated with virulence in Chapter 3.  This phenotype presents as a 
dark red color in the bacterial growth on MH agar plates.  It was originally identified in 
three random mutants, and upon further search seven more mutants with the phenotype 
were isolated.  The mutants generally had healthy growth curves and varying degrees of 
motility, but all had a deficiency in cell invasion.  With mutation reversion, spontaneous 
color reversion, and three knock out mutants produced it was concluded that the mutation 
causing the red phenotype is independent of the mutation due to the transposon.  
Additionally it seems unlikely that the genetic locus responsible for creating the red 
phenotype is identifiable by a transposon mutation.  This can occur when it is lethal to 
inactivate the gene responsible for the phenotype in question.  In these cases the 
phenotypes are likely due to misregulation or point mutations in a gene allowing some 
level of functionality in the cell, just with an altered activity.  A phenotype in yeast with a 
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similar appearance has been previously characterized.  This has been found to be a 
degradation product of AIR, which is a metabolic intermediate of the purine biosynthesis 
pathway. The color is generated when mutations downstream of AIR (genes ade1 and 
ade2) cause a buildup of AIR leading to pigment accumulation.  When the red yeast are 
grown on media supplemented with adenine, the red phenotype is reverted and the 
mutants appear wild type in color.  When we attempted this with our red C. jejuni 
mutants we found reversion of the phenotype to wild type color in all of our strains at the 
same adenine concentrations reported for the red yeast.  This suggests the pathway 
identified in yeast may also be responsible for the phenotype we identified in C. jejuni.  
Subsequent knock out mutagenesis of the ade1 and ade2 equivalent genes in C. jejuni 
(cj0512 and cj0702 respectively) were inconclusive as to whether they were involved in 
the red phenotype.  While the knock out strains where non-red in color, they had a severe 
growth deficiency which, as reported in the red yeast, could prevent the necessary 
buildup of AIR for the pigment production presumably due to a lack of metabolic 
throughput.  Sequence analysis of these two genes found no mutations in our red mutants, 
and expression analysis of them in red mutants found no compelling evidence to explain 
the phenotype.  This suggests that these two genes (cj0702 and cj0512) may not be 
involved in the red phenotype.  But the AIR pathway may still be involved, another gene 
in the pathway may be mutated or misregulated creating an AIR, and therefore pigment, 
accumulation.  Identification of the factor responsible for the pigmentation could be 
important in not only the understanding of the molecular mechanism of C. jejuni, but 
could provide a tool for its control.  Since the red phenotype was always associated with 
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reduced cell invasion, this unknown factor could allow for treatment of infections of C. 
jejuni or other intracellular pathogens to reduce the severity of symptoms. 
Use of the mutagenesis system implemented in Chapter 2 also allowed us to identify 
another novel feature of C. jejuni.  In Chapter 4 we identified a factor, cj1051c, which is 
a major contributor to the restriction barrier in C. jejuni strain NCTC11168.  This is an 
active TypeIIG restriction enzyme which makes the transformation of NCTC11168 with 
plasmids problematic.  We found that knock out mutagenesis of cj1051c resulted in a 
strain with 1000-fold increase in transformation efficiency with plasmid purified from a 
C. jejuni source and permitted transformation of plasmid purified from an E. coli source.  
We also provided evidence that cj1051c does behave as a Type IIG restriction 
modification enzyme having both restriction and methylation activites in one protein.  
This enhances the knowledge of the restriction modification systems active in C. jejuni of 
which there has been limited work to date on.  It also provides an important tool in C. 
jejuni research.  Strain NCTC11168 is one of the most common laboratory strains in C. 
jejuni research, but plasmid based work in it is rare as transformation of plasmids into it 
is problematic.  This work developed the cj1051c knock out strain which is capable of 
efficient transformation of C. jejuni derived plasmids, and transformation of E. coli 
derived plasmids.  Plasmids purified from the knock out strain are also capable of 
transforming the wild type NCTC11168.  Therefore the knock out strain is capable of 
being used as a bridge for plasmid transformation between E. coli and wild type 
NCTC11168.  This allows an important strain in C. jejuni research to be much more 
accessible to plasmid-based molecular biology studies which will enhance future 
research. 
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Transposon mutagenesis is a powerful tool in bacterial genetics for randomly identifying 
factors involved in diverse cellular processes.  We’ve independently implemented and 
validated a powerful version of this type of mutagenesis and developed an enhanced 
detection method for it to be used in conjunction with tagged control strains developed.  
This tool set now has the ability to investigate many different mechanisms in C. jejuni 
which is an important, yet poorly understood, human pathogen.  We used the system here 
to identify and characterize two novel aspects of C. jejuni, both of which provide a better 
understanding of C. jejuni as well as tools for control and research of C. jejuni in future 
work. 
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Appendix 1: Cloning Primers Used In This Study 
 
 
 
Primer Sequence Reference 
ajg227 CCCGGGAATCATTTGAAG [113] 
CC001 TAACTTGGAAAGGAACACCG [113] 
C1 CTCGGCGGTGTTCCTTTCCAAG [185] 
C2 CGCCCTTTAGTTCCTAAAGGGT [185] 
jph34 CCGactagtTGCGCCCTTTAGTTCCTAAAGGGT1 This Work 
jph35 ccgACTAGTcgggtgtgtggtagatagatctatctcgagatagctaggtGCGGTGTTCCTTTCCAAGT This Work 
jph38 CCggatccAAAGCCCAACAGCTATCATCA1 This Work 
jph39 CGgaattcCCGTGATTATGGCAGTGATT1 This Work 
jph41 TTCCCTTCAAGAGCGATACC This Work 
jph42 AACTGTGTAGCAAGGCAGCA This Work 
jph43 TTCTTGGCATTTTCTTGAGTTT This Work 
jph44 TTAATAAAATCCTAAAATTTTCCAC This Work 
jph54 GGGactagtTCCCCGGTCTAACAAAGAAA1 This Work 
jph55 GGGactagtCCCCGGTCTGACACATAGAT1 This Work 
jph144 GGGgaattcAGAAAAGCCTTCGCATTTGA1 This Work 
jph145 GGGgagctcCTATACTCTTTAAAAATATTTTTTCAAAACATCA1 This Work 
jph146 GGGgagctcGCGGTGTTCCTTTCCAAGT1 This Work 
jph147 GGGttcgaaTGCGCCCTTTAGTTCCTAAAGGGT1 This Work 
jph149 GGGggatccGTGAAGAAAGTGCCGTTGGT1 This Work 
jph150 CTTATCCTGTTTTAATGGC This Work 
jph151 AATGCGCACGATATTGATGA This Work 
jph152 GGGgaattcAAAGAGTATAGATGGCTGAACAAG1 This Work 
jph153 GGGttcgaaGAAATTTCTAAGCATTTTTAGTTGT1 This Work 
jph154 GGGactagtTCTTGCACTAGCGATGAAGTG1 This Work 
jph155 GGGactagtCTTTTCGTTGGGATCTTTCG1 This Work 
jph156 GGGttcgaaTTCTATTCTACCGTTACGCTTTTAGC1 This Work 
jph157 GGGggatccGCGCCTTTGATAGGAAGTTG1 This Work 
jph158 GGGactagtGCGGTGTTCCTTTCCAAGT1 This Work 
jph159 GGGgaattcTAGGCTTTTGGGCCTATCAT1 This Work 
jph160 GGGactagtTTTAATGAGTTCAGTAGGAAAACG1 This Work 
jph161 GGTCCTGCGATTTTAACCTTT This Work 
jph162 TCCCAATCATGTGTATTTTGC This Work 
jph163 AATTCAGCCTTCCA This Work 
jph164 GATCTGGAAGGCTG This Work 
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jph165 GGGttcgaaCACCCATGGTATCATGTTCAA1 This Work 
jph166 GGGagatctTGCCAAGAAATTTGGCTAAAAG1 This Work 
jph178 GGGttcGAAATTTCTAAGCATTTTTAGTTAAGC1 This Work 
jph189 GGGgaattcTTGGAGCGATAGAATTTGTG1 This Work 
jph190 CCCgagcTCATTGAACTTTCCTATCCTG1 This Work 
jph191 CCCttcgAAGATTTTATCTTGCTATTTTT1 This Work 
jph193 TTTTTCCCAAGGAGTGATGC This Work 
jph194 CTGGGTGCTTAAGGGTGTGT This Work 
jph197 AGGCTAAACCAGCGATTGAA This Work 
jph198 AAAGCATCATACTTGATTCCAAGA This Work 
jph199 TTCGTCCAAAACAATGCAGA This Work 
jph200 TGAAGCTAAAGAACGCCCTAA This Work 
jph203 CCCctgcagTAGCGATAAAACAGCACTTG1 This Work 
jph204 GGCGATCATACAACAAAATATCG This Work 
jph205 GCGGAGATTTGGAAGTGATT This Work 
jph215 CAAATCAATGATGACGCACA This Work 
jph216 AGCTTTTTCCACCGCTTTG This Work 
jph217 AGCGAAATTCATAGCGGTAA This Work 
jph218 CATTGGCCATCATACCCTTA This Work 
jph219 GGTGGACTTTTAAATCAAGCCATA This Work 
jph220 CTTGGAAAGGAACACCGCCGAGtcattttattgtccttgtttgatattt2 This Work 
jph221 ACCCTTTAGGAACTAAAGGGCGAAggaaaaatatggaagttattgtaaa2 This Work 
jph222 AAAGCTAAGATTGTTGTTATGCTTCA This Work 
jph223 AAAAATGTTGTAGATGTGGCAAG This Work 
jph224 TCCATGGGCAATTGGTAAAT This Work 
jph225 AAGGGCGTACTAAAAGCGAAT This Work 
jph226 CTTGGAAAGGAACACCGCCGAGCAAAATTCATctatatttcctttctt2 This Work 
jph227 ACCCTTTAGGAACTAAAGGGCGAAgggataaaaatgcaaacctat2 This Work 
jph228 CATTTCCAAATCAGGCTCTGT This Work 
jph229 TGAAAATGGTACTCATATTTTTAATTC This Work 
jph230 TCATTTGTGAAAAAGTCATTGTATCTC This Work 
jph231 AACCCTGACGCAGCAACGCC This Work 
jph232 CGCCTACGCGCCCTTTACGC This Work 
jph233 AGAGGCAATGAAAGTGGAAAAGGTGCATT This Work 
jph234 GCACAGTGCCATCTTTAATGCCCAGTC This Work 
jph235 GCAGCTGGAATGGCAGCGCA This Work 
jph236 AGCAGCATTGATTGCTCCAGCCTT This Work 
jph237 GCGATGCTTTGCGTCCTGGCT This Work 
jph238 AGGCGCTCCTTTGCATAAACGCT This Work 
jph239 ACAAGAATTTCGTACGAGTTTGAGA This Work 
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jph240 CTTGGAAAGGAACACCGCCGAGttatttccttataatctcaccaccttagc2 This Work 
jph241 ACCCTTTAGGAACTAAAGGGCGTCTTAAagcatttttcgctaaactttgta2 This Work 
jph242 CTGCCCCACAGGCAAAACCG This Work 
jph243 AAAAAGAGCAAAAAGTCGATGAA This Work 
jph244 TCAAAATATCGCTCTAAATTCACAT This Work 
jph245 TAATACCAGCGTCGGGAAGA This Work 
jph246 TCTTAAAGCAGGAGAGCAAGG This Work 
jph247 CTCGGCGGTGTTCCTTTCCAAGagtgttttggggctattgga2 This Work 
jph249 CGCCCTTTAGTTCCTAAAGGGTcattttatatgacttttgcaagctg2 This Work 
jph250 GGGactagtCTCGGCGGTGTTCCTTTCCAAG1 This Work 
jph251 ACCCTTTAGGAACTAAAGGGCGagttcgtcttgttataattagcttct2 This Work 
jph252 CTTGTTTTAAATTATCTTTTGTAATCATttattatttccttcctcttttctaca2 This Work 
jph253 ATGATTACAAAAGATAATTTAAAACAAG This Work 
jph254 GGGactagtAGAGCAAACCTCCATCACAT1 This Work 
1
Lowercase letters indicate restriction site. 
2 
Uppercase letters indicate overlap region. 
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Appendix 2: STM Primer Designer GUI 
 
 
 
 
 
Graphical user interface (GUI) for the STM primer design software developed.  This 
interface allowed design parameters to be modified (top left), visualization of the 
resulting Primer3 output for each tag along with limiting factors in primer design 
(bottom), and visualization of a particular result selected on the bottom within the overall 
transposon (top right).  This permitted manual optimization of parameters to allow the 
highest quality primer design with compatibility across all the tags in the system.  It also 
aided in determining which tags were the limiting factors in design, and eliminating them 
when primers could not be designed for them within acceptable parameter limits.  
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Appendix 3: Sequence Results for Tags and their Flanking Region 
 
 
Plasmid Tag# Tag Sequence 
Flanking 
Region 
pAJG40 1 acctagctatctcgagatagatctatctaccacacacccg A 
pAJG42 3 ggggagttgttggtattgcgggtggtagctggtgggagct B 
pAJG43 4 ggagagggtgaggggtggtgttgtctagtggtgtgtagat B 
pAJG44 5 aggcgatagggtgcgctcggatgatatcggttgttggtg B 
pAJG45 6 tgatagagagggggcgttcgtgtgcttggtcgtgggtgtg B 
pAJG46 7 aggggggtttggatagggggagttgtatggctggtctttt B 
pAJG47 8 aaaaacaccaaccacactctccataccccgctcccgcac A 
pAJG48 9 atccacccacaccgacaacgaccaaccgctatccctcgct A 
pAJG49 10 aacaaaatcgctcaaccgcgccagctagccaacgacctcc A 
pAJG50 11 gggggtcgaggtggatctcgattgtggggggtagttggct B 
pAJG51 12 agcacgcactcccaccaccaagagagccccagcgccagcc A 
pAJG52 13 cgataccgcccgagacagacacaaccctaacaccctcaat A 
pAJG53 14 cgagagggttagtgctgtggagttggctgtaggggtcggt B 
pAJG55 16 ctcgatagcgggagttatttcgttatgtggggggattgat B 
pAJG56 17 atatcaatcccacacactcgatctcactcgcgccctcgcc A 
pAJG57 18 ggagcgtgagtgtgggggtgtg B 
pAJG58 19 ggtgggagaggggggtgtgtggagagcgggatggaggtgg B 
pAJG59 20 atcccgcgctaacccgcgaaccacctccccctatatcgac A 
pAJG60 21 agctggagctcgagagtgagtgaggggtgtctttagctat B 
pAJG62 23 acccccctagctcacgacaccaagctcgcgcacacgaccg A 
pAJG63 24 aaaccgacctaccgctaaccagctatccacacgcgcccc A 
pAJG65 26 cgcgcgataggtgtggagtggtgtcgttgggggggttgtt B 
pAJG66 27 atggggttaggggtggagtggtagtgcgcgggtggtcggg B 
pAJG67 28 atatagtgtgatcgcttgggtgtgggatatttcgttcgtt B 
pAJG69 30 agccccctagaccgatccaaataccgagcgatccatacct A 
pAJG73 34 acaaatctcaccagctccaacacaaccgcccccgcactcc A 
pAJG74 35 ggcgtgggagtgagggggtgggctggtgagcgttatagtt B 
pAJG76 37 gtggagcgcttgttacatgtttttggagcggtttggatgt B 
pAJG77 38 aggggtggggttatggggctggatagtgcgcgtgctagct B 
pAJG78 39 attgggatggcggtatagttaggtatatcgttcttgattt B 
pAJG80 41 agagagagctggagagtgatcggtggttgtggtgggagtg B 
pAJG82 43 agggatggatggaggtagaggtcgattgtgct B 
pAJG83 44 gtcgatgtattgcgggctgtagggagttcggtattcggt B 
pAJG85 46 ataaccaccccgccccagacccagccataacgatagcact A 
pAJG86 47 gtgggggggtctcggtatcggttgttcgtgtgttggtgtct B 
pAJG87 48 gtcgaggtttatatgttgagggggcgggttattgtgtgtt B 
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pAJG88 49 aaaacgcgaactagccccctaaccctccctcgcgcaccat A 
pAJG89 50 agacctacatcaacatacacatacgtcgcccgaccaagct A 
pAJG90 51 aggtgggtaggggtctatttcttggtgtctatggggcgtt B 
pAJG92 53 cactagcacgacaaaacacactatcgccccccccaccaac A 
pAJG93 54 agaggatagcttgctgtcgctctgtcgggagcggttgtt B 
pAJG94 55 cgagagatagggagagcgtttgcttgtttgtgtgatgtgt B 
pAJG96 57 gtggtgcgattgtgagcgttctgtttttgtctgtagtggt B 
pAJG97 58 cgatccctaacacacgaccgcgagcgctacggccccccac A 
pAJG98 59 aacgcgacaccgcaaccccccccgcc A 
pAJG99 60 ggagagatcggtagattggttgttagtgcgggtgctctct B 
pAJG100 61 agcgaaacatccaccgaccacgctaactccctaactcact A 
pAJG101 62 aaaccacaccccctcccgatctctagctat A 
pAJG102 63 tgatgtttgtcgcggggtgtatttcgggggttgtgtcgct B 
pAJG103 64 ggggcgctaggtcgggggagttgttgcgcgtttgggtgat B 
pAJG104 65 cggtatcgagagagagcggtgttggtgtggaggggttggt B 
pAJG105 66 aactcgctctcacaaacgcccaagatcccccacacaaaag A 
pAJG106 67 ggttgggggtagtgcgctagcgggctaggtgggttgttgt B 
pAJG107 68 atcaaccaccacacagcacaccccataaccatatcgctcc A 
pAJG108 69 cgaacgcgcgcaagccccccaactatctcccaatctcgac A 
pAJG109 70 gtgggggggtctcggtatcggttgttcgtgtgttggtgtct B 
pAJG110 71 gtgtgtggctcgggggttagggctgaggtagtggtagtg B 
pAJG111 72 tgggcgctctcgagtgagctggaggtttggcgagttcgtg B 
pAJG113 74 ccaacaaaccacctcgcacgccagccagcccccacgctat A 
pAJG114 75 ggtgctcggtcgatctgtgggtgggtagggctagtgtggg B 
pAJG115 76 aacgcaagatccaccacccacaacataaccagaaccacct A 
pAJG116 77 cttgttgtatgggtagtgtggtttttgtatggattgctgt B 
pAJG117 78 accaagcaaaccccccaccaaaccaccctcgcaaccacc A 
pAJG118 79 aacaaccaatctaacgcaaccccgacagaccgctcccaca A 
pAJG119 80 agcgcgctggtgggagggctttctttcgggggcttgggat B 
pAJG120 81 ttcggggtatcgggatggtgcgctagcgtgggtgatcgat B 
pAJG121 82 caacctccaaatccacctcaccccaccgcgaccacccgct A 
pAJG122 83 aacaccagctacacacccaacgcgctatctctagcaccct A 
pAJG123 84 aaaacaatacccagagcgcccccactctatctctcgcaca A 
pAJG124 85 agacaccaaaacacacataccccaaaaccgcacactaaca A 
pAJG125 86 accccaccaacccgcactccccccatcgagctcaacacac A 
pAJG126 87 ctatagacaacgacatcccgctcaacacctcgcacccccc A 
pAJG127 88 gggtgtggagagcggttgagttggagatcgggtgcgtgat B 
pAJG129 90 aggtggatatagagggtggtagggggagctggtttgggat B 
pAJG130 91 aaccccctagcacgccaaaacctccac A 
pAJG132 93 ggagtgtgggctgtgtaggtctggaggttgtgag B 
pAJG134 95 aaaccgctaaccacccacatacccatccctacccatagcc A 
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Appendix 4: STM Detection PCR Primers and Probes - Set A 
 
Name Description Sequence 
jph69 Common Primer GGATCTAGTCGACGGTATCGA 
jph70 Common Probe CGAATTCCTGCAGCATTCTAACCAAGC 
jph45 Tag# 1 CGGGTGTGTGGTAGATAGATCTATC 
jph71 Tag# 8 GAGCGGGGTATGGAGAGTGT 
jph72 Tag# 9 GATAGCGGTTGGTCGTTGTC 
jph73 Tag# 10 GGAGGTCGTTGGCTAGCTG 
jph74 Tag# 12 CTCTCTTGGTGGTGGGAGTG 
jph75 Tag# 13 TGAGGGTGTTAGGGTTGTGTC 
jph76 Tag# 17 GTGAGATCGAGTGTGTGGGA 
jph77 Tag# 20 CGATATAGGGGGAGGTGGTT 
jph78 Tag# 23 GAGCTTGGTGTCGTGAGCTA 
jph79 Tag# 24 GGTTAGCGGTAGGTCGGTTT 
jph80 Tag# 30 GATCGCTCGGTATTTGGATC 
jph81 Tag# 34 TTGTGTTGGAGCTGGTGAGA 
jph82 Tag# 46 GCTATCGTTATGGCTGGGTC 
jph83 Tag# 49 GGAGGGTTAGGGGGCTAGTT 
jph84 Tag# 50 GTCGGGCGACGTATGTGTAT 
jph85 Tag# 53 GGGGCGATAGTGTGTTTTGT 
jph86 Tag# 58 GCGGTCGTGTGTTAGGGAT 
jph87 Tag# 61 TTAGGGAGTTAGCGTGGTCG 
jph88 Tag# 62 TAGCTAGAGATCGGGAGGGG 
jph89 Tag# 66 ATCTTGGGCGTTTGTGAGAG 
jph90 Tag# 68 ATGGTTATGGGGTGTGCTGT 
jph91 Tag# 69 GATTGGGAGATAGTTGGGGG 
jph92 Tag# 74 CGTGCGAGGTGGTTTGTT 
jph93 Tag# 76 ATGTTGTGGGTGGTGGATCT 
jph94 Tag# 78 GTGGTTGCGAGGGTGGTT 
jph95 Tag# 79 GGGTTGCGTTAGATTGGTTG 
jph96 Tag# 82 TGAGGTGGATTTGGAGGTTG 
jph97 Tag# 83 GGTGCTAGAGATAGCGCGTT 
jph98 Tag# 84 GTGCGAGAGATAGAGTGGGG 
jph99 Tag# 85 TTGGGGTATGTGTGTTTTGG 
jph100 Tag# 86 GTGTGTTGAGCTCGATGGG 
jph101 Tag# 87 AGCGGGATGTCGTTGTCTAT 
jph102 Tag# 91 GAGGTTTTGGCGTGCTAGG 
jph103 Tag# 95 TATGTGGGTGGTTAGCGGTT 
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Appendix 5: STM Detection PCR Primers and Probes - Set B 
 
Name Description Sequence 
jph104 Common Primer GCTTGATATCGAATTCCTGCA 
jph105 Common Probe GGCGGCCGCTACAACCTCAA 
jph106 Tag# 3 ACCCGCAATACCAACAACTC 
jph107 Tag# 4 CCACTAGACAACACCACCCC 
jph108 Tag# 5 ACAACCGATATCATCCGAGC 
jph109 Tag# 6 GAACGCCCCCTCTCTATCA 
jph110 Tag# 7 CAGCCATACAACTCCCCCTA 
jph111 Tag# 11 CAATCGAGATCCACCTCGAC 
jph112 Tag# 14 CAGCCAACTCCACAGCACTA 
jph113 Tag# 16 CGAAATAACTCCCGCTATCG 
jph114 Tag# 19 CTCCATCCCGCTCTCCAC 
jph115 Tag# 21 CTCACTCTCGAGCTCCAGCT 
jph116 Tag# 26 AACGACACCACTCCACACCT 
jph117 Tag# 28 ACGAAATATCCCACACCCAA 
jph118 Tag# 35 ACTATAACGCTCACCAGCCC 
jph119 Tag# 37 AAACCGCTCCAAAAACATGT 
jph120 Tag# 38 ACTATCCAGCCCCATAACCC 
jph121 Tag# 39 ACCTAACTATACCGCCATCCC 
jph122 Tag# 41 ACAACCACCGATCACTCTCC 
jph123 Tag# 43 TCGACCTCTACCTCCATCCA 
jph124 Tag# 44 CCTACAGCCCGCAATACATC 
jph125 Tag# 48 CGCCCCCTCAACATATAAAC 
jph126 Tag# 51 GCCCCATAGACACCAAGAAA 
jph127 Tag# 54 AGCGACAGCAAGCTATCCTC 
jph128 Tag# 55 ACAAGCAAACGCTCTCCCTA 
jph129 Tag# 57 AGAACGCTCACAATCGCAC 
jph130 Tag# 60 CCCGCACTAACAACCAATCT 
jph131 Tag# 63 ACACAACCCCCGAAATACAC 
jph132 Tag# 64 CAACAACTCCCCCGACCTA 
jph133 Tag# 65 CACCGCTCTCTCTCGATACC 
jph134 Tag# 67 ACAACAACCCACCTAGCCC 
jph135 Tag# 71 ACTACCTCAGCCCTAACCCC 
jph136 Tag# 72 AACCTCCAGCTCACTCGAGA 
jph137 Tag# 75 CTACCCACCCACAGATCGAC 
jph138 Tag# 77 AGCAATCCATACAAAAACCACA 
jph139 Tag# 80 GAAAGAAAGCCCTCCCACC 
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jph140 Tag# 81 ATCGATCACCCACGCTAGC 
jph141 Tag# 88 GATCTCCAACTCAACCGCTC 
jph142 Tag# 90 CTCCCCCTACCACCCTCTAT 
jph143 Tag# 93 ACCTACACAGCCCACACTCC 
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Appendix 6: Purine Metabolism Involement in the Yeast Red Phenotype 
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Appendix 7: Absorbance Spectra Red Bacteria 
 
 
Appendix 7.1: Absorbance of cell suspensions of wild type strain (wt), a moderately red 
strain (T5M52), and the intense red strain (T34M24).
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Appendix 7.2: Absorbance across the visible spectrum of PBS solution after wild type 
(wt), a moderately red strain (T5M52), or the intense red mutant (T34M24) were 
resuspended in after overnight growth on a plate and subsequently spun out of. 
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Appendix 7.3: Absorbance across the visual spectrum of SDS cell lysate of a moderate 
red strain (T5M52) and the intense red strain (T34M24) compared to the wild type (wt). 
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Appendix 7.4: Absorbance across the visible spectrum of the intense red mutant 
(T34M24), a moderately red mutant (T5M52) and the wild type strain (wt) after SDS 
lysis and aqueous phase selection after phenol:chloroform treatment. 
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Appendix 7.5: Absorbance across the visible spectrum of the intense red mutant 
(T34M24), a moderately red mutant (T5M52) and the wild type strain (wt) after SDS 
lysis and organic phase selection after phenol:chloroform treatment. 
  
-0.100 
-0.050 
0.000 
0.050 
0.100 
0.150 
0.200 
0.250 
0.300 
0.350 
350 400 450 500 550 600 650 700 750 
A
b
so
rb
an
ce
 
Wavelength (nm) 
wt 
T5M52 
T34M24 
133 
 
 
Appendix 7.6: Absorbance across the visible spectrum of the intense red mutant 
(T34M24), a moderately red mutant (T5M52) and the wild type strain (wt) after SDS 
lysis and ethanol treatment selecting for the non-precipitaed sample. 
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Appendix 7.7: Absorbance across the visible spectrum of the intense red mutant 
(T34M24), a moderately red mutant (T5M52) and the wild type strain (wt) after SDS 
lysis and ethanol precipitation followed by attempted pellet resuspension. 
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Appendix 8: Plasmid Maps 
 
 
Appendix 8.1: Plasmid pJH19 contains the presumed pseudogene cj0046 cloned into 
pUC19 used for genomic insertions by subsequent cloning in the native SpeI site of 
cj0046. 
 
Appendix 8.2: Plasmid pJH25 contains a Cm
R
 cassette flanked by the genomic regions 
surrounding cj0390 used for cj0390 knock out mutagenesis. 
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Appendix 8.3: Plasmid pJH26 expressed cj0390 with its native RBS and a strong 
synthetic promoter. 
 
 
Appendix 8.4: Plasmid pJH27 expresses cj0390 and Kan
R
 within a disruption of cj0046 
to be used for recombination at the cj0046 locus for complementation of cj0390. 
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Appendix 8.5: Plasmid pJH28 contains a Cm
R
 cassette flanked by the genomic regions 
surrounding cj1365c used for cj1365c knock out mutagenesis. 
 
 
 
 
Appendix 8.6: Plasmid pJH29 expresses cj1365c with its native RBS and a strong 
synthetic promoter. 
138 
 
 
Appendix 8.7: Plasmid pJH31 contains a Cm
R
 cassette flanked by genomic regions 
surrounding cj0238 used for cj0238 knock out mutagenesis. 
  
139 
 
List of References 
 
 
 
 
1. Robinson, D.A., Infective dose of Campylobacter jejuni in milk. Br Med J (Clin Res Ed), 1981. 
282(6276): p. 1584. 
2. Walderhaug, M. Bad Bug Book: Campylobacter jejuni.  1992  [cited 2008. 
3. Skirrow, M.B. and M. Blaser, Campylobacter jejuni, in Infections of the Gastrointestinal Tract, 
M. Blaser, et al., Editors. 1995, Raven Press: New York, New York. p. 825-848. 
4. Jones, F.S. and R.B. Little, The Etiology of Infectious Diarrhea (Winter Scours) in Cattle. J. Exp. 
Med., 1931. 53(6): p. 835-843. 
5. CDC. Campylobacter.  2008 May 21, 2008 [cited 2008; Available from: 
http://www.cdc.gov/nczved/dfbmd/disease_listing/campylobacter_gi.html. 
6. Doyle, M.P. and D.J. Roman, Sensitivity of Campylobacter jejuni to Drying. Journal of Food 
Protection, 1982. 45(6): p. 507-510. 
7. Nachamkin, I. and M.J. Blaser, Campylobacter. 2nd ed. 2000, Washington, D.C.: ASM Press. 
xxiii, 545 p. 
8. Sheppard, S.K., N.D. McCarthy, D. Falush, and M.C.J. Maiden, Convergence of Campylobacter 
Species: Implications for Bacterial Evolution. Science, 2008. 320(5873): p. 237-239. 
9. HPA, Campylobacter now the leading cause of general foodborne outbreaks in England and 
Wales. Health Protection Report, 2011. 5 (hpa.org.uk/hpr/archives/2011/hpr1911.pdf)(19). 
10. HPA, Infection Reports. Health Protection Report, 2012. 6 
(hpa.org.uk/hpr/archives/2012/hpr1512.pdf)(15). 
11. CDC, Foodborne Diseases Active Surveillance Network (FoodNet): FoodNet Surveillance Report 
for 2009 (Final Report). Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 
2011. 
12. Verhoeff-Bakkenes, L., R.R. Beumer, R. de Jonge, F.M. van Leusden, and A.E. de Jong, 
Quantification of Campylobacter jejuni cross-contamination via hands, cutlery, and cutting board 
during preparation of a chicken fruit salad. J Food Prot, 2008. 71(5): p. 1018-22. 
13. Altekruse, S.F., D.A. Street, S.B. Fein, and A.S. Levy, Consumer Knowledge of Foodborne 
Microbial Hazards and Food-Handling Practices. Journal of Food Protection, 1996. 59: p. 287-
294. 
14. Jay, S.L., D. Comar, and L.D. Govenlock, A National Australian Food Safety Telephone Survey. 
Journal of Food Protection, 1999. 62: p. 921-928. 
140 
 
15. Klontz, K.C., B. Timbo, S. Fein, and A. Levy, Prevalence of Selected Food Consumption and 
Preparation Behaviors Associated with Increased Risks of Food-borne Disease. Journal of Food 
Protection, 1995. 58: p. 927-930. 
16. Li-Cohen, A.E. and C.M. Bruhn, Safety of Consumer Handling of Fresh Produce from the Time of 
Purchase to the Plate: A Comprehensive Consumer Survey. Journal of Food Protection, 2002. 65: 
p. 1287-1296. 
17. Mitakakis, T.Z., M.I. Sinclair, C.K. Fairley, P.K. Lightbody, K. Leder, and M.E. Hellard, Food 
Safety in Family Homes in Melbourne, Australia. Journal of Food Protection, 2004. 67: p. 818-
822. 
18. Worsfold, D. and C.J. Griffith, Assessment of the Standard of Consumer Food Safety Behavior. 
Journal of Food Protection, 1997. 60: p. 399-406. 
19. Angelillo, I.F., M.R. Foresta, C. Scozzafava, and M. Pavia, Consumers and foodborne diseases: 
knowledge, attitudes and reported behavior in one region of Italy. International Journal of Food 
Microbiology, 2001. 64(1-2): p. 161-166. 
20. Chen, Y., K.M. Jackson, F.P. Chea, and D.W. Schaffner, Quantification and variability analysis of 
bacterial cross-contamination rates in common food service tasks. J Food Prot, 2001. 64(1): p. 72-
80. 
21. Cogan, T.A., S.F. Bloomfield, and T.J. Humphrey, The effectiveness of hygiene procedures for 
prevention of cross-contamination from chicken carcases in the domestic kitchen. Lett Appl 
Microbiol, 1999. 29(5): p. 354-8. 
22. Cogan, T.A., J. Slader, S.F. Bloomfield, and T.J. Humphrey, Achieving hygiene in the domestic 
kitchen: the effectiveness of commonly used cleaning procedures. J Appl Microbiol, 2002. 92(5): 
p. 885-92. 
23. Dawkins, H.C., F.J. Bolton, and D.N. Hutchinson, A Study of the Spread of Campylobacter jejuni 
in Four Large Kitchens. The Journal of Hygiene, 1984. 92(3): p. 357-364. 
24. Coates, D., D.N. Hutchinson, and F.J. Bolton, Survival of Thermophilic Campylobacters on 
Fingertips and Their Elimination by Washing and Disinfection. Epidemiology and Infection, 
1987. 99(2): p. 265-274. 
25. Blaser, M., J. Cravens, B.W. Powers, and W.L. Wang, Campylobacter enteritis associated with 
canine infection. Lancet, 1978. 2(8097): p. 979-81. 
26. Guerrant, R.L., R.G. Lahita, W.C. Winn, Jr., and R.B. Roberts, Campylobacteriosis in man: 
pathogenic mechanisms and review of 91 bloodstream infections. Am J Med, 1978. 65(4): p. 584-
92. 
27. Simor, A.E. and S. Ferro, Campylobacter jejuni infection occurring during pregnancy. Eur J Clin 
Microbiol Infect Dis, 1990. 9(2): p. 142-4. 
28. Black, R.E., M.M. Levine, M.L. Clements, T.P. Hughes, and M.J. Blaser, Experimental 
Campylobacter jejuni infection in humans. J Infect Dis, 1988. 157(3): p. 472-9. 
29. Young, V.B. and L.S. Mansfield, Campylobacter Infection - Clinical Context, in Campylobacter: 
Molecular and Cellular Biology, J.M. Ketley and M.E. Konkel, Editors. 2005, Horizon 
Bioscience: Wymondham, U.K. 
141 
 
30. Skirrow, M.B., D.M. Jones, E. Sutcliffe, and J. Benjamin, Campylobacter Bacteraemia in England 
and Wales, 1981-91. Epidemiology and Infection, 1993. 110(3): p. 567-573. 
31. Smith, G.S. and M.J. Blaser, Fatalities associated with Campylobacter jejuni infections. JAMA, 
1985. 253(19): p. 2873-2875. 
32. Youngs, E.R. and C. Roberts, Campylobacter carriage and pregnancy. Br J Obstet Gynaecol, 
1985. 92(5): p. 541-2. 
33. Wong, S.N., A.Y. Tam, and K.Y. Yuen, Campylobacter infection in the neonate: case report and 
review of the literature. Pediatr Infect Dis J, 1990. 9(9): p. 665-9. 
34. Moscuna, M., Z. Gross, R. Korenblum, M. Volfson, and M. Oettinger, Septic abortion due to 
Campylobacter jejuni. Eur J Clin Microbiol Infect Dis, 1989. 8(9): p. 800-1. 
35. Denton, K.J. and T. Clarke, Role of Campylobacter jejuni as a placental pathogen. J Clin Pathol, 
1992. 45(2): p. 171-172. 
36. Nachamkin, I., Chronic effects of Campylobacter infection. Microbes and Infection, 2002. 4(4): p. 
399-403. 
37. Thomas J. Koobatian, G.S.B.M.M.S.R.L.V., The use of hospital discharge data for public health 
surveillance of guillain-barré syndrome. Annals of Neurology, 1991. 30(4): p. 618-621. 
38. Lecuit, M., E. Abachin, A. Martin, C. Poyart, P. Pochart, F. Suarez, D. Bengoufa, J. Feuillard, A. 
Lavergne, J.I. Gordon, P. Berche, L. Guillevin, and O. Lortholary, Immunoproliferative Small 
Intestinal Disease Associated with Campylobacter jejuni. N Engl J Med, 2004. 350(3): p. 239-248. 
39. Mesnard, B., B.n.d. De Vroey, V. Maunoury, and M. Lecuit, A new case of immunoproliferative 
small intestinal disease associated with Campylobacter jejuni. Digestive and Liver Disease, 2012. 
In Press(0). 
40. Seligmann, M., F. Danon, D. Hurez, E. Mihaesco, and J.L. Preud'homme, Alpha-chain disease: a 
new immunoglobulin abnormality. Science, 1968. 162(860): p. 1396-7. 
41. Isaacson, P.G., A. Dogan, S.K. Price, and J. Spencer, Immunoproliferative small-intestinal 
disease. An immunohistochemical study. Am J Surg Pathol, 1989. 13(12): p. 1023-33. 
42. Wotherspoon, A.C., T.T. MacDonald, and J. Spencer, Gastrointestinal Lymphoma, in Mucosal 
Immunology, P.L. Ogra, et al., Editors. 1999, Academic Press: New York. p. 1025-1033. 
43. Wotherspoon, A.C., C. Ortiz-Hidalgo, M.R. Falzon, and P.G. Isaacson, Helicobacter pylori-
associated gastritis and primary B-cell gastric lymphoma. The Lancet, 1991. 338(8776): p. 1175-
1176. 
44. Kramer, J.M., J.A. Frost, F.J. Bolton, and D.R. Wareing, Campylobacter contamination of raw 
meat and poultry at retail sale: identification of multiple types and comparison with isolates from 
human infection. J Food Prot, 2000. 63(12): p. 1654-9. 
45. Cason, J.A., J.S. Bailey, N.J. Stern, A.D. Whittemore, and N.A. Cox, Relationship between 
aerobic bacteria, salmonellae and Campylobacter on broiler carcasses. Poult Sci, 1997. 76(7): p. 
1037-1041. 
142 
 
46. Burgess, F., C.L. Little, G. Allen, K. Williamson, and R.T. Mitchell, Prevalence of 
Campylobacter, Salmonella, and Escherichia coli on the External Packaging of Raw Meat. 
Journal of Food Protection, 2005. 68: p. 469-475. 
47. Fernando, U., D. Biswas, B. Allan, P. Willson, and A.A. Potter, Influence of Campylobacter jejuni 
fliA, rpoN and flgK genes on colonization of the chicken gut. International Journal of Food 
Microbiology, 2007. 118(2): p. 194-200. 
48. Hald, B., H. Skovgard, K. Pedersen, and H. Bunkenborg, Influxed Insects as Vectors for 
Campylobacter jejuni and Campylobacter coli in Danish Broiler Houses. Poult Sci, 2008. 87(7): 
p. 1428-34. 
49. Garin, B., M. Gouali, M. Wouafo, A.-M. Perchec, P.M. Thu, N. Ravaonindrina, F. Urbes, M. Gay, 
A. Diawara, A. Leclercq, J. Rocourt, and R. Pouillot, Prevalence, quantification and antimicrobial 
resistance of Campylobacter spp. on chicken neck-skins at points of slaughter in 5 major cities 
located on 4 continents. International Journal of Food Microbiology, 2012: p. In Press. 
50. Robinson, D.A. and D.M. Jones, Milk-borne campylobacter infection. Br Med J (Clin Res Ed), 
1981. 282(6273): p. 1374-6. 
51. Wood, R.C., K.L. MacDonald, and M.T. Osterholm, Campylobacter enteritis outbreaks 
associated with drinking raw milk during youth activities. A 10-year review of outbreaks in the 
United States. JAMA, 1992. 268(22): p. 3228-30. 
52. Mentzing, L.O., Waterborne outbreaks of campylobacter enteritis in central Sweden. Lancet, 
1981. 2(8242): p. 352-4. 
53. Vogt, R.L., H.E. Sours, T. Barret, T.A. Feldman, R.J. Dickinson, and L. Witherell, Campylobacter 
Enteritis Associated with Contaminated Water. Annals of Internal Medicine, 1982. 96(3): p. 292-
296. 
54. Taylor, D.N., K.T. McDermott, J.R. Little, J.G. Wells, and M.J. Blaser, Campylobacter Enteritis 
from Untreated Water in the Rocky Mountains. Annals of Internal Medicine, 1983. 99(1): p. 38. 
55. Kwan, P.S.L., M. Barrigas, F.J. Bolton, N.P. French, P. Gowland, R. Kemp, H. Leatherbarrow, M. 
Upton, and A.J. Fox, The Molecular Epidemiology of Campylobacter jejuni Populations in Dairy 
Cattle, Wildlife and the Environment in a Farmland Area. Appl. Environ. Microbiol., 2008: p. 
AEM.02198-07. 
56. Svedhem, A. and G. Norkrans, Campylobacter jejuni enteritis transmitted from cat to man. 
Lancet, 1980. 1(8170): p. 713-4. 
57. Wolfs, T.F., B. Duim, S.P. Geelen, A. Rigter, F. Thomson-Carter, A. Fleer, and J.A. Wagenaar, 
Neonatal sepsis by Campylobacter jejuni: genetically proven transmission from a household 
puppy. Clin Infect Dis, 2001. 32(5): p. E97-9. 
58. Blaser, M.J., R.J. Waldman, T. Barrett, and A.L. Erlandson, Outbreaks of Campylobacter enteritis 
in two extended families: evidence for person-to-person transmission. J Pediatr, 1981. 98(2): p. 
254-7. 
59. Axelsson-Olsson, D., J. Waldenstrom, T. Broman, B. Olsen, and M. Holmberg, Protozoan 
Acanthamoeba polyphaga as a Potential Reservoir for Campylobacter jejuni. Appl. Environ. 
Microbiol., 2005. 71(2): p. 987-992. 
143 
 
60. King, C.H., E.B. Shotts, Jr., R.E. Wooley, and K.G. Porter, Survival of coliforms and bacterial 
pathogens within protozoa during chlorination. Appl. Environ. Microbiol., 1988. 54(12): p. 3023-
3033. 
61. Snelling, W.J., N.J. Stern, C.J. Lowery, J.E. Moore, E. Gibbons, C. Baker, and J.S. Dooley, 
Colonization of broilers by Campylobacter jejuni internalized within Acanthamoeba castellanii. 
Arch Microbiol, 2008. 189(2): p. 175-9. 
62. Hu, L. and D.J. Kopecko, Campylobacter jejuni 81-176 Associates with Microtubules and Dynein 
during Invasion of Human Intestinal Cells. Infect. Immun., 1999. 67(8): p. 4171-4182. 
63. Konkel, M.E., J.D. Klena, V. Rivera-Amill, M.R. Monteville, D. Biswas, B. Raphael, and J. 
Mickelson, Secretion of Virulence Proteins from Campylobacter jejuni Is Dependent on a 
Functional Flagellar Export Apparatus. J. Bacteriol., 2004. 186(11): p. 3296-3303. 
64. Parkhill, J., B.W. Wren, K. Mungall, J.M. Ketley, C. Churcher, D. Basham, T. Chillingworth, 
R.M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A.V. Karlyshev, S. Moule, M.J. Pallen, C.W. 
Penn, M.A. Quail, M.A. Rajandream, K.M. Rutherford, A.H. van Vliet, S. Whitehead, and B.G. 
Barrell, The genome sequence of the food-borne pathogen Campylobacter jejuni reveals 
hypervariable sequences. Nature, 2000. 403(6770): p. 665-8. 
65. Oelschlaeger, T.A., P. Guerry, and D.J. Kopecko, Unusual microtubule-dependent endocytosis 
mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci U S 
A, 1993. 90(14): p. 6884-8. 
66. Kalischuk, L.D., G.D. Inglis, and A.G. Buret, Strain-dependent induction of epithelial cell oncosis 
by Campylobacter jejuni is correlated with invasion ability and is independent of cytolethal 
distending toxin. Microbiology, 2007. 153(9): p. 2952-2963. 
67. Majno, G. and I. Joris, Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol, 
1995. 146(1): p. 3-15. 
68. Karlyshev, A.V., J.M. Ketley, and B.W. Wren, The Campylobacter jejuni glycome. FEMS 
Microbiol Rev, 2005. 29(2): p. 377-90. 
69. Szymanski, C.M. and B.W. Wren, Protein glycosylation in bacterial mucosal pathogens. Nat Rev 
Microbiol, 2005. 3(3): p. 225-37. 
70. Szymanski, C.M., S.M. Logan, D. Linton, and B.W. Wren, Campylobacter--a tale of two protein 
glycosylation systems. Trends Microbiol, 2003. 11(5): p. 233 - 238. 
71. Hallet, B., Playing Dr Jekyll and Mr Hyde: combined mechanisms of phase variation in bacteria. 
Current Opinion in Microbiology, 2001. 4(5): p. 570-581. 
72. Moxon, R., C. Bayliss, and D. Hood, Bacterial Contingency Loci: The Role of Simple Sequence 
DNA Repeats in Bacterial Adaptation. Annual Review of Genetics, 2006. 40(1): p. 307-333. 
73. De Bolle, X., C.D. Bayliss, D. Field, T. Van De Ven, N.J. Saunders, D.W. Hood, and E.R. Moxon, 
The length of a tetranucleotide repeat tract in Haemophilus influenzae determines the phase 
variation rate of a gene with homology to type III DNA methyltransferases. Molecular 
Microbiology, 2000. 35(1): p. 211-222. 
74. Badger, J.L. and V.L. Miller, Expression of invasin and motility are coordinately regulated in 
Yersinia enterocolitica. J Bacteriol, 1998. 180(4): p. 793-800. 
144 
 
75. Grundling, A., L.S. Burrack, H.G. Bouwer, and D.E. Higgins, Listeria monocytogenes regulates 
flagellar motility gene expression through MogR, a transcriptional repressor required for 
virulence. Proc Natl Acad Sci U S A, 2004. 101(33): p. 12318-23. 
76. Schmitt, C.K., S.C. Darnell, V.L. Tesh, B.A. Stocker, and A.D. O'Brien, Mutation of flgM 
attenuates virulence of Salmonella typhimurium, and mutation of fliA represses the attenuated 
phenotype. J. Bacteriol., 1994. 176(2): p. 368-377. 
77. Allen-Vercoe, E. and M.J. Woodward, The Role of Flagella, But not Fimbriae, in the Adherence 
of Salmonella enterica Serotype Enteritidis to Chick Gut Explant. J Med Microbiol, 1999. 48(8): 
p. 771-780. 
78. Allen-Vercoe, E., A.R. Sayers, and M.J. Woodward, Virulence of Salmonella enterica serotype 
Enteritidis aflagellate and afimbriate mutants in a day-old chick model. Epidemiology and 
Infection, 1999. 122(03): p. 395-402. 
79. Eaton, K.A., D.R. Morgan, and S. Krakowka, Motility as a factor in the colonisation of 
gnotobiotic piglets by Helicobacter pylori. J Med Microbiol, 1992. 37(2): p. 123-127. 
80. Eaton, K., S. Suerbaum, C. Josenhans, and S. Krakowka, Colonization of gnotobiotic piglets by 
Helicobacter pylori deficient in two flagellin genes. Infect. Immun., 1996. 64(7): p. 2445-2448. 
81. Dietrich, C., K. Heuner, B.C. Brand, J. Hacker, and M. Steinert, Flagellum of Legionella 
pneumophila Positively Affects the Early Phase of Infection of Eukaryotic Host Cells. Infect. 
Immun., 2001. 69(4): p. 2116-2122. 
82. Leong, J.M., R.S. Fournier, and R.R. Isberg, Identification of the integrin binding domain of the 
Yersinia pseudotuberculosis invasin protein. EMBO J, 1990. 9(6): p. 1979-89. 
83. Isberg, R.R. and S. Falkow, A single genetic locus encoded by Yersinia pseudotuberculosis 
permits invasion of cultured animal cells by Escherichia coli K-12. Nature, 1985. 317(6034): p. 
262-4. 
84. Gaillard, J.L., P. Berche, C. Frehel, E. Gouin, and P. Cossart, Entry of L. monocytogenes into cells 
is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive 
cocci. Cell, 1991. 65(7): p. 1127-41. 
85. Tran Van Nhieu, G., A. Ben-Ze'ev, and P.J. Sansonetti, Modulation of bacterial entry into 
epithelial cells by association between vinculin and the Shigella IpaA invasin. EMBO J, 1997. 
16(10): p. 2717-29. 
86. Adam, T., M. Arpin, M.C. Prevost, P. Gounon, and P.J. Sansonetti, Cytoskeletal rearrangements 
and the functional role of T-plastin during entry of Shigella flexneri into HeLa cells. J Cell Biol, 
1995. 129(2): p. 367-81. 
87. Finlay, B., S. Ruschkowski, and S. Dedhar, Cytoskeletal rearrangements accompanying 
salmonella entry into epithelial cells. J Cell Sci, 1991. 99(2): p. 283-296. 
88. Francis, C.L., T.A. Ryan, B.D. Jones, S.J. Smith, and S. Falkow, Ruffles induced by Salmonella 
and other stimuli direct macropinocytosis of bacteria. Nature, 1993. 364(6438): p. 639-42. 
89. Hu, L., B.D. Tall, S.K. Curtis, and D.J. Kopecko, Enhanced Microscopic Definition of 
Campylobacter jejuni 81-176 Adherence to, Invasion into, Translocation across, and Exocytosis 
from Polarized Human Intestinal Caco-2 Cells. Infect. Immun., 2008: p. IAI.01408-07. 
145 
 
90. Hu, L., J.P. McDaniel, and D.J. Kopecko, Signal transduction events involved in human epithelial 
cell invasion by Campylobacter jejuni 81-176. Microbial Pathogenesis, 2006. 40(3): p. 91-100. 
91. Steele-Mortimer, O., S. Meresse, J.P. Gorvel, B.H. Toh, and B.B. Finlay, Biogenesis of 
Salmonella typhimurium-containing vacuoles in epithelial cells involves interactions with the 
early endocytic pathway. Cell Microbiol, 1999. 1(1): p. 33-49. 
92. Meresse, S., O. Steele-Mortimer, B.B. Finlay, and J.P. Gorvel, The rab7 GTPase controls the 
maturation of Salmonella typhimurium-containing vacuoles in HeLa cells. EMBO J, 1999. 18(16): 
p. 4394-403. 
93. Salcedo, S.P. and D.W. Holden, SseG, a virulence protein that targets Salmonella to the Golgi 
network. EMBO J, 2003. 22(19): p. 5003-14. 
94. Fauchere, J.L., A. Rosenau, M. Veron, E.N. Moyen, S. Richard, and A. Pfister, Association with 
HeLa cells of Campylobacter jejuni and Campylobacter coli isolated from human feces. Infect. 
Immun., 1986. 54(2): p. 283-287. 
95. Watson, R.O. and J.E. Galan, Campylobacter jejuni Survives within Epithelial Cells by Avoiding 
Delivery to Lysosomes. PLoS Pathogens, 2008. 4(1): p. e14. 
96. Geoffroy, C., J.L. Gaillard, J.E. Alouf, and P. Berche, Purification, characterization, and toxicity 
of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect. Immun., 
1987. 55(7): p. 1641-1646. 
97. Pistor, S., T. Chakraborty, K. Niebuhr, E. Domann, and J. Wehland, The ActA protein of Listeria 
monocytogenes acts as a nucleator inducing reorganization of the actin cytoskeleton. EMBO J, 
1994. 13(4): p. 758-63. 
98. Friederich, E., E. Gouin, R. Hellio, C. Kocks, P. Cossart, and D. Louvard, Targeting of Listeria 
monocytogenes ActA protein to the plasma membrane as a tool to dissect both actin-based cell 
morphogenesis and ActA function. EMBO J, 1995. 14(12): p. 2731-44. 
99. May, R.C., M.E. Hall, H.N. Higgs, T.D. Pollard, T. Chakraborty, J. Wehland, L.M. Machesky, 
and A.S. Sechi, The Arp2/3 complex is essential for the actin-based motility of Listeria 
monocytogenes. Current Biology, 1999. 9(14): p. 759-762. 
100. Gedde, M.M., D.E. Higgins, L.G. Tilney, and D.A. Portnoy, Role of listeriolysin O in cell-to-cell 
spread of Listeria monocytogenes. Infect Immun, 2000. 68(2): p. 999-1003. 
101. Lett, M.C., C. Sasakawa, N. Okada, T. Sakai, S. Makino, M. Yamada, K. Komatsu, and M. 
Yoshikawa, virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG 
protein and determination of the complete coding sequence. J Bacteriol, 1989. 171(1): p. 353-9. 
102. Suzuki, T., H. Miki, T. Takenawa, and C. Sasakawa, Neural Wiskott-Aldrich syndrome protein is 
implicated in the actin-based motility of Shigella flexneri. EMBO J, 1998. 17(10): p. 2767-76. 
103. Egile, C., T.P. Loisel, V. Laurent, R. Li, D. Pantaloni, P.J. Sansonetti, and M.-F. Carlier, 
Activation of the CDC42 Effector N-WASP by the Shigella flexneri IcsA Protein Promotes Actin 
Nucleation by Arp2/3 Complex and Bacterial Actin-based Motility. J. Cell Biol., 1999. 146(6): p. 
1319-1332. 
146 
 
104. Hilbi, H., J.E. Moss, D. Hersh, Y. Chen, J. Arondel, S. Banerjee, R.A. Flavell, J. Yuan, P.J. 
Sansonetti, and A. Zychlinsky, Shigella-induced Apoptosis Is Dependent on Caspase-1 Which 
Binds to IpaB. J. Biol. Chem., 1998. 273(49): p. 32895-32900. 
105. Hersh, D., D.M. Monack, M.R. Smith, N. Ghori, S. Falkow, and A. Zychlinsky, The Salmonella 
invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc Natl Acad Sci U S A, 
1999. 96(5): p. 2396-401. 
106. Muller, A., D. Gunther, F. Dux, M. Naumann, T.F. Meyer, and T. Rudel, Neisserial porin (PorB) 
causes rapid calcium influx in target cells and induces apoptosis by the activation of cysteine 
proteases. EMBO J, 1999. 18(2): p. 339-52. 
107. Pei, Z., C. Burucoa, B. Grignon, S. Baqar, X.Z. Huang, D.J. Kopecko, A.L. Bourgeois, J.L. 
Fauchere, and M.J. Blaser, Mutation in the peb1A locus of Campylobacter jejuni reduces 
interactions with epithelial cells and intestinal colonization of mice. Infect Immun, 1998. 66(3): p. 
938-43. 
108. Bacon, D.J., C.M. Szymanski, D.H. Burr, R.P. Silver, R.A. Alm, and P. Guerry, A phase-variable 
capsule is involved in virulence of Campylobacter jejuni 81-176. Mol. Microbiol., 2001. 40(3): p. 
769-777. 
109. Bacon, D.J., R.A. Alm, L. Hu, T.E. Hickey, C.P. Ewing, R.A. Batchelor, T.J. Trust, and P. Guerry, 
DNA sequence and mutational analyses of the pVir plasmid of Campylobacter jejuni 81-176. 
Infect Immun, 2002. 70(11): p. 6242-50. 
110. Javed, M.A., A.J. Grant, M.C. Bagnall, D.J. Maskell, D.G. Newell, and G. Manning, Transposon 
mutagenesis in a hyper-invasive clinical isolate of Campylobacter jejuni reveals a number of 
genes with potential roles in invasion. Microbiology, 2010. 156(4): p. 1134-1143. 
111. Hendrixson, D.R., B.J. Akerley, and V.J. DiRita, Transposon mutagenesis of Campylobacter 
jejuni identifies a bipartite energy taxis system required for motility. Mol Microbiol, 2001. 40(1): 
p. 214-24. 
112. Hensel, M., J.E. Shea, C. Gleeson, M.D. Jones, E. Dalton, and D.W. Holden, Simultaneous 
identification of bacterial virulence genes by negative selection. Science, 1995. 269(5222): p. 400-
3. 
113. Grant, A.J., C. Coward, M.A. Jones, C.A. Woodall, P.A. Barrow, and D.J. Maskell, Signature-
tagged transposon mutagenesis studies demonstrate the dynamic nature of cecal colonization of 2-
week-old chickens by Campylobacter jejuni. Appl. Environ. Microbiol., 2005. 71(12): p. 8031-41. 
114. Smirnov, M.N., V.N. Smirnov, E.I. Budowsky, S.G. Inge-Vechtomov, and N.G. Serebrjakov, Red 
pigment of adenine-deficient yeast Saccharomyces cerevisiae. Biochemical and Biophysical 
Research Communications, 1967. 27(3): p. 299-304. 
115. Reaume, S.E. and E.L. Tatum, Spontaneous and nitrogen mustard-induced nutritional deficiencies 
in Saccharomyces cerevisiae. Arch Biochem, 1949. 22(3): p. 331-8. 
116. Levine, R.A. and M.W. Taylor, Mechanism of adenine toxicity in Escherichia coli. Journal of 
Bacteriology, 1982. 149(3): p. 923-930. 
117. Bish, J.T. and A. Sarachek, Influences of Temperature and Adenine Concentration upon the 
Cultural Instability of a Red Adenine Auxotroph of Candida albicans. Mycologia, 1967. 59(4): p. 
671-688. 
147 
 
118. Ugolini, S. and C.V. Bruschi, The red/white colony color assay in the yeast Saccharomyces 
cerevisiae: epistatic growth advantage of white ade8-18, ade2 cells over red ade2 cells. Current 
Genetics, 1996. 30(6): p. 485-492. 
119. Meskauskas, A., V. Ksenzenko, M. Shlyapnikov, V. Kryukov, and D. Citavicius, 'Red pigment' 
from ADE-2 mutants of S. cerevisiae prevents DNA cleavage by restriction endonucleases. FEBS 
Letters, 1985. 182(2): p. 413-414. 
120. Cohen, H. and D.A. Sinclair, Recombination-mediated lengthening of terminal telomeric repeats 
requires the Sgs1 DNA helicase. Proceedings of the National Academy of Sciences, 2001. 98(6): 
p. 3174-3179. 
121. Bender, A. and J.R. Pringle, Use of a screen for synthetic lethal and multicopy suppressee mutants 
to identify two new genes involved in morphogenesis in Saccharomyces cerevisiae. Mol. Cell. 
Biol., 1991. 11(3): p. 1295-1305. 
122. Kramer, B., W. Kramer, M.S. Williamson, and S. Fogel, Heteroduplex DNA correction in 
Saccharomyces cerevisiae is mismatch specific and requires functional PMS genes. Mol. Cell. 
Biol., 1989. 9(10): p. 4432-4440. 
123. Wallis, J.W., G. Chrebet, G. Brodsky, M. Rolfe, and R. Rothstein, A hyper-recombination 
mutation in S. cerevisiae identifies a novel eukaryotic topoisomerase. Cell, 1989. 58(2): p. 409-
419. 
124. Kobayashi, T. and T. Horiuchi, A yeast gene product, Fob1 protein, required for both replication 
fork blocking and recombinational hotspot activities. Genes to Cells, 1996. 1(5): p. 465-474. 
125. Akakura, N., M. Kobayashi, I. Horiuchi, A. Suzuki, J. Wang, J. Chen, H. Niizeki, K.-i. 
Kawamura, M. Hosokawa, and M. Asaka, Constitutive Expression of Hypoxia-inducible Factor-
1alpha Renders Pancreatic Cancer Cells Resistant to Apoptosis Induced by Hypoxia and Nutrient 
Deprivation. Cancer Research, 2001. 61(17): p. 6548-6554. 
126. Hackett, J.A., D.M. Feldser, and C.W. Greider, Telomere Dysfunction Increases Mutation Rate 
and Genomic Instability. Cell, 2001. 106(3): p. 275-286. 
127. Sherman, F. and H. Roman, Evidence for two types of allelic recombination in yeast. Genetics, 
1963. 48: p. 255-61. 
128. Sandell, L.L. and V.A. Zakian, Loss of a yeast telomere: Arrest, recovery, and chromosome loss. 
Cell, 1993. 75(4): p. 729-739. 
129. Toffaletti, D.L., T.H. Rude, S.A. Johnston, D.T. Durack, and J.R. Perfect, Gene transfer in 
Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol., 1993. 175(5): p. 1405-
1411. 
130. Zan, Y., J.D. Haag, K.-S. Chen, L.A. Shepel, D. Wigington, Y.-R. Wang, R. Hu, C.C. Lopez-
Guajardo, H.L. Brose, K.I. Porter, R.A. Leonard, A.A. Hitt, S.L. Schommer, A.F. Elegbede, and 
M.N. Gould, Production of knockout rats using ENU mutagenesis and a yeast-based screening 
assay. Nat Biotech, 2003. 21(6): p. 645-651. 
131. Firmenich, A., M. Elias-Arnanz, and P. Berg, A novel allele of Saccharomyces cerevisiae RFA1 
that is deficient in recombination and repair and suppressible by RAD52. Mol. Cell. Biol., 1995. 
15(3): p. 1620-1631. 
148 
 
132. Hieter, P., C. Mann, M. Snyder, and R.W. Davis, Mitotic stability of yeast chromosomes: A colony 
color assay that measures nondisjunction and chromosome loss. Cell, 1985. 40(2): p. 381-392. 
133. Bai, Y. and L.S. Symington, A Rad52 homolog is required for RAD51-independent mitotic 
recombination in Saccharomyces cerevisiae. Genes & Development, 1996. 10(16): p. 2025-2037. 
134. Roberts, R.J., T. Vincze, J. Posfai, and D. Macelis, REBASE--a database for DNA restriction and 
modification: enzymes, genes and genomes. Nucleic Acids Res., 2010. 38(Database issue): p. 
D234-6. 
135. Arber, W. and D. Dussoix, Host specificity of DNA produced by Escherichia coli: I. Host 
controlled modification of bacteriophage lambda. Journal of Molecular Biology, 1962. 5(1): p. 
18-36. 
136. Bertani, G. and J.J. Weigle, Host Controlled Variation in Bacterial Viruses. Journal of 
Bacteriology, 1953. 65(2): p. 113-121. 
137. Smith, J.D., W. Arber, and U. KÃ¼hnlein, Host specificity of DNA produced by Escherichia coli: 
XIV. the role of nucleotide methylation in in vivo B-specific modification. Journal of Molecular 
Biology, 1972. 63(1): p. 1-8. 
138. Roberts, R.J., M. Belfort, T. Bestor, A.S. Bhagwat, T.A. Bickle, J. Bitinaite, R.M. Blumenthal, 
S.K. Degtyarev, D.T.F. Dryden, K. Dybvig, K. Firman, E.S. Gromova, R.I. Gumport, S.E. 
Halford, S. Hattman, J. Heitman, D.P. Hornby, A. Janulaitis, A. Jeltsch, J. Josephsen, A. Kiss, 
T.R. Klaenhammer, I. Kobayashi, H. Kong, D.H. Kruger, S. Lacks, M.G. Marinus, M. Miyahara, 
R.D. Morgan, N.E. Murray, V. Nagaraja, A. Piekarowicz, A. Pingoud, E. Raleigh, D.N. Rao, N. 
Reich, V.E. Repin, E.U. Selker, P.C. Shaw, D.C. Stein, B.L. Stoddard, W. Szybalski, T.A. 
Trautner, J.L. Van Etten, J.M.B. Vitor, G.G. Wilson, and S.y. Xu, A nomenclature for restriction 
enzymes, DNA methyltransferases, homing endonucleases and their genes. Nucleic Acids Res., 
2003. 31(7): p. 1805-1812. 
139. Dryden, D.T.F., N.E. Murray, and D.N. Rao, Nucleoside triphosphate-dependent restriction 
enzymes. Nucleic Acids Research, 2001. 29(18): p. 3728-3741. 
140. Murray, N.E., Type I Restriction Systems: Sophisticated Molecular Machines (a Legacy of Bertani 
and Weigle). Microbiol. Mol. Biol. Rev., 2000. 64(2): p. 412-434. 
141. Wilson, G.G. and N.E. Murray, Restriction and modification systems. Annu Rev Genet, 1991. 25: 
p. 585-627. 
142. Humbert, O. and N.R. Salama, The Helicobacter pylori HpyAXII restriction-modification system 
limits exogenous DNA uptake by targeting GTAC sites but shows asymmetric conservation of the 
DNA methyltransferase and restriction endonuclease components. Nucleic Acids Res, 2008. 
36(21): p. 6893-906. 
143. Gallagher, L.A., M. McKevitt, E.R. Ramage, and C. Manoil, Genetic Dissection of the Francisella 
novicida Restriction Barrier. J. Bacteriol., 2008. 190(23): p. 7830-7837. 
144. Keller, K.L., K.S. Bender, and J.D. Wall, Development of a markerless genetic exchange system 
for Desulfovibrio vulgaris Hildenborough and its use in generating a strain with increased 
transformation efficiency. Appl. Environ. Microbiol., 2009. 75(24): p. 7682-91. 
145. Dong, H., Y. Zhang, Z. Dai, and Y. Li, Engineering clostridium strain to accept unmethylated 
DNA. PLoS ONE, 2010. 5(2): p. e9038. 
149 
 
146. Kawabata, H., S.J. Norris, and H. Watanabe, BBE02 Disruption Mutants of Borrelia burgdorferi 
B31 Have a Highly Transformable, Infectious Phenotype. Infect. Immun., 2004. 72(12): p. 7147-
7154. 
147. Hobson, N., N. Price, J. Ward, and T. Raivio, Generation of a restriction minus enteropathogenic 
Escherichia coli E2348/69 strain that is efficiently transformed with large, low copy plasmids. 
BMC Microbiol., 2008. 8(1): p. 134. 
148. Elhai, J., A. Vepritskiy, A.M. Muro-Pastor, E. Flores, and C.P. Wolk, Reduction of conjugal 
transfer efficiency by three restriction activities of Anabaena sp. strain PCC 7120. J. Bacteriol., 
1997. 179(6): p. 1998-2005. 
149. Mermelstein, L.D. and E.T. Papoutsakis, In vivo methylation in Escherichia coli by the Bacillus 
subtilis phage phi 3T I methyltransferase to protect plasmids from restriction upon transformation 
of Clostridium acetobutylicum ATCC 824. Appl. Environ. Microbiol., 1993. 59(4): p. 1077-1081. 
150. Yasui, K., Y. Kano, K. Tanaka, K. Watanabe, M. Shimizu-Kadota, H. Yoshikawa, and T. Suzuki, 
Improvement of bacterial transformation efficiency using plasmid artificial modification. Nucleic 
Acids Res., 2009. 37(1): p. e3. 
151. Kim, J.Y., Y. Wang, M.S. Park, and G.E. Ji, Improvement of transformation efficiency through in 
vitro methylation and SacII site mutation of plasmid vector in Bifidobacterium longum MG1. J. 
Microbiol. Biotechnol., 2010. 20(6): p. 1022-6. 
152. Moser, D.P., D. Zarka, and T. Kallas, Characterization of a restriction barrier and 
electrotransformation of the cyanobacterium Nostoc PCC 7121. Arch. Microbiol., 1993. 160(3): 
p. 229-237. 
153. Donahue, J.P., D.A. Israel, R.M. Peek, M.J. Blaser, and G.G. Miller, Overcoming the restriction 
barrier to plasmid transformation of Helicobacter pylori. Mol. Microbiol., 2000. 37(5): p. 1066-
1074. 
154. Groot, M.N., F. Nieboer, and T. Abee, Enhanced Transformation Efficiency of Recalcitrant 
Bacillus cereus and Bacillus weihenstephanensis Isolates upon In Vitro Methylation of Plasmid 
DNA. Appl. Environ. Microbiol., 2008. 74(24): p. 7817-7820. 
155. Lee, S.Y., L.D. Mermelstein, G.N. Bennett, and E.T. Papoutsakis, Vector Construction, 
Transformation, and Gene Amplification in Clostridium acetobutylicum ATCC 824a. Ann. N. Y. 
Acad. Sci., 1992. 665(1): p. 39-51. 
156. Bayliss, C.D., F.A. Bidmos, A. Anjum, V.T. Manchev, R.L. Richards, J.-P. Grossier, K.G. 
Wooldridge, J.M. Ketley, P.A. Barrow, M.A. Jones, and M.V. Tretyakov, Phase variable genes of 
Campylobacter jejuni exhibit high mutation rates and specific mutational patterns but mutability 
is not the major determinant of population structure during host colonization. Nucleic Acids Res., 
2012. 
157. Kim, J.-S., J. Li, I.H.A. Barnes, D.A. Baltzegar, M. Pajaniappan, T.W. Cullen, M.S. Trent, C.M. 
Burns, and S.A. Thompson, Role of the Campylobacter jejuni Cj1461 DNA Methyltransferase in 
Regulating Virulence Characteristics. J. Bacteriol., 2008. 190(19): p. 6524-6529. 
158. Miller, W.G., B.M. Pearson, J.M. Wells, C.T. Parker, V.V. Kapitonov, and R.E. Mandrell, 
Diversity within the Campylobacter jejuni type I restriction-modification loci. Microbiology, 
2005. 151(Pt 2): p. 337-51. 
150 
 
159. Srikhanta, Y.N., K.L. Fox, and M.P. Jennings, The phasevarion: phase variation of type III DNA 
methyltransferases controls coordinated switching in multiple genes. Nat Rev Micro, 2010. 8(3): 
p. 196-206. 
160. Adamczyk-Poplawska, M., M. Lower, and A. Piekarowicz, Deletion of One Nucleotide within the 
Homonucleotide Tract Present in the hsdS Gene Alters the DNA Sequence Specificity of Type I 
Restriction-Modification System NgoAV. Journal of Bacteriology. 193(23): p. 6750-6759. 
161. Skoglund, A., B. Bjorkholm, C. Nilsson, A.F. Andersson, C. Jernberg, K. Schirwitz, C. Enroth, M. 
Krabbe, and L. Engstrand, Functional Analysis of the M.HpyAIV DNA Methyltransferase of 
Helicobacter pylori. Journal of Bacteriology, 2007. 189(24): p. 8914-8921. 
162. Srikhanta, Y.N., S.J. Dowideit, J.L. Edwards, M.L. Falsetta, H.J. Wu, O.B. Harrison, K.L. Fox, 
K.L. Seib, T.L. Maguire, A.H. Wang, M.C. Maiden, S.M. Grimmond, M.A. Apicella, and M.P. 
Jennings, Phasevarions mediate random switching of gene expression in pathogenic Neisseria. 
PLoS Pathog, 2009. 5(4): p. e1000400. 
163. de Vries, N., D. Duinsbergen, E.J. Kuipers, R.G.J. Pot, P. Wiesenekker, C.W. Penn, A.H.M. van 
Vliet, C.M.J.E. Vandenbroucke-Grauls, and J.G. Kusters, Transcriptional Phase Variation of a 
Type III Restriction-Modification System in Helicobacter pylori. Journal of Bacteriology, 2002. 
184(23): p. 6615-6623. 
164. Brocchi, M., A.T.R.d. Vasconcelos, and A. Zaha, Restriction-modification systems in Mycoplasma 
spp. Genetics and Molecular Biology, 2007. 30: p. 236-244. 
165. Fox, K.L., Y.N. Srikhanta, and M.P. Jennings, Phase variable type III restriction-modification 
systems of host-adapted bacterial pathogens. Molecular Microbiology, 2007. 65(6): p. 1375-1379. 
166. Larsen, R.A., M.M. Wilson, A.M. Guss, and W.W. Metcalf, Genetic analysis of pigment 
biosynthesis in Xanthobacter autotrophicus Py2 using a new, highly efficient transposon 
mutagenesis system that is functional in a wide variety of bacteria. Arch Microbiol, 2002. 178(3): 
p. 193-201. 
167. Harris, N.B., Z. Feng, X. Liu, S.L.G. Cirillo, J.D. Cirillo, and R.G. Barletta, Development of a 
transposon mutagenesis system for Mycobacterium avium subsp. paratuberculosis. FEMS 
Microbiology Letters, 1999. 175(1): p. 21-26. 
168. Maier, T.M., R. Pechous, M. Casey, T.C. Zahrt, and D.W. Frank, In Vivo Himar1-Based 
Transposon Mutagenesis of Francisella tularensis. Applied and Environmental Microbiology, 
2006. 72(3): p. 1878-1885. 
169. Akerley, B.J., E.J. Rubin, A. Camilli, D.J. Lampe, H.M. Robertson, and J.J. Mekalanos, 
Systematic identification of essential genes by in vitro mariner mutagenesis. Proceedings of the 
National Academy of Sciences, 1998. 95(15): p. 8927-8932. 
170. Rubin, E.J., B.J. Akerley, V.N. Novik, D.J. Lampe, R.N. Husson, and J.J. Mekalanos, In vivo 
transposition of mariner-based elements in enteric bacteria and mycobacteria. Proceedings of the 
National Academy of Sciences, 1999. 96(4): p. 1645-1650. 
171. Hendrixson, D.R. and V.J. DiRita, Identification of Campylobacter jejuni genes involved in 
commensal colonization of the chick gastrointestinal tract. Mol Microbiol, 2004. 52(2): p. 471-84. 
172. Datsenko, K.A. and B.L. Wanner, One-step inactivation of chromosomal genes in Escherichia coli 
K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A., 2000. 97(12): p. 6640-5. 
151 
 
173. Gaynor, E.C., S. Cawthraw, G. Manning, J.K. MacKichan, S. Falkow, and D.G. Newell, The 
Genome-Sequenced Variant of Campylobacter jejuni NCTC 11168 and the Original Clonal 
Clinical Isolate Differ Markedly in Colonization, Gene Expression, and Virulence-Associated 
Phenotypes. J. Bacteriol., 2004. 186(2): p. 503-517. 
174. Skirrow, M.B., Campylobacter enteritis: a "new" disease. Br Med J, 1977. 2(6078): p. 9-11. 
175. Yanisch-Perron, C., J. Vieira, and J. Messing, Improved M13 phage cloning vectors and host 
strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene, 1985. 33(1): p. 103-119. 
176. Akerley, B.J. and D.J. Lampe, Analysis of gene function in bacterial pathogens by GAMBIT, in 
Meth. Enzymol. 2002, Academic Press. p. 100-108. 
177. Yao, R., R.A. Alm, T.J. Trust, and P. Guerry, Construction of new Campylobacter cloning vectors 
and a new mutational cat cassette. Gene, 1993. 130(1): p. 127-130. 
178. Lampe, D.J., B.J. Akerley, E.J. Rubin, J.J. Mekalanos, and H.M. Robertson, Hyperactive 
transposase mutants of the Himar1 mariner transposon. Proc. Natl. Acad. Sci. U.S.A., 1999. 
96(20): p. 11428-11433. 
179. Van Vliet, A.H., A.C. Wood, J. Henderson, K.G. Wooldridge, and J. Ketley, Genetic 
Manipulation of Enteric Campylobacter Species, in Bacterial Pathogenesis, P.H. Williams, J. 
Ketley, and G. Salmond, Editors. 1998, Academic Press: San Diego. p. 407-419. 
180. Rozen, S. and H. Skaletsky, Primer3 on the WWW for general users and for biologist 
programmers. Methods Mol Biol, 2000. 132: p. 365-86. 
181. Coward, C., A.J. Grant, C. Swift, J. Philp, R. Towler, M. Heydarian, J.A. Frost, and D.J. Maskell, 
Phase-Variable Surface Structures Are Required for Infection of Campylobacter jejuni by 
Bacteriophages. Appl. Environ. Microbiol., 2006. 72(7): p. 4638-4647. 
182. Colegio, O.R., T.J. Griffin, IV, N.D.F. Grindley, and J.E. Galan, In Vitro Transposition System for 
Efficient Generation of Random Mutants of Campylobacter jejuni. J. Bacteriol., 2001. 183(7): p. 
2384-2388. 
183. Datsenko, K.A. and B.L. Wanner, One-step inactivation of chromosomal genes in Escherichia coli 
K-12 using PCR products. Proc. Natl. Acad. Sci. U.S.A., 2000. 97(12): p. 6640-6645. 
184. Miller, W.G., A.H. Bates, S.T. Horn, M.T. Brandl, M.R. Wachtel, and R.E. Mandrell, Detection 
on Surfaces and in Caco-2 Cells of Campylobacter jejuni Cells Transformed with New gfp, yfp, 
and cfp Marker Plasmids. Appl. Environ. Microbiol., 2000. 66(12): p. 5426-5436. 
185. Hansen, C.R., A. Khatiwara, R. Ziprin, and Y.M. Kwon, Rapid construction of Campylobacter 
jejuni deletion mutants. Lett. Appl. Microbiol., 2007. 45(6): p. 599-603. 
186. Larkin, M.A., G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. 
Valentin, I.M. Wallace, A. Wilm, R. Lopez, J.D. Thompson, T.J. Gibson, and D.G. Higgins, 
Clustal W and Clustal X version 2.0. Bioinformatics, 2007. 23(21): p. 2947-8. 
187. Goujon, M., H. McWilliam, W. Li, F. Valentin, S. Squizzato, J. Paern, and R. Lopez, A new 
bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res, 2010. 38(Web Server 
issue): p. W695-9. 
152 
 
188. Alazzam, B., S. Bonnassie-Rouxin, V. Dufour, and G. Ermel, MCLMAN, a new minimal medium 
for Campylobacter jejuni NCTC 11168. Res Microbiol, 2011. 162(2): p. 173-9. 
189. MeÅ¡kauskas, A., V. Ksenzenko, M. Shlyapnikov, V. Kryukov, and D. ÄŒitaviÄ•ius, â€˜Red 
pigmentâ€™ from ADE-2 mutants of S. cerevisiae prevents DNA cleavage by restriction 
endonucleases. FEBS Letters, 1985. 182(2): p. 413-414. 
190. Hendrixson, D.R., A phase-variable mechanism controlling the Campylobacter jejuni FlgR 
response regulator influences commensalism. Mol. Microbiol., 2006. 61(6): p. 1646-1659. 
191. Hendrixson, D.R., Restoration of flagellar biosynthesis by varied mutational events in 
Campylobacter jejuni. Mol. Microbiol., 2008. 70(2): p. 519-536. 
192. Sorensen, M.C.H., L.B. van Alphen, A. Harboe, J. Li, B.B. Christensen, C.M. Szymanski, and L. 
Brondsted, Bacteriophage F336 Recognizes the Capsular Phosphoramidate Modification of 
Campylobacter jejuni NCTC11168. J. Bacteriol., 2011. 193(23): p. 6742-6749. 
193. Jeltsch, A., Maintenance of species identity and controlling speciation of bacteria: a new function 
for restriction/modification systems? Gene, 2003. 317(0): p. 13-16. 
194. Tock, M.R. and D.T.F. Dryden, The biology of restriction and anti-restriction. Curr. Opin. 
Microbiol., 2005. 8(4): p. 466-472. 
195. Wang, Y. and D.E. Taylor, Natural transformation in Campylobacter species. J. Bacteriol., 1990. 
172(2): p. 949-955. 
196. Hitchen, P., J. Brzostek, M. Panico, J.A. Butler, H.R. Morris, A. Dell, and D. Linton, Modification 
of the Campylobacter jejuni flagellin glycan by the product of the Cj1295 homopolymeric-tract-
containing gene. Microbiology, 2010. 156(7): p. 1953-1962. 
197. Thomas, M.T., M. Shepherd, R.K. Poole, A.H.M. van Vliet, D.J. Kelly, and B.M. Pearson, Two 
respiratory enzyme systems in Campylobacter jejuni NCTC 11168 contribute to growth on l-
lactate. Environ. Microbiol., 2011. 13(1): p. 48-61. 
198. Miller, C.E., J.D. Rock, K.A. Ridley, P.H. Williams, and J.M. Ketley, Utilization of Lactoferrin-
Bound and Transferrin-Bound Iron by Campylobacter jejuni. J. Bacteriol., 2008. 190(6): p. 1900-
1911. 
199. Holmes, C.W., C.W. Penn, and P.A. Lund, The hrcA and hspR regulons of Campylobacter jejuni. 
Microbiology, 2010. 156(1): p. 158-166. 
200. Karlyshev, A.V. and B.W. Wren, Development and Application of an Insertional System for Gene 
Delivery and Expression in Campylobacter jejuni. Appl. Environ. Microbiol., 2005. 71(7): p. 
4004-4013. 
201. Gundogdu, O., S. Bentley, M. Holden, J. Parkhill, N. Dorrell, and B. Wren, Re-annotation and re-
analysis of the Campylobacter jejuni NCTC11168 genome sequence. BMC Genomics, 2007. 8(1): 
p. 162. 
202. Pearson, B.M., D.J.H. Gaskin, R.P.A.M. Segers, J.M. Wells, P.J.M. Nuijten, and A.H.M. van 
Vliet, The Complete Genome Sequence of Campylobacter jejuni Strain 81116 (NCTC11828). J. 
Bacteriol., 2007. 189(22): p. 8402-8403. 
153 
 
203. Hofreuter, D., J. Tsai, R.O. Watson, V. Novik, B. Altman, M. Benitez, C. Clark, C. Perbost, T. 
Jarvie, L. Du, and J.E. Galan, Unique Features of a Highly Pathogenic Campylobacter jejuni 
Strain. Infect. Immun., 2006. 74(8): p. 4694-4707. 
204. Korlath, J.A., M.T. Osterholm, L.A. Judy, J.C. Forfang, and R.A. Robinson, A Point-Source 
Outbreak of Campylobacteriosis Associated with Consumption of Raw Milk. J. Infect. Dis., 1985. 
152(3): p. 592-596. 
205. Frazer, K.A., L. Pachter, A. Poliakov, E.M. Rubin, and I. Dubchak, VISTA: computational tools 
for comparative genomics. Nucleic Acids Res., 2004. 32(suppl 2): p. W273-W279. 
206. Mayor, C., M. Brudno, J.R. Schwartz, A. Poliakov, E.M. Rubin, K.A. Frazer, L.S. Pachter, and I. 
Dubchak, VISTA : visualizing global DNA sequence alignments of arbitrary length. 
Bioinformatics, 2000. 16(11): p. 1046-1047. 
207. Punta, M., P.C. Coggill, R.Y. Eberhardt, J. Mistry, J. Tate, C. Boursnell, N. Pang, K. Forslund, G. 
Ceric, J. Clements, A. Heger, L. Holm, E.L.L. Sonnhammer, S.R. Eddy, A. Bateman, and R.D. 
Finn, The Pfam protein families database. Nucleic Acids Res., 2012. 40(D1): p. D290-D301. 
208. Altschul, S.F., T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman, 
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl. 
Acids Res., 1997. 25(17): p. 3389-3402. 
209. Takamiya, M., A. Ozen, M. Rasmussen, T. Alter, T. Gilbert, D.W. Ussery, and S. Knochel, 
Genome Sequences of Two Stress-Tolerant Campylobacter jejuni Poultry Strains, 305 and 
DFVF1099. J. Bacteriol., 2011. 193(19): p. 5546-5547. 
210. Baserisalehi, M. and N. Bahador, A Study on Relationship of Plasmid with Antibiotic Resistance in 
Thermophilic Campylobacter spp. Isolates from Environmental Samples. Biotechnology, 2008. 
7(4): p. 813-817. 
211. Poly, F., T. Read, D.R. Tribble, S. Baqar, M. Lorenzo, and P. Guerry, Genome Sequence of a 
Clinical Isolate of Campylobacter jejuni from Thailand. Infect. Immun., 2007. 75(7): p. 3425-
3433. 
212. Furuta, Y., K. Abe, and I. Kobayashi, Genome comparison and context analysis reveals putative 
mobile forms of restriction-modification systems and related rearrangements. Nucleic Acids Res., 
2010. 38(7): p. 2428-43. 
 
 
  
154 
 
Vita 
Jeffrey Paul Holt born July 19
th
, 1979 in Media, PA attended Ohio University from 1997 
to 2002 receiving a Bachelor of Science degree in microbiology with minors in computer 
science and chemistry.  In 1999 he began working at the Salmonella Reference Center at 
the University of Pennsylvania under Dr. Charles Benson and Dr. Shelley Rankin.  Here 
he performed research on Salmonella, Pseudomonas, and Staphylococcus on a variety of 
topics as well as serotyping, phage typing and molecularly characterizing isolates 
submitted to the center.  In parallel with some of this work he performed research under 
Dr. Dean Richardson also at the University of Pennsylvania on gene therapy 
methodologies for joint injuries and conditions.  During this time at the University of 
Pennsylvania Jeffrey attended classes part time and in 2007 received his Master of 
Biotechnology degree.  He then attended Drexel University under Dr. Jennifer Quinlan in 
the Department of Biology performing research on Campylobacter jejuni genetics and 
virulence where he received his Ph.D. in 2012.  During this time he taught microbiology 
and biology laboratory classes, and currently has papers submitted and in preparation 
titled: “Cj1051c is a Major Determinant for the Restriction Barrier of Campylobacter 
jejuni Strain NCTC11168”, “Identification and characterization of a novel virulence 
associated red phenotype in Campylobacter jejuni” and “Development of a detection 
system and independent validation of the Campylobacter jejuni signature tagged 
mutagenesis system.” 
 
